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Expressionsanalyse von regulierenden MircoRNA im bovinen Kumulus-Oocyten 
Komplex und präimplantierten Embryonen 
 
MicroRNAs (miRNAs) sind kleine nicht-kodierende endogene Moleküle, die an der 
post-trankriptionellen Genregulierung beteiligt sind. Diese kleinen RNAs sind an einer 
Reihe von biologischen Prozessen, wie Entwicklung, Zelldifferenzierung, 
Zellproliferation und Apoptose in verschiedenen Organismen, involviert. Jedoch ist 
bisher nur wenig über ihre Rolle in bovinen zellen und umgebenden Kumuluszellen 
während der Eizellenentwicklung bekannt. Um dieses aufzuklären, untersuchten wir die 
relativen Expressionsmuster zwischen bovinen Eizellen und den umgebenden 
Kumuluszellen während der in vitro Maturation. Die Expressionsmuster eines Sets von 
88 miRNAs wurden mittels eines miRNA PCR Arrays für humane Zellentwicklung 
und-differenzierung erfasst. Die Ergebnisse zeigten, dass insgesamt 47 bzw. 51 
miRNAs unterschiedlich zwischen immaturen (GV) bzw. reifen Eizellen (MII) und 
ihren umgebenden Kumuluszellen exprimiert waren (p ≤ 0.05, fold change ≥2). Dabei 
wurden 8 bzw. 6 miRNAs stärker in den Kumuluszellen exprimiert beim Vergleich von 
Eizellen im reifen bzw. unreifen Stadium. Weitere Expressionsanalysen wurden von 
sechs ausgewählten miRNAs (miR-205, -150, -122, -96, -146a und 146b-5p) in bovinen 
Embryonen des Präimplantationsstadiums durchgeführt, da diese in Eizellen 
angereichert auftraten. Die Ergebnisse zeigten, dass die Expression dieser miRNAs 
stark erhöht in frühen Stadien der Embryonalentwicklung und reduziert nach dem 8- 
Zellen-Stadium. Zu beobachten waren bis zum Blastozysten Stadium folgten die 
Embryonen den typischen maternalen Transkriptionsmustern. Vergleichbare Ergebnisse 
wurden bei der in situ Lokalisierung von miR-205 in Embryonen des 
Präimplantationsstadiums beobachtet. Leider zeigten die ausgewählten miRNAs (miR- 
210 und miR-452), die in Kumuluszellen vermehrt exprimiert waren, kein definiertes 
Profil. Die gleichen acht miRNAs wurden in einer hohen Menge in voll 
ausgewachsenen Eizellen (BCB+) im Vergleich zu noch wachsenden Eizellen (BCB-) 
detektiert. Interessanterweise konnte beobachtet werden, dass die Präsenz oder 
Abwesenheit von Eizelle oder Kumuluszellen während der Maturation einen Einfluss 
auf die Expression der ausgewählten miRNAs in den entsprechenden Zelltypen hatte. 
Des Weiteren wurden miR-205 und miR-210 in situ in Follikeln lokalisiert und zeigten 
eine raum-zeitliche Expression während der Follikelentwicklung. Unsere Ergebnisse 
zeigen die Präsenz einer definierten Gruppe von miRNAs in Eizellen und 
Kumuluszellen, welch möglicherweise eine Rolle in der Regulation der bidirektionellen 
Kommunikation zwischen diesen zwei Zelltypen spielen. 
 
 
Expression analysis of regulatory MicroRNA in bovine cumulus oocyte 
complex and preimplantation embryos 
 
MicroRNAs (miRNAs) are small non coding endogenous molecules which participate 
in gene regulation post transcriptionally. These small RNAs are shown to be involved in 
a wide range of biological processes including development, cell differentiation, cell 
proliferation, and apoptosis in diverse organisms. However, little is known about their 
abundance in bovine oocytes and their surrounding cumulus cells during oocyte 
development. To elucidate this, we investigated the relative expression pattern of a set 
of 88 miRNAs between bovine oocytes and the surrounding cumulus cells during in 
vitro maturation, using miRNA PCR array related to human cell development and 
differentiation. Results revealed a total of 47 and 51 miRNAs to be differentially 
expressed (p ≤ 0.05 and fold change ≥ 2) between immature (GV) and matured (MII) 
oocytes, respectively compared to their surrounding cumulus cells. However, 8 and 6 
miRNAs were found to be highly abundant in cumulus cells compared to oocytes at 
immature and matured stages, respectively. The expression analysis of six oocytes 
enriched miRNAs (miR-205, -150, -122, -96, -146a and -146b-5p) in bovine 
preimplantation embryo stages was performed. Results showed that expression of these 
miRNAs were highly abundant in early stages of embryo development and reduced after 
8-cell until the blastocyst stage following a typical maternal transcript profile. 
Comparable results were obtained by in situ localization of miR-205 in preimplantation 
embryo stages. However, the two selected miRNAs enriched in cumulus cells (miR-210 
and miR-452) showed no defined profile. The same eight miRNAs were detected at 
high level in fully grown oocyte (BCB+) compared to growing one (BCB-). 
Interestingly, the presence or absence of oocytes or cumulus cells during maturation 
was found to affect the expression of selected miRNAs in each of the two cell types. 
Furthermore, miR-205 and miR-210 were in situ localized in ovarian follicle and 
revealed a spatio-temporal expression during follicular development. Hence, our results 
evidenced the presence of distinct set of miRNAs in oocytes and cumulus cells which 
may have potential role in regulation of bidirectional communication between the two 
cell types. Moreover, maternal miRNAs were found to persist until the major genome 
activation in bovine. 
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Introduction 1 
1 Introduction 
 
Bidirectional communication between oocytes and cumulus cells is essential for proper 
maturation of oocytes, fertilization and further embryonic development (Buccione et al. 
1990; Eppig 1991; Matzuk et al. 2002). During oocyte maturation, the cumulus cells 
provide a network of gap junction transmembrane channels that allows the transport of 
nutrient, regulatory molecules and paracrine factors between oocytes and cumulus cells 
to promote the nuclear and cytoplasmic maturation of oocyte and acquisition of 
developmental competence (Eppig 1991; Gilchrist et al. 2004; Grazul-Bilska et al. 
1997; Tanghe et al. 2002). This has been evidenced from removal of cumulus cells 
before maturation whereby the oocyte maturation was suppressed (Assidi et al. 2008; 
Fatehi et al. 2002; Vozzi et al. 2001; Wongsrikeao et al. 2005). On the other hand, the 
oocyte, through its secreted paracrine growth factors, play an important role in 
regulating the proliferation and differentiation of granulosa cells into two 
phenotypically and functionally distinct subtypes namely, cumulus granulosa cells and 
mural granulosa cells (Eppig et al. 1997; Li et al. 2000). Furthermore, oocytes secreted 
factors (OSFs) are believed to regulate key cumulus cell functions which in turn 
enhance positive regulatory factors that are required during subsequent development of 
the oocytes (Sugiura et al. 2005). Therefore, the bidirectional communication between 
oocyte and their surrounding cumulus cells is essential for oocyte and cumulus cells 
development during folliculogenesis.  
 
Oocytes are known to have high transcriptional activity in the germinal vesicle (GV) 
stage leading to the metaphase II (MII). The stored mRNAs and proteins in the oocyte 
support the early embryogenesis following fertilization (Dalbies-Tran and Mermillod 
2003; Fulka et al. 1998; Vallee et al. 2005). However, as development proceeds and 
maternally inherited informational molecules decay, early embryogenesis becomes 
dependent on the expression of genetic information from the embryonic genome 
(Telford et al. 1990). The dynamic change in transcript abundance before and after in 
vitro maturation of bovine oocytes has been documented underlying the tight temporal 
control of gene expression required for oocyte maturation, fertilization and early 
embryo development (Dalbies-Tran and Mermillod 2003; Fair et al. 2007). Recently, it 
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has been postulated that the mRNA storage and translations are post transcriptionally 
under the control of non coding regulatory small RNAs mainly microRNAs. 
 
MicroRNAs (miRNAs), the key regulator of many biological function, are small 
noncoding RNAs (~18-22 nt) that originate from endogenous hairpin transcripts called 
primary miRNA (pri-miRNA) which processed by the RNase III Drosha in the nucleus 
before being exported as ~70-nucleotide precursor miRNA (pre-miRNA) to the 
cytoplasme, where further processed by another RNase, Dicer, into mature double-
stranded miRNA (van den Berg et al. 2008). One strand of this matured miRNA 
incorporated into the RNA-induced silencing complex (RISC), where it acts as a guide 
to mediate their targets messages either by translational repression or/and mRNA decay 
via a deadenylation and decapping mechanism (Behm-Ansmant and Izaurralde 2006; 
Giraldez et al. 2006; Wu et al. 2006). Although under certain conditions, miRNAs have 
been reported to induce gene expression (Vasudevan et al. 2007). Similar to mRNA, 
miRNAs have been reported to show a dynamic change during oocyte maturation in 
bovine (Tesfaye et al. 2009), mouse and human (Tang et al. 2007; Xu et al. 2011a). 
Furthermore, the presence of regulatory miRNAs has been reported in oocytes and 
numerous reproductive tissues (Carletti and Christenson 2009; Creighton et al. 2010; 
Hong et al. 2008; Murchison et al. 2007; Nagaraja et al. 2008). In addition, disruption of 
Dicer (a polymerase II enzyme responsible for miRNA processing) in mouse oocytes 
was found to be result in defects in meiotic spindle organization and chromosome 
congression, reduced maturation rate and reduced the transcripts of Dicer miRNAs (Liu 
et al. 2010; Murchison et al. 2007).  
 
Apart from oocytes, miRNAs have been identified in embryo of mice, cow and human 
(Coutinho et al. 2007; Cui et al. 2009; McCallie et al. 2010). The role of miRNAs in 
early embryo development and maternal-to-zygotic transition has been reported, where 
loss of maternal miRNAs by specific deletion of Dicer results in an arrest of zygotic 
development in mice (Tang et al. 2007) and a specific miRNA such as miR-430 and 
miR-427, has been shown to be responsible of the degradation of many maternal 
mRNAs in zebrafish and xenopus laevis embryos, respectively (Giraldez et al. 2006; 
Lund et al. 2009). Recently, the expression pattern of miR-196a in bovine 
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preimplantation embryo stages indicated the involvement of this miRNA in maternal 
transcript degradation during maternal-to-zygotic transition (Tripurani et al. 2011).  
 
Although, the accumulating evidences support the notion of potential role of these non 
coding miRNAs in post transcriptional regulation of genes involved in various aspects 
of mammalian reproduction, so far little is known about the distinct abundance of 
miRNAs in bovine oocyte and its surrounding cumulus cells before and after oocyte 
maturation. Therefore, the objectives of the present study were: 1) To identify 
differentially expressed miRNAs in bovine oocytes and surrounding cumulus cells at 
immature or germinal vesicle (GV) and matured or metaphase II (MII) stages, 2) To 
characterize the expression pattern of selected oocyte and cumulus cells enriched 
miRNAs and their predicted target genes in bovine preimplantation embryo stages, 3) 
To investigate the association of the expression of selected miRNAs with oocytes 
developmental potential, 4) To reveal the effect of presence or absence of oocyte or 
cumulus cells during maturation on the expression of selected miRNAs in either of the 
two cell types and 5) To identify spatio-temporal expression of two selected miRNAs in 
ovarian sections, COCs and bovine preimplantation embryo stages.  
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2 Literature review 
 
2. 1 Oogenesis and folliculogenesis 
 
Oogenesis is the process of oocyte formation involves several steps including 
primordial germ cell formation, migration to the gonads and differentiation into 
oogonia, followed by the initiation of meiosis and subsequent arrest at the diplotene 
stage during prophase I (van den Hurk and Zhao 2005). When the bovine embryo is 
about 15 mm in length, the primordial germ cells (precursors of the oocyte) migrated by 
amoeboid movement from the epithelium of the yolk sac via the dorsal mesentery of the 
hindgut to the genital ridges located at the ventral sides of the mesonephroi (Gordon 
2003a; Smitz and Cortvrindt 2002). The primordial germ cells in female fetal gonads 
expand the population of germ cells through a high frequency of mitotic division and 
eventually undergo one last round of DNA replication, before entering meiosis and 
becoming oocytes (Gosden and Bownes 1995). The onset of oocyte first meiotic 
division occurs between days 75 and 80 of pregnancy in cattle (Erickson 1966). The 
oocyte passes through leptotene, zygotene, pachytene and arrested at diplotene stage. 
During this time the transcription level become nearly undetectable by early pachytene 
while its higher at the diplotene stage (Picton et al. 1998). 
 
Folliculogenesis is the developmental process in which an activated primordial follicle 
develops to a preovulatory follicle following the growth and differentiation of the 
oocyte and its surrounding granulosa cells (Gougeon 1996; Knight and Glister 2001; 
Senger 1997). During folliculogenesis, a follicle may be classified as primordial, 
primary, secondary or tertiary (Figure 2.1) (Pedersen and Peters 1968). This 
classification is based on the size of oocyte, the morphology of granulosa cells, and the 
number of granulosa cell layers surrounding the oocyte (Braw-Tal and Yossefi 1997; 
Lussier et al. 1987). It’s accepted that folliculogenesis in bovine occur during fetal 
development. Once oocytes reaching to diplotene stage of prophase I, it’s surrounded by 
a single layer of squamous pre-granulosa cells resting on a basement membrane and 
forming the non-growing or primordial follicle (Baker and Hunter 1978; Picton et al. 
1998). The large population of non-growing primordial follicles serves as the source of 
developing follicles and oocytes until the end of a female’s reproductive life, when 
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granulosa cells surrounding the oocytes become cuboidal and the oocyte begin its 
extensive growth phase, the primordial follicles are transformed into primary follicles 
(Eppig 2001; van Wezel and Rodgers 1996). Progression to the secondary follicle stage 
also known as preantral follicle or growing follicle is characterized by the appearance of 
a second layer of granulosa cells, increased oocyte diameter (Driancourt 1991; Hyttel et 
al. 1997), zona pellucida and cortical granule formation, development of gap junction 
between oocyte and granulosa cell which may serve both to maintain meiotic arrest and 
oocyte growth (Braw-Tal and Yossefi 1997; Fair et al. 1997a), first detectable signs of 
oocyte RNA synthesis (Fair et al. 1997b) and gonadotrophin responsiveness where the 
follicular stimulating hormone (FSH) receptor mRNA expression has been detected in 
follicles with one to two layers of granulosa cells in cattle (Bao and Garverick 1998; 
Fair 2003; Xu et al. 1995). Development beyond the early antral follicle stage is clearly 
dependent upon gonadotrophins, antral follicles are sometimes called tertiary follicles 
and well developed antral follicles are often referred to as Graafian follicle (Eppig 
2001). The transition to antral follicle characterized by formation of antrum which is 
fluid filled cavity surrounded by multiple layer of granulosa cells, this fluid contain 
important regulatory substance to be delivered to oocyte (Braw-Tal and Yossefi 1997; 
Eppig 2001; Lussier et al. 1987). After antrum formation, granulosa cells are divided 
into two distinct subtypes, the cumulus granulosa surrounding and in intimate metabolic 
contact with the oocyte forming a structure called cumulus oocyte complex (COC) and 
the mural granulosa lining the follicle wall and adjacent to the basal lamina, the mural 
granulosa cells nearest the antrum are called periantral granulosa cells (Eppig 2001). 
Finally, in response to preovulatory gonadotrophins surge, two marked events occur in 
cumulus oocyte complex (Figure 2.1) : 1- The fully grown oocyte (GV) resume meiosis 
to complete first meiotic division via germinal vesicle break down (GVBD), chromatin 
re-condensation, the pairs of homologous chromosomes are separated and half of them 
are expelled forming the first polar body and the mature oocyte arrested again in 
metaphase of second meiotic division and 2- The cumulus cell surrounding the oocyte 
undergo expansion or mucification through secretion of hyaluronic acid, a non-
sulphated glycosaminoglycan bound to the cumulus cells by linker proteins (Buccione 
et al. 1990; Chen et al. 1996; Eppig 1979; Salustri et al. 1989), and when the hyaluronic 
acid becomes hydrated, the spaces between cumulus cells become enlarged and the cells 
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become embedded in a sticky mucified matrix. If cumulus expansion is suppressed, 
ovulation rate is greatly reduced (Chen et al. 1993). 
 
After ovulation, the rest of follicle developed into corpus luteum which consider highly 
vascularised endocrine organ produced progesterone hormone which is essential for the 
maintenance of pregnancy. 
 
 
 
Figure 2.1: Follicular growth and oocyte meiotic maturation (Kimura et al. 2006). 
 
Growth of the mammalian oocyte is coordinated with the follicle that enclosed it 
(Figure 2.2), as follicle size increased there is a corresponding increase in oocyte 
diameter until follicle has grown to 3 mm and oocyte reach maximum size (Fair et al. 
1995). The transcriptional activity in bovine oocyte, where the messenger RNA and 
ribosomal RNA are synthesized, is activated in the secondary follicle and is maintained 
up to an oocyte diameter of about 110 mm in the tertiary follicle (Crozet 1989; Fair et 
al. 1995; Fair et al. 1996). At a diameter of 110 mm, the oocyte achieves competence to 
undergo meiotic maturation and sustain embryonic development (Fair et al. 1995).  
 
The accumulation of messenger RNAs (mRNAs), ribosomes and polypeptides by the 
oocyte during the growth phase is important to later development (Moor et al. 1998). 
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The maternal mRNAs are stored in an inactive form as message-ribonucleoprotein 
(mRNP) complexes and they can be released from the mRNP compartment and 
recruited for translation in a stage-specific manner during oocyte maturation or early 
embryo development (Mtango et al. 2008). 
 
 
Figure 2.2: The relationship between follicle development and oocyte development in 
cattle. The growth of oocytes (surrounded by granulosa cells) is shown schematically in 
relation to follicle diameter, oocyte diameter and estimated duration of stage of 
folliculogenesis from the primordial to preovulatory stage (Fair 2003, based on data 
from Hulshof et al. (1992) and Lussier et al. (1987)).  
 
2.2 Oocyte maturation  
 
Oocyte maturation is progression of meiosis from the GV stage up to the formation of 
the metaphase plate of the second meiotic division (MII) and involves nuclear and 
cytoplasmic maturation. Nuclear maturation mainly involves chromosomal segregation 
while cytoplasmic maturation involves organelle reorganization and storage of mRNAs, 
proteins and transcription factors that act in the overall maturation process, fertilization 
and early embryogenesis (Ferreira et al. 2009). Luteinizing hormone (LH) surge or 
removal of the oocyte from its follicular environment leads to induced nuclear 
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maturation. In bovine oocyte nuclear maturation starts with germinal vesicle breakdown 
which is characterized by gradual chromatin condensation, the disappearance of a 
compact nucleolus and nuclear membrane disintegration, arrangement of condensed 
homologues chromosome on equatorial plate of the meiotic spindle. After that, the 
oocyte extrude the first polar body into the perivitelline space and now the oocyte called 
a secondary oocyte, begins the second meiotic division and proceeds until it reaches 
MII (Gordon 2003b), at this stage the oocyte contains the haploid number of 
chromosomes, however, the second meiotic division is not completed unless sperm 
penetration. 
 
The essential enzyme complex in oocyte maturation is maturation-promoting factor 
(MPF), a protein complex composed of cyclin B1 and P32cdc2, which is synthesized 
and/or activated depending on the species (Sirard and Blondin 2006). The MPF activity 
appears shortly before GVBD reaches a maximal level in MI oocytes, decreases 
markedly during the transition from MI to MII and regains its peak level in MII oocytes. 
This changeable pattern of MPF activity means that the transition from MI to MII is 
correlated with a decrease in MPF activity (Gordon 2003b). In addition, Gordo et al. 
(2001) mentioned that, mitogen-activated protein kinase (MAPK) activity is also 
necessary for metaphase II arrest, the maintenance of MPF activity and spindle 
organization. 
 
During cytoplasmic maturation, many events that have relevance on developmental 
competence occur as: redistribution of mitochondria, lipid droplet, cortical granules 
(Hosoe and Shioya 1997; Hyttel et al. 1997; Kruip et al. 1983), reorganization of 
endoplasmic reticulum (ER) and calcium store, increased number of 1,4,5-inositol 
triphosphate receptor type 1 (IP3R1) and their biochemical prosperities (Ajduk et al. 
2008; Shiraishi et al. 1995; Stricker 2006) and modified organization of the oocyte 
cytoskeleton that forms a network in which the organelles encased by a membrane 
move and occupy defined positions (Albertini 1992). Morphological changes are 
accompanied by molecular processes which correspond to the phases of oocyte growth 
and maturation and it involves the transcription, storage and processing of the mRNAs 
expressed by the chromosomes, which will be further translated into proteins by the 
ribosomes (Ferreira et al. 2009). The proteins derived from these mRNAs are being 
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stored until the appropriate time for their utilization (Fulka et al. 1998). These proteins 
involved both in maturation and in subsequent cellular events such as fertilization, 
pronucleus formation and early embryogenesis. The molecular changes in the oocyte 
are under the influence a signal from follicular cells which produced in response to 
precisely timed changes in circulating level of gonadotrophins before ovulation (Moor 
et al. 1998). 
 
2.3 Oocyte-somatic follicular cell interaction 
 
The cumulus oocyte complex is consisting of secondary oocyte which arrested at 
metaphase I and surrounding cumulus cells which contact to each other via gap junction 
and the innermost layer of cumulus cells surrounding the oocyte extend cytoplasmic 
processes through the zona pellucida, forming gap junctions with the oocyte plasma 
membrane (Albertini et al. 2001; Hyttel 1987; Kruip et al. 1983). These interactions are 
essential for the development and function of both cell compartments (Eppig 2001). The 
gap junction channels allowing intercellular communication and transfer of low 
molecular weight substrates such as ions, nucleotides, amino acids and metabolites that 
are necessary for oocyte development, as well as, regulatory molecules such as cAMP 
that control nuclear oocyte maturation (Buccione et al. 1990; Downs et al. 1986; Kumar 
and Gilula 1996), while the large molecules are transported by receptor mediated 
endocytosis. The essential role of gap junction in folliculogenesis has came from the 
genetic deletion of oocyte-specific gap junction subunit, connexin 37 (Cx37) which its 
deficiency display arrested folliculogenesis and oocyte growth and oocyte development 
arrested before meiotic competence is achieved (Carabatsos et al. 2000; Simon et al. 
1997). Moreover, mice deficient in connexin (Cx43) fail to properly develop granulosa 
cell layers in antral follicle (Ackert et al. 2001). In experiments designed to decrease 
Cx43 in vitro, the primary gap junctional protein in COCs, a recombinant adenovirus 
expressing the antisense code for Cx43 resulted a two-fold decrease in coupling 
between cumulus cells and the oocyte and an overall fifty percent decrease in oocyte 
maturation. Thus, this experiment demonstrated that gap junctional communication 
between oocytes and the surrounding cumulus cells is vital for oocyte maturation 
(Vozzi et al. 2001).   
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Granulosa cells are supporting oocyte growth and development by providing essential 
nutrients to oocyte, participate in maintenance of oocyte meiotic arrest, global 
suppression of oocyte transcriptional activity, and the induction of oocyte meiotic and 
cytoplasm maturation (Buccione et al. 1990; Eppig et al. 2004). In turn, oocyte itself is 
not passive structure within the follicle, it plays a central role in regulating 
folliculogenesis through paracrine secretion of peptide growth factor called oocyte 
secreting factors (OSFs). Oocyte secreting factors regulate many functions within the 
follicle including: proliferation of granulosa cells/cumulus cells, inhibition of apoptosis 
of cumulus cells, stimulates prostaglandin and progesterone synthesis and/or signaling 
pathways in preovulatory cumulus granulosa cells, suppresses the luteinization of 
cumulus granulosa cells by inhibiting LH receptor expression, regulation of cumulus 
cell metabolism and promotion of cumulus cells expension (Elvin et al. 2000; Gilchrist 
et al. 2008; Sugiura et al. 2005). However, not all of these OSFs are known. The much 
focused OSFs are transforming growth factor beta (TGF-β) superfamily members, 
particularly growth differentiation factor 9 (GDF-9), GDF-9B also known as bone 
morphogenetic protein 15 (BMP-15) and to a lesser bone morphogenetic protein 6 
(BMP6) and activin (Dube et al. 1998; Gilchrist et al. 2004; Laitinen et al. 1998; 
McGrath et al. 1995). This bidirectional communication mode in the ovary is essential 
for development and fertility (Simon et al. 1997) and though to play a key role in 
disseminating local and endocrine signal to the oocyte via the cumulus cells (Figure 2.3) 
(Gilchrist et al. 2004). 
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Figure 2.3: Oocyte cumulus cell communication. Both paracrine (bold arrow) and gap-
junctional (dashed arrow) communication between the oocyte and cumulus cells are 
required for normal oocyte and follicle development. Both communications pathways 
are bidirectional. Factors transmitted via these pathways include follicular fluid meiosis-
activating sterol (FF-MAS), cAMP, purines and pyrimidines, metabolites, amino acids, 
growth differentiation factor-9 (GDF-9) and GDF-9B or bone morphogenic protein 
(BMP-15), fibroblast growth factor (FGF) and activin (Sutton et al. 2003b). 
 
2.3.1 Role of oocyte secreting factors 
  
The role of oocyte not only in transmission of genetic information and raw material to 
early embryo but the oocyte is a central regulator of follicular cell function and play a 
critical role in regulation of oogenesis, ovulation rate and fecundity (Eppig 2001; 
Gilchrist et al. 2004; Gilchrist and Thompson 2007; McNatty et al. 2004). The oocyte 
do this by secreting paracrine growth factors (OSFs) which act on surrounding follicular 
cells to regulate several aspect of its function and thereby the oocytes create and control   
their microenvironment to regulate their own development.  
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Growth differentiation factor 9 (GDF-9) and bone morphogenetic protein 15 (BMP-15) 
are two members of transforming growth factor β (TGF-β) superfamily, which are 
translated as preproproteins, consisting of a signal peptide, prodomain, and mature 
domain (Chang et al. 2002; Shimasaki et al. 2004). Expression of ovarian GDF-9 and 
BMP-15 are restricted exclusively to oocyte in many species (Juengel and McNatty 
2005). They are considered probably major players of the oocyte-granulosa cell 
regulatory loop and participate in many functions of oocytes (Eppig 2001; Erickson and 
Shimasaki 2001; Matzuk et al. 2002; McNatty et al. 2004). Mutation in these genes 
causes major effect on ovarian function and fertility in mice and sheep (Bodin et al. 
2007; Dong et al. 1996; Galloway et al. 2000; Hanrahan et al. 2004). More sever 
fertility defect was observed in double mutant BMP-15–/– GDF-9+/– than in BMP-15–/– 
mice females which appear to be due to abnormalities in ovarian folliculogenesis, 
cumulus cell physiology and fertilization (Yan et al. 2001). 
 
Addition of recombinant GDF-9 or BMP-15 to granulosa cells in vitro mimic several 
regulatory actions of oocyte on granulosa cells activities, for example increased follicle 
growth and inhibin α production (Hayashi et al. 1999), reduced the levels of FSH 
receptor mRNA (Otsuka et al. 2001), stimulated DNA synthesis and steriodogenesis in 
rat granulosa cells (Vitt et al. 2000) and induced cytochrome c oxidase subunit II (COX-
2), hyaluronan synthase 2 (HAS2), steroidogenic acute regulatory protein (StAR) 
mRNA synthesis, but suppressed plasminogen activator, urokinase (uPA) and LHR 
mRNA synthesis in mouse granulosa cells (Elvin et al. 1999a).   
 
 The GDF-9 and BMP-15 signal depend on the TGF-β superfamily receptor which in 
turn activate the SMAD intracellular cascade (Juengel and McNatty 2005; Kaivo-oja et 
al. 2006; Shimasaki et al. 2004). The TGF-β superfamily growth factors are binded to 
type–I receptor also known as activin receptor-like kinase (ALK) or type–II receptor 
leads to ALK phosphorylation then intracellular receptor-regulated signal transducers 
(SMADs) phosphorylation (Massague 2000; Shimasaki et al. 2004). Formation of 
heterodimeric complex (between receptor-regulated SMADs and receptor independent 
co-SMADs, such as SMAD4) occurred to mediate ligand-induced gene transcription.  
The TGF-β superfamily growth factors intracellular signaling can be broadly divided 
into two distinct groups: those utilizing the TGF-β/activin signaling pathway leading to 
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activation of the SMAD2 and SMAD3 proteins and those using the BMP pathway 
leading to activation of SMAD1, SMAD5 and/or SMAD8 molecules (Massague 2000). 
In granulosa cells and cumulus cells (Figure 2.4), BMP-15 and BMP-6 use the classic 
BMP signaling pathway through binding the BMP type-II  and ALK6, and activating 
the SMAD1/5/8 intracellular pathway and GDF-9 used TGF-β superfamily signaling 
systems, GDF-9 binding BMP type-II receptor and ALK5 leads to activation of ALK5 
which in turn phosphorylates SMAD2 and SMAD3 signal transducers which  associates 
with the common SMAD4 and then this complex translocates to the nucleus to interact 
with specific DNA motifs and transcriptional regulators, leading to expression of target 
genes (Gilchrist et al. 2008). Furthermore, GDF-9 and BMP-15 may also activate 
alternate pathways, particularly when acting synergistically or with non superfamily 
members such as fibroblast growth factors (FGFs) (Sugiura et al. 2007). 
 
 
 
Figure 2.4: Molecular basis of oocyte–CC paracrine signaling, details of the molecules 
mediating oocyte paracrine signaling to CCs are still emerging; however, TGF-β 
superfamily signaling is central to this communication axis. Key OSFs include GDF-9, 
BMP-15 and possibly BMP-6. GCs and CCs express a large compliment of TGF-β 
superfamily receptors, co-receptors and intracellular signal transducer molecules 
(SMAD). BMPRII is the critical type-II receptor utilized by all three OSF ligands, 
although BMP6 also binds ActRIIA (Gilchrist et al. 2008). 
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The oocyte secreted factor promotes the expansion of cumulus through enabling the 
cumulus cells to respond to the gonadotrophic/EGF signal to induce expression of 
several transcripts (HAS2, TNFAIP6, PTX3, and PTGS2) required for formation and 
stability of the hyaluronan rich matrix (Diaz et al. 2006; Dragovic et al. 2005; Dragovic 
et al. 2007; Elvin et al. 1999b; Varani et al. 2002; Yoshino et al. 2006). Hyaluronan 
synthase 2 (HAS2), is the key enzyme required for the production of hyaluronic acid, a 
non-sulfated glycosaminoglycan secreted by cumulus cells that is a main component of 
the cumulus matrix (Camaioni et al. 1993; Chen et al. 1993). Prostaglandin-
endoperoxide synthase 2 (PTGS2) is produced by cumulus cells as well as mural 
granulosa cells and is required for maximum cumulus expansion and ovulation (Lim et 
al., 1997). Tumor necrosis factor-induced protein 6 (TNFAIP6) is a secreted protein that 
binds both hyaluronic acid and inter-α trypsin inhibitor (ITI), a serum derived protein 
important for matrix formation (Fülöp et al. 2003; Mukhopadhyay et al. 2004). 
Pentraxin 3 (PTX3) is also secreted by cumulus cells and acts to stabilize TNFAIP6 
protein to maintain the expanded matrix (Salustri et al. 2004; Varani et al. 2002). The 
tumor necrosis factor alpha-induced protein 6 (TNFAIP6) was not only a hyaluronan 
binding protein involved in cumulus cells expansion, but it has been also reported to be 
associated with the expression of a common receptor of luteinizing hormone/human 
chorionic gonadotrophin (LH/hCGR) in cumulus cells (Fülöp et al. 2003; Haouzi et al. 
2009). On the contrary, cow, rat and pig COC expansion can be induced by FSH in 
absence of the oocyte (Ralph et al. 1995; Singh et al. 1993; Vanderhyden 1993). 
Although, some factor produced by bovine oocytes enabled  expansion of murine 
oocytectomised complexes (OOX) when cultured in media conditioned by 
bovine oocytes (Ralph et al. 1995). 
 
In bovine oocyte cumulus cell communication, Hussein and his colleagues (2005) 
demonstrated that oocyte removal led to increase in cumulus cell apoptosis compared 
with COC and the level of apoptosis in cumulus cells without oocyte (OOX) was 
reversed in dose dependant manner when co-culture with oocyte. They also revealed 
that oocyte secreted factors, particularly BMP-15 and BMP-6 are responsible for the 
low incidence of apoptosis within cumulus cells, through the establishment of a 
paracrine network of BMP growth factors and their binding proteins (Figure 2.5). 
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Furthermore, the incidence of apoptosis was lowest close to the oocyte and apoptosis 
increased with increasing distance from the oocyte (Hussein et al. 2005).  
 
 
Figure 2.5: Proposed model by which the paracrine network of BMP/GDF-9 growth 
factors and their binding proteins interact to regulate apoptosis in the COC 
microenvironment. Oocyte-secreted BMP-15 and BMP-6 signal through the cumulus 
cell receptor BMPR-II to actively prevent cumulus cell death. Oocyte-secreted GDF-9, 
also acting through BMPR-II but using a different type-I receptor to the BMPs, does not 
prevent cumulus cell apoptosis but induces cumulus cell gremlin expression. GDF-9 
stimulated gremlin expression may in turn block theca and granulosa cell-derived BMPs 
from competing with BMP-15, BMP-6 and GDF-9 for BMPR-II binding. In addition, 
follistatin produced by mural granulosa cells and present in follicular fluid, may limit 
the anti-apoptotic effects of oocyte BMP-15 specifically to the COC microenvironment 
(Hussein et al. 2005). 
 
Recently, in addition to oocyte secreted factors, there is another oocyte derived ligand 
called intermedin (IMD) also known as adrenomedullin 2 (ADM2) which according to 
studies based on in vitro-cultured COCs and animal models in vivo. The  IMD/ADM2 
plays a direct role in enhancement cumulus cell survival because its exhibiting an anti- 
apoptosis effect and regulating cell-cell contacts in COCs, moreover, intrabursal 
injections of IMD antagonist led to oocyte atresia and reduction of follicular cyclin D2 
(activator of cell cycle progression) expression (Chang et al. 2011). Thus, oocyte 
considers the main regulator of follicular cell functions through its secreting substances.  
 Literature review 16 
Exposure of bovine cumulus oocyte complexes (COCs) during oocyte maturation to 
oocyte-secreted factors (OSFs), whether in their native form as an uncharacterized mix 
of growth factors secreted by the oocyte or as recombinant exogenous BMP-15 or GDF-
9, substantially improved subsequent oocyte developmental competence, where the 
blastocyst rate increased from ~40% to ~60% (Hussein et al. 2006). 
 
2.3.2 The role of cumulus cell during oocyte development 
 
During ovarian folliculogenesis in mammals, the transition from a secondary follicle to 
an antral follicle is signaled by the formation of a fluid-filled antrum, differentiation of 
granulosa cells and development of a cumulus oocyte complex. Cumulus cells have a 
characteristic function different from mural granulosa cells such as: cumulus cells have 
high proliferation rate, low steriodogenic capacity, very low LH receptor expression and 
ability to produced and secret hyalouronic acid and undergo expansion (Armstrong et al. 
1996; Eppig et al. 1997; Li et al. 2000). 
 
Bovine COC have very high capacity to incorporate tritiated thymidine (used as marker 
of DNA synthesis) and lower capacity produced progesterone in comparison to mural 
granulosa cells (MGC). In the same study when oocytes were microsurgically removed 
from oocyte cumulus cell complexes (oocytectomy), OOX displayed in vitro more 
characteristic like MGC (reduced DNA synthesis and increased secretion of 
progesterone) however, this MGC character of OOX complex was completely restored 
to COC level by co-culture with denuded oocyte (DO) (Li et al. 2000). Likewise, 
another study showed dramatic elevation of the expression of LHR mRNA in the OOX 
complex and this expression was suppressed below detectable level in OOX after co-
culture of OOX complex with oocyte (Eppig et al. 1997). Both previous studies support 
the hypothesis that the oocyte actively promotes the development of the cumulus cell 
phenotype.  
 
Cumulus cells are known to play a critical role during oocyte maturation, in keeping the 
mammalian oocyte under meiotic arrest, in participating in the induction of meiotic 
resumption and in supporting cytoplasmic maturation (Tanghe et al. 2002). Also in 
some species, it is evident that cumulus cells and their inter-cellular matrix participate 
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the capture of COC by oviduct infundibulum through its adhesion with ciliated 
oviductal epithelium (Kölle et al. 2009; Lam et al. 2000) and involved in the induction 
of sperm capacitation and acrosome reaction (Chian et al. 1995; Cox et al. 1993; Fukui 
1990). Recently, the evidence of crosstalk between sperms and cumulus mass and 
cumulus induced acrosome reaction has emerged via a sperm membrane protein, NYD-
SP8 which is glycosylphosphatidylinositol (GPI) anchored membrane protein cleaved 
from sperm head upon its interaction with the cumulus and binds to the cumulus cells, 
resulted in calcium mobilization and progesterone production in cumulus cells. The 
secreted progesterone subsequently initiates sperm acrosome reaction within the 
cumulus layer (Sun et al. 2011; Yin et al. 2009). Moreover, removal of CCs at the 
beginning of oocyte in vitro maturation (IVM) or shortly before in vitro fertilization or 
the blockade of the gap junction is detrimental to oocyte maturation, fertilization and 
subsequent development (Fatehi et al. 2002; Fukui and Sakuma 1980; Vanderhyden and 
Armstrong 1989; Vozzi et al. 2001; Zhang et al. 1995). In recent study, removal of 
companion CCs at GV stage appeared to affect the gene expression of MII oocytes as a 
number of genes are over-expressed in oocytes cultured with CCs relative to those 
cultured without  (Regassa et al. 2011). 
 
During oocyte maturation, the metabolic requirement of COC increased, such as the 
consumption of glucose, oxygen and pyruvate increased by two fold over the 24 hr 
period of bovine COC culture (Sutton et al. 2003a). The COC used glucose for energy 
production and other numerous essential metabolic processes such as nucleic acid and 
purine synthesis, mucification and cellular homeostasis (Sutton et al. 2003b). However, 
the oocyte itself has a poor capacity to utilize glucose (Biggers et al. 1967) and relies on 
cumulus cells to convert glucose mainly via glycolysis to substrate it can readily utilize 
such as pyruvate (Donahue and Stern 1968; Sutton-McDowall et al. 2010; Sutton et al. 
2003b), then oocyte metabolized pyruvate through oxidative phosphorylation to 
produce energy for growth and maturation (Biggers et al. 1967; Brinster 1971; Eppig 
1976). In mice, oocytes regulate the co-operativity between oocytes and cumulus cells 
for energy metabolism by paracrine secreted factors which regulating expression levels 
of genes encoding glycolytic enzymes (such as ENO1, PKM2, TPI, ALDOA, Ldh1, and 
PFKP) in granulosa/cumulus cells (Sugiura et al. 2005). While, the oocyte secreted 
factors didn’t appear to affect the glucose consumption rate in bovine as COCs, OOX 
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and OOX co-culture with denuded oocytes all showed similar rate of glucose 
consumption over a 24 hr culture period (Sutton et al. 2003a). This indicated that, might 
be there is species difference in regulatory role of oocyte to cumulus cell glycolysis 
(Sutton-McDowall et al. 2010). In addition to nutritional support of the developing 
oocyte, cumulus cells have another metabolic and protective role in oocyte cytoplasmic 
maturation, for instance, cumulus cells have the ability to reduce cystine to cysteine and 
promote its uptake by bovine oocyte during maturation (de Matos et al. 1997), as 
consequence, bovine cumulus enclosed oocyte have higher contain of gluthatione 
(GSH) than denuded oocyte (Geshi et al. 2000). Gluthatione participate in sperm 
decondansation in parallel with oocyte activation and transformation of penetrated 
sperm head into male pronucleus during fertilization (Perreault et al. 1988; Sutovsky 
and Schatten 1997; Yoshida 1993). Moreover, GSH is well known to play an important 
role in protecting cells against the destructive effect of reactive oxygen intermediates 
and free radicals (Lim et al. 1996; Meister 1983). Cumulus cells play a critical role in 
protecting the oocyte against oxidative stress which induced apoptosis through the 
enhancement of the GSH content in pig oocyte (Tatemoto et al. 2000). Another example 
of metabolic cooperation between oocyte and cumulus cells, involved in amino acid 
uptake. Some amino acids such as L-alanine can not uptake by the oocyte, however, the 
cumulus cells take them up and then transfer to the oocytes through gap junctions and 
this supported by the high expression of Slc38a3 which known as a transcript encoding 
sodium-coupled neutral amino acid transporter in cumulus cell but not in oocytes 
(Colonna and Mangia 1983; Eppig et al. 2005). 
 
During in vitro maturation, cumulus cell benefits bovine oocyte development either by 
secreting soluble factors, which induce developmental competence, or by removing 
inhibitory or toxic components from the maturation medium (Hashimoto et al. 1998). 
Additionally, cumulus cells might have unknown promoting effects on subsequent 
oocyte development which might be attributable to intracellular changes such as pH or 
calcium ions (Mori et al. 2000). The gap junction communication between oocyte and 
surrounding cumulus cells are required during IVM of bovine oocyte for cytoplasmic 
maturation and subsequent early development, where the absence of cumulus cells 
during maturation did not affect the development of the 2–8 cell stages 72 hr after 
insemination but development beyond the blastocyst stage was significantly lower in 
 Literature review 19 
cumulus free than in cumulus-intact oocytes (Atef et al. 2005) while, sheep oocytes 
matured without cumulus cells failed to undergo cleavage after fertilization (Crosby et 
al. 1981). 
 
The cumulus and its communication with the oocyte have role in oocyte competence 
acquisition process, as we mentioned before, the presence of cumulus cells and intact 
gap junctions were reported to support oocyte competence in vitro and conversely, the 
inhibition of the functional coupling between the oocyte and its cumulus using gap 
junction inhibitors significantly reduced the oocyte competence expressed in terms of 
blastocyst rate (Atef et al. 2005; Hashimoto et al. 1998).  
 
The oocyte developmental competence is the intrinsic ability of oocytes to undergo 
meiotic maturation, fertilization and embryonic development. Several studies used 
microarray technology and reverse transcription polymerase chain reaction to identify 
and validate gene expressed in cumulus cell and used as biomarkers related to oocyte 
competence and associated with embryo quality and pregnancy outcome (Assidi et al. 
2008; Assou et al. 2008; Caixeta et al. 2009; McKenzie et al. 2004; van Montfoort et al. 
2008). The prostaglandin-endoperoxide synthase-2 (PTGS2), hyaluronan synthase 2 
(HAS2), inhibin beta A (INHBA), betacellulin (BTC) which is a member of the EGF 
family of growth factors, CD44, tumor necrosis factor-induced protein 6 (TNFAIP6), 
follicle stimulating hormone receptor (FSHR), growth hormone receptor (GHR) and 
epidermal growth factor receptor (EGFR) have been identified as biomarkers in bovine 
cumulus cell that predict oocyte competence and select higher embryo quality (Assidi et 
al. 2008; Caixeta et al. 2009). Similarly, expression of PTGS2, HAS2 and GREM1 were 
increased in human cumulus cell isolated from oocyte which produced high quality 
embryos (cleavage stage) than those detected in cumulus cell from poor quality 
embryos, hence theses genes may be markers of human oocyte developmental 
competence (McKenzie et al. 2004). The same results were obtained for HAS2 and 
GREM1 by Cillo et al. (2007), which indicate that the measurement of transcriptional 
levels of these genes in cumulus cells would reliably complement the morphological 
evaluation providing a useful tool for selecting oocytes with greater chances to be 
fertilized and develop in vitro. Other genes expressed in cumulus cells and associated 
with embryo quality based on early cleavage rates during embryonic development: 
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glutathione peroxidase 3 (GPX3), chemokines receptor 4 (CXCR4), cyclin D2 
(CCND2), catenin delta 1 (CTNND1), 7-dehydrocholesterol reductase (DHCR7), 
dishevelled dsh homolog 3 (DVL3), heatshock 27 kDa protein 1 (HSPB1) and tripartite 
motif-containing 28 (TRIM28). These genes reflect hypoxic conditions or delayed 
oocyte maturation in non early cleavage embryo, hence these also provide a set of 
potential markers could be used for oocyte selection (van Montfoort et al. 2008). Assou 
et al. (2008) have proposed that three of genes expressed in cumulus cells issued from 
oocytes that developed into embryos with a good morphology, BCL2L11 (involved in 
apoptosis), PCK1 (phosphoenlpyruvate carboxykinas 1 involved in gluconeogenesis) 
and NFIB (a transcription factor) could be used as biomarkers for embryo potential and 
pregnancy outcome.  
 
2.4 Short history for microRNAs 
 
 MicroRNAs (miRNAs) represent an exciting discovery in the field of biology in recent 
years. Originally described in 1993, lin-4 was the first miRNA to be discovered in the 
Caenorhabditis elegans, by the joint efforts of Ambros’s and Ruvkun’s laboratories 
(Bartel 2004; Lee et al. 1993), lin-4 discovered by the isolation of a null mutation that 
caused a failure in temporal development (Chalfie et al. 1981; Horvitz and Sulston 
1980). The activity of lin-4 is required for the transition from the L1 to L2 stage of 
larval development (Chalfie et al. 1981; Lee et al. 2004a). Ferguson et al. (1987) found 
that a suppressor mutation in the gene lin-14 was able to revert the null-lin-4 mutation 
phenotype. So this opposite phenotype between defects in lin-4 and lin-14 genes 
indicated that lin-4 could negatively regulate lin-14 (Lee et al. 2004a). In June 1992, 
Ambros and Ruvnkun independently concluded that lin-4 transcripts were 
complementary to a repeated sequence in the 3'-UTR of the lin-14 gene. Morover, in 
December 1993, Ambros and Ruvkun independently reported that the small and non-
protein-coding transcript lin-4 regulates lin-14 through its 3'-UTR (Lee et al. 2004a; Lee 
et al. 1993; Wightman et al. 1993). Likewise lin-4, let-7 is a heterochronic gene of 
C.elegans and was the second miRNA to be discovered, in 2000, seven years after the 
finding of the first miRNA. Reinhart et al. (2000) at Ruvkun's laboratory reported that 
let-7 was a 21-nt RNA controlling the L4-to-adult transition of larval development and 
loss of let-7 activity caused reappearance of larval cell fates during the adult stage of 
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development, while increased let-7 activity caused precocious expression of adult fates. 
Counter to lin-4, the let-7 sequence is conserved across species from flies to humans 
(Pasquinelli et al. 2000) and this conserved across species triggered a revolution in the 
research of a new class of small ncRNAs, called miRNAs. Presently, thousands of 
miRNAs have been identified in humans and other species, and miRNA sequences are 
available online in database, such as miRbase (Griffiths-Jones 2004; Griffiths-Jones et 
al. 2006; Griffiths-Jones et al. 2008). 
 
2.5 Genomic location of microRNAs 
 
Nowadays, 1424, 720 and 662 miRNAs were identified in human, mice and bovine, 
respectively (miRBase, release 17, http://www.mirbase.org/). Approximately 50% of 
miRNAs are in miRNA clusters that are found to be encoded as a polycistronic 
transcript that is subsequently cleaved into multiple miRNAs (Lee et al. 2002). The 
clustered miRNAs may be functionally related in terms of targeting the same gene or 
different genes in the same biochemical pathway (Singh et al. 2008). In most cases, 
polycistronic miRNAs share the same expression pattern. Initially, it was thought that 
most miRNA are encoded in intergenic region and transcript from their promoter as 
independent genes (Lagos-Quintana et al. 2001; Lau et al. 2001; Lee and Ambros 
2001). Although, a number of miRNA genes have been also reside within the 
transcription unit (Tu) of other genes, both intronic and exonic (Lagos-Quintana et al. 
2003; Lau et al. 2001; Lee et al. 2002). Rodriguez et al. (2004) showed that about 40% 
of mammalian miRNAs are located in the intronic region of either protein-coding or 
non-coding transcription unit (e.g miR-208 and miR-100 respectively), whereas 10% 
are encoded within the exonic region. With few exceptions, miRNAs that are embedded 
in, or overlap with, exons of known transcripts are always in the same orientation, and 
most of these known transcripts are in the non-coding 5' or 3'-UTRs (e.g. miR-198 in 
follistatin-like 1) and their maturation often excludes host gene function (Cullen 2004; 
Rodriguez et al. 2004). A new class of intronic miRNAs (called ‘mirtrons’) has been 
derived from short hairpin introns via a non-classical miRNA pathway and constitute 5-
10% of miRNA genes in invertebrates and vertebrates (Berezikov et al. 2007; Glazov et 
al. 2008; Okamura et al. 2007; Ruby et al. 2007) So, concerning the genomic location of 
miRNA genes, it can be categorized into three groups (Figure 2.6): 
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a) Intergenic miRNA which located in between protein coding genes and have its own 
promoter 
b) Intronic miRNA which located within intron of their host protein coding genes 
c) Exonic miRNA which located within exon of host protein coding genes or overlap an 
exon and an intron of non-coding gene  
 
 
 
Figure 2.6: Genomic location of microRNAs (Olena and Patton 2010). 
 
2.6 MicroRNA biogenesis 
 
MicroRNA biogenesis is a multistep process; the first two steps are localized in the 
nucleus followed by maturation in the cytoplasm (Figure 2.7). The majority of miRNAs 
are transcribed by RNA polymerase II as long primary miRNAs (pri-miRNAs) that 
contain a hairpin stem carry a 7-methyl guanylate cap at the 5' end and poly (A) tail at 
the 3' end (Cai et al. 2004; Kim 2005; Lee et al. 2004b). RNA polymerase III has also 
been demonstrated to generate the transcripts of a subset of miRNAs (Borchert et al. 
2006; Ozsolak et al. 2008). 
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Following transcription, the nuclear microprocessor complex, which contains the 
RNase-III type endonuclease Drosha and its dsRNA-binding partner, Dgcr8/Pasha 
cleaved the pri-miRNA transcripts and release a short stem–loop precursor miRNA 
(pre-miRNA) (Denli et al. 2004; Han et al. 2004; Lee et al. 2003). DiGeorge syndrome 
critical region gene 8 (Dgcr8) functions at least in part by binding to single-stranded 
RNA–double-stranded RNA (ssRNA-dsRNA) junction of the pri-miRNA stem and 
directing Drosha to cleave ~11 bp away from this junction produce a pre-miRNA which 
containing ~60-70 nt stem-loop with a 5' phosphate and a 3' 2-nt hydroxyl overhang that 
act as recognition site for the next processing step (Han et al. 2006). Also, 
microprocessor complex contains other accessory proteins, such as the DEAD box RNA 
helicases p68 (DDX5), p72 (DDX17) and heterogeneous nuclear ribonucleoproteins 
(hnRNPs) (Fukuda et al. 2007; Gregory et al. 2004; Guil and Caceres 2007; Liu et al. 
2008). These accessory proteins may function to promote the fidelity, specificity, and/ 
or activity of Drosha cleavage. Moreover, these binding protien act as regulator for 
miRNA processing (Slezk-Prochazka et al. 2010). 
 
After nuclear processing, the short 3' overhang structure in the pre-miRNA is 
recognized by Exportin-5, a nuclear transport receptor, in complex with Ran-GTP and 
export the pre-miRNA into the cytoplasm after hydrolysis of Ran-GTP to Ran-GDP 
(Lund et al. 2004; Okada et al. 2009; Yi et al. 2003). Exportin-5 is also important for 
stabilizing pre-miRNAs in the nucleus (Zeng and Cullen 2004). 
  
 In the cytoplasm, the pre-miRNA is processed by Dicer (an RNase III enzyme), 
together with its dsRBD protein partner, Loquacious (Loqs) in Drosophila or the trans-
activator RNA (tar)-binding protein (TRBP) in mammals, cleaves the pre-miRNA into a 
~19- 24bp double-stranded miRNA termed miRNA duplexes by cutting near the hairpin 
loop (Chendrimada et al. 2005; Grishok et al. 2001; Ketting et al. 2001; Saito et al. 
2005). The miRNA duplex are then unwound and one of the strands (mature miRNA) 
are associates with an Argonaute protein (Ago) within RNA-induced silencing complex 
(RISC) or miRNA-containing ribonucleoprotein complexs (miRNPs), where it acts as a 
guide to repress target messages (Hutvagner and Simard 2008; Hutvagner and Zamore 
2002; Mourelatos et al. 2002; Murchison and Hannon 2004). An Argonaute protein is 
the core component of RISC, its highly conserved family of proteins involved in the 
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RNA interference and miRNA pathway. The Ago have PIWI domain flanked by N-
terminal (N) and middle (Mid) domains, PAZ domain which binding to 3' end of small 
RNA while Mid domain providing a binding pocket for the phosphorylated 5' end  and 
the PIWI domain shows an RNase H-like structure (Carthew and Sontheimer 2009; 
Lingel et al. 2004; Liu et al. 2004; Ma et al. 2004).  
 
The strand selection is identified by inherent features of the miRNA duplex, including 
thermodynamic asymmetry/stability (Khvorova et al. 2003; Schwarz et al. 2003), where 
the RNA strand which thermodynamically least stable at 5' end will be more frequently 
selected as the functional guide strand and the other strand (the passenger strand or 
miRNA*) is assumed to be excluded from miRISC assembly and subsequently 
degraded (Liu et al. 2008). However, deep-sequencing efforts have revealed that a large 
number of miRNA* strands can be appreciably detected in Ago complexes, and are in 
large part functional (Czech et al. 2009; Okamura et al. 2008; Seitz et al. 2008). 
Additionally, in recent study they demonstrated that miR-223 and miR-223* targeted 
the insulin-like growth factor 1 receptor/phosphatidylinositol 3-kinase axis and the high 
miR-223* levels were associated with increased overall survival in patients with acute 
myeloid leukemia, thus indicate the active role for both arms of the miR-223 duplex 
(Kuchenbauer et al. 2011). 
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Figure 2.7: MicroRNA biogenesis (Bushati and Cohen 2007). 
 
2.7 Principal of miRNA-mRNA complementary 
 
MicroRNAs control in expression of target mRNA by Watson-Crick base pairing 
between to  sequence motifs in the 3'-UTR of mRNAs and the miRNA at position 2–7 
in the 5' end of the mature miRNA with perfect or near perfect complementarities 
(Bartel 2009; Lai 2002; Lewis et al. 2003; Xie et al. 2005). Also, in the 3'-UTR there is 
a certain AU-rich elements (AREs) which interact with miRNAs and act both directly 
and indirectly as potent post-transcriptional regulatory signals (Vasudevan and Steitz 
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2007). The analysis of miRNA target sites indicated that genes with longer 3'-UTRs 
usually have higher density of miRNA binding sites and are mainly involved in 
developmental modulations, while genes with shorter 3'-UTRs usually have lower 
density of miRNA-binding sites and tend to be involved in basic cellular processes 
(Cheng et al. 2009; Osada and Takahashi 2007; Sandberg et al. 2008). So these facts 
give indication about the importance of 3'-UTR interaction with miRNA, although, 
some miRNA from plants and animals repression regulation by specifically targeting 
the 5'-UTR or coding region of some mRNAs (Easow et al. 2007; Fang and Rajewsky 
2011; Jopling et al. 2005; Selbach et al. 2008; Sunkar and Zhu 2004). However, sites 
located in coding regions appear to be less robust than those in the 3'-UTR (Easow et al. 
2007; Gu et al. 2009). There are five types of seed-matched sites are known (Figure 2.8 
A): two 6mer, two 7mer and one 8mer. The 6mer which have perfect 6 nt match to the 
miRNA seed (miRNA nucleotides 2–7) (Lewis et al. 2005) and the 6mer contains six 
matches to nucleotides 3–8, referred to as offset 6mer sit, but they are thought to have a 
limited functionality (Friedman et al. 2009; Witkos et al. 2011). The two 7mer site, one 
called 7mer-m8 site which the seed match augmented by a match to miRNA nucleotide 
8 (Brennecke et al. 2003; Brennecke et al. 2005; Krek et al. 2005; Lewis et al. 2005; 
Lewis et al. 2003), while the other one is the 7mer-A1 site, which contains the seed 
match augmented by an adenine (A) in target position 1 at the 5' end of miRNA (Lewis 
et al. 2005). The 8mer site includes the seed match flanked by both the match at 
position 8 and the A at position 1 (Lewis et al. 2005). The site which have complete 
pairing within the seed region (7mer-m8, 7mer-A1 and 8mer site) known as canonical 
sites which account for the majority of validated conserved targets, 7mer sites are most 
abundant for highly conserved miRNAs (Friedman et al. 2009). Moreover, the adenine 
opposite position 1 of miRNA improves the degree of gene silencing (Nielsen et al. 
2007). 
 
All the pervious sites can have additional paring within the 3' region of the miRNA, at 
least 3-4 nucleotides consecutively paired in positions 13-16 of miRNA are usually 
required to enhance the effectiveness of miRNA-mRNA interaction which facilitates 
target prediction and such sites are called “3' supplementary sites” (Figure 2.8B) 
(Friedman et al. 2009; Grimson et al. 2007). However, this pairing to the 3' region of the 
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miRNA not only supplementary, it can be also compensate for a single-nucleotide bulge 
or mismatch in the seed region (Figure 2.8C) (Vella et al. 2004; Yekta et al. 2004). 
 
 
 
Figure 2.8: Sites matching the miRNA seed region (A), share six contiguous Watson–
Crick matches to the miRNA seed (nucleotides 2–7); the offset 6mer contains six 
contiguous matches to nucleotides 3–8. Conserved pairing to the 3' ends of miRNAs (B, 
C) preferential occurrence of pairing to the 3' region of the miRNA as supplementary 
pairing or compensatory pairing, respectively, modified from Friedman et al. (2009). 
 
Many different algorithms have been developed for the prediction of miRNA targets 
such as PicTar, TargetScan, miRanda, DIANA-microT, rna22 and PITA (John et al. 
2004; Kertesz et al. 2007; Krek et al. 2005; Kuhn et al. 2008; Lewis et al. 2003; 
Rajewsky 2006). These algorithms based on various important features of miRNA-
target nucleotide sequence interaction to search for mRNA target. At least some of the 
following features used by prediction programs: base pairing pattern of the seed region 
at the 5' end of miRNA and 3′-UTR of target mRNA and this criteria are the most 
common ones, evolutionary conservation of putative miRNA-binding site, secondary 
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structure of target transcript and nucleotide composition of target sequences which often 
added to increased accuracy (Grimson et al. 2007; Grün et al. 2005; Kertesz et al. 2007; 
Lewis et al. 2003; Long et al. 2007). The miRanda, TargetScan, and PicTar are most 
popular softwares. A proper integration of miRNA prediction algorithms can 
significantly improve the prediction accuracy (Zhang and Verbeek 2010). 
 
2.8 Mechanisms of microRNA-mediated gene regulation  
 
It is believed that the degree of miRNA-mRNA complementarity determines the 
mechanism of miRNA-mediated regulation. Perfect or almost perfect complementarity, 
like most of miRNAs in plants, allows Ago catalyzed direct cleavage of their target 
mRNAs as siRNA functions (Llave et al. 2002; Rhoades et al. 2002). However, perfect 
complementarity between miRNAs and their targets is rare in animals. A very few 
extensive microRNA target interactions can lead to mRNA cleavage in mammals, for 
example miR-196 and miR-434-5p which directs the cleavage of the Homeobox protein 
(HOXB8) and Rtl1/Peg11 transcript, respectively (Davis et al. 2005; Yekta et al. 2004). 
Most animal miRNAs mediate regulation of their targets through translational 
repression or/and mRNA decay via a deadenylation and decapping mechanism (Behm-
Ansmant and Izaurralde 2006; Giraldez et al. 2006; Wu et al. 2006). 
  
The precise mechanism by which miRNAs regulate gene expression still elusive, there 
are numbers of models has been proposed over the last years and have been the subject 
of an intense discussion in various reviews (Carthew and Sontheimer 2009; Chekulaeva 
and Filipowicz 2009; Eulalio et al. 2008a; Filipowicz et al. 2008; Jackson and Standart 
2007; Nilsen 2007; Pillai et al. 2007; Richter 2008; Standart and Jackson 2007; Wu and 
Belasco 2008; Zhao and Liu 2009). Moreover, some studies suggest that, miRNAs can 
activate rather than repress their targets under specific conditions (Henke et al. 2008; 
Orom et al. 2008; Vasudevan et al. 2007). 
 
2.8.1 Translation repression 
 
Many experiments investigating miRNA function point to initiation of translation as a 
target of repression, however, evidence also exists that miRNA inhibition occurs at 
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various post-initiation steps (Eulalio et al. 2008a; Filipowicz et al. 2008). Briefly, in 
eukaryotic mRNA translation can be divided into three steps: initiation, elongation and 
termination. Initiation starts with the recognition of the mRNA 5'-terminal cap structure 
m7GpppN by the eIF4E subunit of the eukaryotic translation initiation factor eIF4F 
complex, which also contains eIF4A (an RNA helicase) and eIF4G (an important 
scaffold for the assembly of the ribosome initiation complex) (Edery et al. 1983; Grifo 
et al. 1983; Sonenberg et al. 1979). The eIF4G interact with another initiation factor, 
eIF3, and contributes to the small ribosomal subunit (40S) assembly at the 5' end of the 
mRNA to enable the preinitiation complex (Kapp and Lorsch 2004; Merrick 2004). The 
40S preinitiation complex joins with the large ribosomal subunit (60S) at the AUG 
codon to begin elongation phase which can be regulated by phosphorylation of the 
elongation factor eEF2 (Herbert and Proud 2007; Taylor et al. 2007). The eIF4G also 
interacts with the polyadenylate binding protein 1 (PABP1) that decorates the 3' end of 
the message (Gingras et al. 1999; Imataka et al. 1998). The interaction of eIF4G with 
eIF4E and PABP1 lead to circularization of mRNA, this circularization stimulates 
translation initiation by increasing the affinity of eIF4E for m7GpppN, and might 
facilitate ribosome recycling (Derry et al. 2006; Wells et al. 1998). The termination 
process mediate by translation release factors when the ribosome reaches the stop codon 
(UAA, UGA and UAG) (Ehrenberg et al. 2007). Some viral mRNAs initiate translation 
without the involvement of the m7G cap and eIF4F. In such cases, the 40S ribosomes 
are bind to mRNA through the internal ribosome entry site (IRES) directly (Pestova et 
al. 2001; Pestova et al. 1998). 
 
2.8.1.1 Repression at the initiation step 
 
There is different models proposed translation repression at initiation step, early study 
shown that miRNAs and their targets are not associated with the polysomal fraction in 
sucrose gradients but rather with the free mRNP pool in mammalian cells, indicating 
that translation inhibition occurs at the initiation step (Pillai et al. 2005). Additionally in 
other study, miRNA can affect translation initiation and implicate the cap-binding 
protein eukaryotic initiation factor 4E as a molecular target. In this study, replacing the 
cap structure with an internal ribosome entry site from either the cricket paralysis virus 
or the encephalomyocarditis virus impairs miRNA-mediated repression (Humphreys et 
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al. 2005). In agreement with a role for miRNAs in repression translation initiation, 
Kiriakidou et al. (2007) reported that the MID domain of Ago2 protein, the core of the 
miRNA effector complex (RISC), contains limited sequence homology to m7G cape 
binding region of eIF4E, this indicated that Ago2 can compete with eIF4E for m7G 
binding and represses translation initiation process (Figure 2.9C) but this has been 
controversial in Drosophila cells (Eulalio et al. 2008b). Also, there is evidence 
suggesting that miRNAs inhibit an early translation step through inhibition ribosomal 
subunit joining. The Eukaryotic initiation factor 6 (eIF6) is known to interacts with the 
60S ribosomal subunit and prevents its premature association with the 40S ribosomal 
subunit  to generate transnational competent 80S ribosome particles (Ceci et al. 2003). 
Chendrimada and co-workers identify eIF6 as a binding partner of miRISC and 
depleting eIF6 in either human cells or C.elegans effectively abolishes miRNA-
mediated translational repression (Chendrimada et al. 2007). Other data from 
Drosophila S2 cells suggest that eIF6 may not be widely required for miRNA function 
(Eulalio et al. 2008b). In addition, the experiments in reticulocyte lysate showed that 
miRNA-targeted mRNAs are enriched for 40S, but not 60S, ribosome components, thus 
author postulated that miRNA may repress initiation by inhibiting 60S subunit joining 
(Figure 2.9D) (Wang et al. 2008). Furthermore, miRNA can affect translation initiation 
by inhibit mRNA circularization (Figure 2.9E). The reported interaction of the GW182 
protein, one of the component of miRISC, with the poly (A)-binding protein (PABP) 
(Fabian et al. 2009; Zekri et al. 2009) may interfere with the closed-loop formation 
mediated by the eIF4G-PABP interaction and thus contribute to the repression of 
translation initiation (Fabian et al. 2010). The interaction of GW182 with PABPC1 is 
also required for the degradation of miRNA targets, most likely because the interaction 
facilitates the recruitment of the CCR4-NOT deadenylase complex (Zekri et al. 2009). 
 
For instance some natural or model miRNA repress translation at the initation step such 
as miR-122 in human hepatoma cells targeted CAT mRNA (Bhattacharyya et al. 2006), 
let-7 in C. elegans targeted Daf-12 and lin-41 (Ding and Grosshans 2009) and let-7 in 
mammalian cell (Humphreys et al. 2005; Pillai et al. 2005). 
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2.8.1.2 Repression at post-initiation step 
 
The observation that miRNA and their repressed target in both C. elegans and 
mammalian cells are associated with polyribosome (no change in polyribosome 
profiles) compared with non repressed mRNAs, suggesting that most miRNA targets 
are regulated after translational initiation (Maroney et al. 2006; Nottrott et al. 2006; 
Olsen and Ambros 1999; Petersen et al. 2006; Seggerson et al. 2002). Furthermore, the 
cap independent translation initiated by internal ribosome entry site (IRES) was also 
repressed by miRNA (Lytle et al. 2007; Petersen et al. 2006). The post-initiation 
repression by miRNA could result from degradation of nascent polypeptide chain 
derived from mRNA under miRNA control or miRNA leading to increase rate of 
ribosome drop off  and increased immature termination during elongation, resulting in 
incomplete protein product, (Figure 2.9A,B) (Nottrott et al. 2006; Petersen et al. 2006). 
 
2.8.2 mRNA decay mediated by microRNA 
 
It was originally thought that miRNAs affect primarily translation of mRNAs, it is now 
clear that the repression of many miRNA targets is frequently associated with their 
destabilization as demonstrated by microarray analysis of transcript level in cells and 
organ in which the miRNA pathway was inhibited (Bagga et al. 2005; Behm-Ansmant 
and Izaurralde 2006; Eulalio et al. 2007; Giraldez et al. 2006; Rehwinkel et al. 2005; 
Schmitter et al. 2006) or in which miRNA level were experimentally changed (Esau et 
al. 2006; Krutzfeldt et al. 2005; Lau et al. 2008; Lim et al. 2005; Linsley et al. 2007; 
Webster et al. 2009). 
 
In animal cells, the majority of miRNA target degradation is not because of 
endonucleolytic cleavage  by Ago but rather miRNA direct their targets to the cellular 5' 
-to-3' mRNA decay pathway, where mRNAs are first deadenylated by the CAF1–
CCR4–NOT deadenylase complex, and then decapped by the decapping enzyme DCP2 
(Figure 2.9F), which require several decapping activators including DCP1, Ge-1, EDC3, 
and RCK/p54, followed by the exonucleolytic decay (Behm-Ansmant and Izaurralde 
2006; Eulalio et al. 2008b; Eulalio et al. 2009; Eulalio et al. 2007; Giraldez et al. 2006; 
Rehwinkel et al. 2005; Valencia-Sanchez et al. 2006; Wu et al. 2006). The 
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exonucleolytic decay can occur for deadenylated mRNA from the 3' end by the 
exosome and cofactors and also can be subsequent for decapping by the 5'-to-3' 
exoribonuclease, Xrn1p (Parker and Song 2004; Valencia-Sanchez et al. 2006). The 
exact process of target selection to be degraded or not was not clear, but it has been 
proposed that the number, type, and position of mismatches in the miRNA/mRNA 
duplex play an important role in triggering degradation or translation arrest (Aleman et 
al. 2007). 
 
  
Figure 2.9 : Mechanisms of miRNA-mediated gene silencing  (Eulalio et al. 2008a). 
 
 
 
 Literature review 33 
2.8.3 Another mode of action (Activation by microRNA) 
 
Several studies give evidences that miRNA may also function to induce gene expression 
through different mechanism under certain conditions, Vasudevan and collaborators 
demonstrated that miRNA act as translation repression in proliferating cells and as 
activator in cells arrested in G0/G1. Their result showed that miR-369-3 directs 
association of Ago and fragile X mental retardation–related protein 1 (FXR1) with 
AREs in tumor necrosis factor alpha (TNFα) to activate translation under serum 
starvation by direct base pairing between miRNA seed sequence and complementary 
AREs in TNFα (Vasudevan et al. 2007). In another studies, miR-10a bind to 5'-UTR of 
mRNA encoding ribosomal protein and enhanced their translation during amino acid 
starvation, although this miRNA caused translation repression of Ras-related nuclear 
protein (Ran) and penicillin- binding protein (Pbp1) when binding to its 3'-UTR (Orom 
et al. 2008). 
 
The effect of miRNA on gene expression showed to be position dependant, for instance, 
liver specific miRNA (miR-122) was shown to up-regulate the level of hepatitis C virus 
(HCV) RNA by stimulating RNA replication following its interaction with the 5'-UTR 
of HCV RNA genome, while binding of miR-122 to 3'-UTR of reporter mRNA lead to 
down regulation of mRNA expression (Henke et al. 2008; Jopling et al. 2008), miR-122 
may protect HVC RNA from nucleolytic degradation through binding to 5' terminus of 
HVC RNA with 3' overhanging nucleotide and masking the 5' terminal sequence of the 
virus genome (Machlin et al. 2011). 
 
 Some miRNA induced gene expression through targeted promoter sequence of this 
gene as miR-373 which have target sit within promoter sequence of E-cadherin and cold 
shock domain containing protein (CSDC2) and induced expression of their protein, 
moreover, enrichment of RNA polymerase II was detected at both promoter after miR-
373 transfection (Place et al. 2008). Similarly, miR-205 induced expression of tumor 
suppressor genes IL24 and IL32 at both the messenger RNA and protein levels by 
targeting specific sites in their promoters (Majid et al. 2010). 
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The ability of miRNAs to concurrently down-regulate transcripts by post-transcriptional 
gene silencing mechanisms and potentially up-regulate target genes reveal a more 
complex nature and fundamental importance of miRNAs in regulating gene expression 
(Place et al. 2008). 
 
2.9 Regulation of microRNA  
 
MicroRNAs have been shown to be important regulators of many biological process 
including: temporal development events, cell differentiation, proliferation, cell cycle 
regulation, oocyte maturation, spermatogenesis, embryonic development, apoptosis, 
metabolism,  placenta formation, immunity and tumorigenesis (Asangani et al. 2008; 
Carleton et al. 2007; Cloonan et al. 2008; Cui et al. 2009; Esquela-Kerscher and Slack 
2006; Houbaviy et al. 2003; Maatouk et al. 2008; Silber et al. 2008; Taganov et al. 
2007; Tesfaye et al. 2009; Wilfred et al. 2007; Zhao and Srivastava 2007). However, 
miRNA itself also has developmental and tissue specific regulation mechanisms 
although a considerable amount of known miRNAs are expressed universally in various 
tissues and species (Biemar et al. 2005). Regulation and control of miRNAs biogenesis, 
expression  and  function affected by different factors and regulatory mechanisms such 
as sequence specific RNA binding proteins with double-strand RNA binding domains 
(dsRBDs), single nucleotide polymorphisms (SNPs) which created by changes in DNA 
sequences of miRNA-coding genes or in an miRNA-binding site in mRNAs, RNA 
editing which displays a micro-regulatory role in controlling the miRNA processing 
machinery,  methylation and circadian clock modulated mechanisms (Han et al. 2007; 
Kawahara et al. 2007; Kedde et al. 2007; Lehmann et al. 2008; Slezak-Prochazka et al. 
2010; Sun et al. 2009; Yang et al. 2006).  
 
2.10 MicroRNA in oocyte and ovarian somatic cells 
 
The target deletion of Dicer, the RNase III enzyme that processes precursor microRNA 
into mature single stranded miRNA, within female reproductive tissues indicated to the 
importance of miRNA in a variety of developmental and functional processes. First 
report of miRNA processing role in reproductive function was reported for the female 
germline during meiosis in mouse (Murchison et al. 2007). In this study, Murchison and 
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his colleagues (2007) showed that  knockouts of Dicer in mouse oocyte lead to specific 
arrest in meiosis I and exhibit both chromosome segregation defects and multiple 
disorganized spindles, moreover, the authors posit that loss of miRNAs could deregulate 
the levels of gene products needed for successful meiosis and in support of this, they 
indicated that analysis of the transcripts found in developing oocytes lacking Dicer are 
enriched for genes involved in microtubule related processes including twelve genes 
with predicted miRNA targets, among them being the GTPase Ran whose activity is 
known to be directly regulated by the condensation state of chromosomes. Similar result 
obtained from mouse oocyte injected with Dicer siRNA showed significant reduction in 
maturation rate, increased spindle disorganization and chromosome misalignment rates 
and reduced transcript of Dicer, miRNA, spindle formation proteins and spindle check 
point genes, thus, indicated that Dicer and miRNA appear to have important role during 
oogenesis and meiosis completion (Liu et al. 2010). 
 
Reduced expression of dicer in females results in infertility (Carletti and Christenson 
2009; Otsuka et al. 2008). In addition, females without Dicer exhibited disrupted 
oviduct and uterine development, as well as reduced ovarian function, as evidenced by 
decreased ovulation rate and presence of oocyte being trapped within the luteinized 
follicles (Hong et al. 2008). 
 
The expression of microRNA genes is tightly regulated spatially among tissues and 
temporally during development within tissues in all species studied, indicating the 
importance of determining miRNA expression profiles to fully understand livestock 
biology (Aboobaker et al. 2005; Coutinho et al. 2007; Wienholds and Plasterk 2005). 
Several studies have identify and analyzed the expression profiles of miRNAs in female 
reproductive tissue of different species, such as, Ro et al. (2007) identified 122 (15 are 
novel) miRNAs in adult mouse ovary, Tang et al. (2007) showed dynamic changes in 
miRNA expression during oogenesis by a real-time PCR-based miRNA expression 
profiling method in single mouse oocyte, Mishima et al. (2008) obtained 154 known 
miRNAs in the adult ovary,  Hossain et al. (2009) identified 74 miRNAs in the bovine 
ovary, 36 were found to be reported in miRBase 12.0 for different species including 
bovine, 14 are registered only for other species and 24 were completely new, Tesfaye et 
al. (2009) revealed the differential expression of 59 miRNAs, of which 31 and 28 
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miRNAs were found to be differentially expressed in immature and matured oocytes, 
respectively, Yao et al. (2010b) identified 260 mature miRNA transcripts in rat 
granulose cells via microarray analysis, Tripurani et al. (2010a) identified 58 miRNAs 
in the bovine fetal ovary, 42 are known bovine miRNAs present in the miRBase 
database and the remaining 16 miRNAs include 15 new bovine miRNAs that are 
homologous to miRNAs identified in other species, and one novel miRNA and the  
expression analysis of these miRNAs in fetal ovaries in comparison to somatic tissue 
pools identified 8 miRNAs predominantly expressed in fetal ovaries. Moreover, further 
analysis of the eight miRNAs in germinal vesicle (GV) stage oocytes identified two 
miRNAs that are highly abundant in both GV oocytes and Metaphase II stage oocytes.  
Ahn et al. (2010) identified 398 known miRNA species and 118 are novel miRNAs in 
new born mouse ovary using the Illumina Genome Analyzer and Creighton et al. (2010) 
reported the identification of 132 novel miRNAs through deep sequencing of small 
RNA libraries from 103 tissues or cell lines derived from human female reproductive 
organs in both normal and diseased states. 
 
The ovary contains multiple somatic cell types such as granulosa cells, cumulus cells 
and theca cells in addition to oocytes. Bidirectional communication between the oocyte 
and companion somatic cells plays a very important role in follicle development 
(Matzuk et al. 2002). Deletion of Dicer1 in follicular granulosa cells led to impaired 
functional gene expression in granulosa cells, degenerate oocytes with obvious 
morphological defects and down-regulation of oocyte-specific genes (Lei et al. 2010). 
Although, ovulation could occur in presence of the deletion of Dicer1 in follicle 
granulosa cells, but impaired egg development is one of the major reasons for the 
infertility of dicer conditional knockout mice (Gonzalez and Behringer 2009; Nagaraja 
et al. 2008). 
 
Many miRNA have been identified in ovarian granulosa cell (Fiedler et al. 2008; Yao et 
al. 2010b) and the putative function of some identified miRNA being revealed. Specific 
microRNAs (miR-21, miR-132 and miR-212) appear to be up-regulated after the LH 
surge and inhibition of miR-132 using complementary locked nucleic acid (LNA) 
oligonucleotides decrease C terminal binding protein-1 (CTBP1) protein levels, which 
in turn may directly affect granulose cell steroid production as was shown to regulate 
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adrenal steroidogenesis by serving as a corepressor of steroidogenic factor-1 (SF1) 
activity (Dammer and Sewer 2008; Fiedler et al. 2008). Furthermore, the ectopic 
expression of miR-224 can enhance TGF-β1 induced GC proliferation through targeting 
SMAD4 and partial inhibition of these miRNA lead to suppression of GC proliferation 
induced by TGF-β1. In addition, both miR-224 and TGF-β1 can promote estradiol 
release from GC, at least in part, through increasing CYP19A1 mRNA levels. Such 
miRNA-mediated effects could be potentially used for regulation of reproductive 
processes or for treatment of reproductive disorders (Yao et al. 2010a). Conversely, 
miR-378 down-regulates porcine ovarian garnulosa cell aromatase protein levels and 
estradiol production via binding within the 3'-UTR of the aromatase transcript (Xu et al. 
2011b). In human primary granulose cells, multiple microRNAs can control 
reproductive functions resulting in enhancement or inhibition the release of ovarian 
progesterone, androgen and estrogen. So, such miRNA-mediated effects could be 
potentially used for regulation of reproductive processes, including fertility, and for 
treatment of reproductive and other steroid-dependent disorders (Sirotkin et al. 2010). 
On the other hand, expression of 31 miRNAs altered during the process of FSH induced 
progesterone production of cultured rat granulosa cell by using microarray analysis and 
this indicated that FSH may have role in regulation of miRNA expression (Yao et al. 
2010b). 
 
MicroRNAs are arising as important mediators of proliferation, differentiation, and 
apoptotic events (Ademokun and Turner 2008; Bueno et al. 2008; Chivukula and 
Mendell 2008; Gangaraju and Lin 2009; He et al. 2007; Jovanovic and Hengartner 
2006). Recent study, demonstrated the involvement of miRNAs in controlling both 
proliferation and apoptosis by ovarian granulose cells, 11 and 53 from 80 tested 
miRNAs constructs resulted in stimulation and inhibition of PCNA (proliferation 
marker) expression, respectively and 11 of the 80 tested miRNAs promoted 
accumulation of Bax (apoptosis marker), while 46 miRNAs caused a reduction in Bax 
in human ovarian cells. Furthermore, the opposite effects of tested miR-15a antagonist 
and precursor on PCNA, as well as the similarity of effect of some selected miRNAs on 
the expression of two markers of cell proliferation (PCNA and cyclin B1) and of three 
markers of apoptosis (Bax, TdT and caspase 3) confirm the specificity of miRNAs 
effect on both proliferation and apoptosis of human ovarian cells (Sirotkin et al. 2010).  
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MiR-21 acts as an anti-apoptotic factor in in vivo and in vitro cultured murine granulosa 
cells, also loss of miR-21 in vivo leads to reduced ovulation rates (Carletti et al. 2010). 
 
All studies mentioned above provide direct evidence for the significant role of miRNA 
in regulation of gene function in the ovary. However, other contradictory reports 
demonstrated that miRNA function is limited in mouse oocyte and early embryo based 
on Dgcr8-deficient oocytes, although miRNA levels of mouse oocytes with Dgcr8 
deletion were reduced to the similar levels as Dicer-deficient mice, meiosis was not 
affected as in the oocytes from Dicer knockout mice but the Dgcr8 knockout mice 
suffered from unexpected low fecundity (Ma et al. 2010; Suh et al. 2010). In addition 
the limite miRNA change in human oocytes during meiosis (Xu et al. 2011a) supports 
the notion that miRNAs may play specific, rather than global, regulatory functions in 
gene expression during oocyte maturation. Furthermore, species difference may  
interpret the distinct temporal miRNA expression patterns during oocytes development  
as Mtango et al. (2009) showed that the expression of genes involved in miRNA 
processing in oocyte (DICER, GEMIN, TNRC6B, RANGAP1 and RNASEN) appeared 
to be regulated differently in mouse and rhesus monkey. Up to now, the exact role of 
miRNAs in the oocytes remains unclear.  
 
2.11 MicroRNA in embryonic development 
 
Embryonic development in mammals including a various critical events: transition from 
oocyte to embryo, the first cell cleavage, the establishment of cellular contacts and the 
first cell lineage. During all previous steps there are several molecular events that the 
preimplantation embryo passes it including maternal mRNA degradation, transcriptional 
zygotic activation, compaction and inner cell mass/trophoectoderm differentiation. 
Early embryo development depends on maternal transcripts accumulated during oocyte 
growth. The maternal control period on embryonic development vary among species 
according to the beginning of embryonic genome activation and the degradation of 
maternal gene products (DeRenzo and Seydoux 2004). The embryonic genome 
activation begins in mice at two-cell stage, in humans, rats and pigs at four-cell stage 
and in cattle and sheep at eight-cell to 16-cell stage (Barnes and First 1991; Telford et 
al. 1990). 
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Degradation of maternal mRNA is critical for early embryo development, There are 
multiple negative regulatory mechanisms which have important role in post-
transcriptional regulation of maternal transcripts, for instance, transcript deadenylation 
and interaction with RNA-binding proteins in a nonspecific or sequence-specific 
fashion (Bettegowda and Smith 2007). The first direct evidence of miRNA action in 
early embryonic development became clear after the establishment of null embryos for 
Dicer in mice (Bernstein et al. 2003). Also in mouse embryos, 390 miRNAs were 
detected using deep sequencing and some of these miRNAs showed temporal 
expression profiles during prenatal development (Mineno et al. 2006). 
 
The role of microRNAs as key regulatory molecules targeting maternal mRNA for 
degradation during the maternal-to-embryonic transition (MET) have been established 
in zebrafish, where the miR-430 level increased at the onset of embryonic genome 
activation and targeting several hundred maternal mRNAs by binding to their 3'-UTR 
and promotes their deadenylation (Giraldez et al. 2006). Furthermore, maternal 
deposited miRNAs are needed for zygotic function in mouse as the zygotes result from 
occyte lacking dicer failed to complete the first cell division (Tang et al. 2007). Another 
specific miRNA has been shown to be responsible of the degradation of many maternal 
mRNAs such as miR-290 in mouse and miR-427 in Xenopus (Lund et al. 2009; Tang et 
al. 2007). Additionally, zygotic specific miRNA (miR-135a) modulates the first cell 
cleavage through regulating expression of E3 ubiquitin ligase, Seven in absentia 
homolog 1A (Siah1a), which in turns affect destabilization of chemokinesin DNA 
binding protein (Kid), which mediates chromosome compaction and is degraded by the 
proteasome pathway during mitosis (Germani et al. 2000; Ohsugi et al. 2008; Pang et al. 
2011). In addition, embryonic tissues of Drosophila and mouse expressed more miRNA 
than that of adults (Yu et al. 2007). So, these previous data could implicate the active 
role of miRNA in embryonic development. 
 
In bovine, little is known about the expression of miRNA in embryonic tissue. The first 
profile of miRNA expression in day 30 bovine embryos was providing data for at least 
17 new miRNAs not previously known in cattle and not matching published human or 
mouse data (Coutinho et al. 2007). Moreover, expression profiling of miRNA during 
late elongation of bovine in vitro produced and somatic cell nuclear transfer (SCNT) 
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embryos identified 39 miRNAs expressed in elongated Day 17 cloned bovine embryos 
produced by handmade cloning (HMC), 32 miRNAs expressed in time-matched IVP 
embryos, and 22 miRNAs in the somatic cells used for cloning. The subset of miRNAs 
expressed in the IVP embryos could be considered embryonic miRNAs, most were also 
present in cloned bovine embryos (Castro et al. 2010), as well as, the most highly 
expressed miRNAs in IVP bovine embryo (miR-30d and miR-26a) interact with 
Trophoblast kunitz domain protein (TKDP) which involved in maternal recognition of 
pregnancy in cattle (Castro et al. 2010; Lagos-Quintana et al. 2001). Tesfaye et al. 
(2009) showed highly variable trends in expression patterns of six miRNAs (miR-125a, 
miR-25, miR-127, miR-208, miR-145 and miR-496) during bovine preimplantation 
development. 
 
From eight miRNAs predominantly expressed in bovine fetal ovary, two miRNA bta-
miR-424 and bta-miR-10b being highly abundant in GV and MII stage oocytes as well 
as in early stage embryos (until 16-cell) with a tendency of decreasing in morula and 
blastocyst stage embryos, such expression pattern of these two miRNAs indicated that 
these miRNAs are maternally inherited and may potentially be involved in the maternal 
transcript turnover during zygotic gene activation as miR-430 in Zebrafish (Giraldez et 
al. 2006; Tripurani et al. 2010a). 
 
Recently, Tripurani et al. indicated that miR-196a involvement in maternal transcript 
degradation during the maternal-to-zygotic transition through its expression which 
increased near the eight-cell stage and declines at morula and blastocyst stages of 
embryogenesis, furthermore, they demonstrated that miR-196a is negative regulator of 
NOBOX, which is maternal transcription factor and have functional role in bovine early 
embryonic development (Tripurani et al. 2010b; Tripurani et al. 2011). 
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3 Materials and methods 
3.1 Materials for laboratory analysis 
In this section, materials used in this study such as chemicals, kits, all other biological 
materials, reagents, media, equipments, softwares and their sources are mentioned.  
3.1.1 Chemicals, kits, biological and other materials 
 
Chemicals, kits, biological and other 
materials 
Supplier 
Acetic acid Roth, Karlsruhe, Germany 
Acetic anhydride Sigma-Aldrich Chemie GmbH,  
  Munich, Germany 
Agar-Agar Roth, Karlsruhe, Germany 
Agarose Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Ampicillin Roth, Karlsruhe, Germany 
Anti-Digoxigenin-AP Roche 
Diagnostics 
BME EAA 50X  
(essential amino acids) 
Roche Diagnostics GmbH, 
Mannheim, Germany 
Invitrogen Life Technologies, 
Karlsruhe, Germany 
Brilliant cresyl blue stain (BCB) Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Bromophenol blue Roth, Karlsruhe, Germany 
Calcium chloride dihydrate 
 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Chloroform Roth, Karlsruhe, Germany 
Citric acid Sigma-Aldrich Chemie GmbH, 
Munich, Germany  
Diethylpyrocarbonate (DEPC) Roth, Karlsruhe, Germany 
Dithiothreitol (DTT) Invitrogen Life Technologies, 
Karlsruhe, Germany  
dNTPs Roth, Karlsruhe, Germany 
Dye Terminator Cycle Sequencing 
(DTCS) 
Beckman Coulter, Krefeld,  
Germany 
Ethanol Roth, Karlsruhe, Germany 
Ethidium bromide Roth, Karlsruhe, Germany 
Ethylenediaminetetraacetic acid  Roth, Karlsruhe, Germany 
(EDTA)  
ExoSAP-IT USB, Ohio, USA 
Fast Red Substrate System Dako Deutschland GmbH, Hamburg, 
Germany 
Fetal Calf Serum (FCS) Gibco, Karlsruhe, Germany 
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Follicular stimulating hormon (FSH) Folltropin, Vetrepharm, Canada 
Formamide 65% Roth, Karlsruhe, Germany 
GenElute TM plasmid Miniprep kit Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Gentamycin Invitrogen Life Technologies, 
Karlsruhe, Germany 
Gentamycin sulphate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Glucose Roth, Karlsruhe, Germany 
Glycerol Roth, Karlsruhe, Germany 
Glycogen for sequencing Beckman Coulter, Krefeld, Germany 
Heparin Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Hemi-calcium lactate Promega, WI, USA 
HEPES Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Hyaluronidase Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Hydrochloric acid (HCL) Roth, Karlsruhe, Germany 
Igepal Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Isopropyl -D-thiogalactoside (IPTG) Roth, Karlsruhe, Germany 
iTaqTM SYBR® Green Supermix with  
ROX  
Bio-Rad, Hercules, CA 
L-Glutamine  Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
LNA-modified oligonucleotide ISH probes 
(1pM) for miR-205, miR-210, U6 RNA 
and scrambled RNA sequence  
Exiqon, Vedbaek, Denmark 
Magnesium chloride hexahydrate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Medium 199 Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
MEM NEAA 100X 
(non-essential amino acids) 
Invitrogen Life Technologies, 
Karlsruhe, Germany  
Methanol Roth, Karlsruhe, Germany 
Mineral oil Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
MiRNA PCR array SABiosciences, Frederick, MD 
MiRNeasy® mini kit QIAGEN, Hilden, Germany 
Oligonucleotide primers MWG Biotech, Eberberg, Germany 
Oligo (dT) 23 Promega, WI, USA 
pGEM®-T vector Promega, WI, USA 
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Penicillin G Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Peptone Roth, Karlsruhe, Germany 
Phenol red solution (5% in D-PBS) Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Potassium chloride Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Proteinase K Roth, Karlsruhe, Germany 
QIAquick PCR Purification Kit QIAGEN, Hilden, Germany 
Random hexamer Invitrogen, CA, USA 
Ribo-nuclease inhibitor (RNasin) Promega, WI, USA 
RT2 miRNA first Strand kit 
RT2 miRNA PCR Array 
SABiosciences, Frederick, MD 
SABiosciences, Frederick, MD   
RT2 qPCR-Grade miRNA isolation kit SABiosciences, Frederick, MD 
RT2 miRNA qPCR assay primer set  SABiosciences, Frederick, MD 
and U6  (endogenous controls)   
RT2 Real-TimeTM PCR master mix  SABiosciences, Frederick, MD 
(RT2 SYBR Green PCR master mix)  
Sample loading solution (SLS) Beckman Coulter, Krefeld, Germany 
Sequagel XR Sequencing Gel Biozym Diagnostic, Epicentre 
Technologies, Hessisch-Oldendorf 
Sodium acetate (NaOAc) Roth, Karlsruhe, Germany 
Sodium chloride (NaCl) Roth, Karlsruhe, Germany 
Sodium citrate Roth, Karlsruhe, Germany 
Sodium hydroxide Roth, Karlsruhe, Germany 
Sodium hydrogen carbonate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Sodium monohydrogen phosphate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Sodium dihydrogenphosphate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Sodium pyruvate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Sodium lactate solution 60% Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Streptomycin sulfate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Sucrose Roth, Karlsruhe, Germany 
Superscript II reverse transcriptase Invitrogen, CA, USA 
Taq DNA polymerase Sigma-Aldrich Inc, MO, USA  
TCM-199   Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
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T4 DNA ligase Promega, WI, USA 
Tissue-Tek OCT reagent  Sakura Finetek, Zoeterwoude, NL 
Triethanolamine Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Tris Roth, Karlsruhe, Germany 
TURBO DNA-freeTM kit  Ambion, Foster City, CA 
Tween-20 Roth, Karlsruhe, Germany 
X-Gal (5-bromo-4-chloro-3- indolylbeta Roth, Karlsruhe, Germany 
-D-galactopyranoside) 
Vectashield containing DAPI 
 
Vector laboratories, Burlingame, CA 
Yeast extract Roth, Karlsruhe, Germany 
Yeast tRNA Invitrogen, CA, USA 
10X PCR buffer Promega, WI, USA 
 5 α DH Escherichia coli competent  Stratagene, Amsterdam 
Cells  
5X First strand buffer Invitrogen Life Technologies, 
Karlsruhe, Germany 
2X rapid ligation buffer Promega, WI, USA 
3'-Digoxigenin (DIG) labeled  Exiqon, Vedbaek, Denmark 
 
3.1.2 Reagents and media preparation 
 
During this experiment, the following reagents and media formulation were used. All 
solutions used in this study were prepared with deionised and demineralised millipore 
water (ddH2O) and when necessary, the pH was adjusted with sodium hydroxide 
(NaOH) or hydrochloric acid (HCl). In addition, the solutions or buffers were 
subsequently filtered through 0.2 µ filter and autoclaved at 120°C for 20 minutes when 
it is necessary. 
 
       Amount/ Name of the medium/buffer  Constituents 
       Volume 
Physiological saline solution  : Sodium chloride 9.0 g 
( NaCl 9%)   added to water                                   1000.0 ml 
   
Maturation medium : HEPES 0.149 g 
(Modified Parker Medium)                                               Sodium pyruvate 0.025 g 
   L-Glutamine    0.010 g 
   Gentamycin                 500.0 µl 
   Medium 199       99.0 ml 
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   Hemi Calcium lactate     0.06 g 
   Add to water                                                               110.0 ml 
  
 
Manipulation medium : TCM-199 1500.0 g 
   Gentamycine sulfate 0.050 g 
   Sodium pyruvate 0.022 g 
   NaHCO3 0.350 g 
   BSA 1.00 g 
   Water up to 1000.0 ml 
  
 
Fertilization medium : Sodium chloride  0.3300 g 
(Fert-TALP medium)   Potassium chloride 0.0117 g 
   Sodium hydrogen carbonate 0.1050 g 
   Sodium dihydrogen phosphate 0.0021 g 
   Penicillin 0.0032 g 
 
  Magnesium chloride 
hexahydrate 0.0050 g 
   Calcium chloride dihydrate 0.0150 g 
   Sodium lactate solution (60%) 93.0 µl 
 
  Phenol red solution (5% in D-       
PBS) 100.0 µl 
   Water up to 50.0 ml 
   
Capacitation medium (50 ml) : Sodium chloride 0.2900 g 
   Potassium chloride 0.0115 g 
   Sodium hydrogen carbonate 0.1050 g 
 
  Sodium dihydrogene   
phosphate 0.0017 g 
   Hepes 0.1190 g 
 
  Magnesium chloride 
  dihydrate  0.0115 g 
   Calcium chloride dihydrate 0.0145 g 
   Sodium lactate solution  (60%) 184.0µl 
        
  Phenol red solution (5% in D-
PBS)   100.0 µl 
   ddH2O up to 50.0 ml 
   
Penicillamine hypotaurine   : Physiological saline (0.9%) 16.0 ml 
adrenaline medium   Hypotaurin solution 10.0 ml 
   Epinephrin solution 4.0 ml 
   
CR1aa culture media (50 ml) : Hemi-calcium lactate 0.0273 g 
   Streptomycin sulphate 0.0039 g 
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   Penicillin G 0.0019 g 
   Sodium chloride 0.3156 g 
   Potassium chloride 0.0112 g 
   Sodium hydrogen carbonate 0.1050g 
   Sodium pyruvate 0.0022 g 
   L-Glutamine 0.0073 g 
 
  Phenol red solution (5% in D-
PBS) 100.0 µl 
   Sodium hydrogen carbonate 0.080 g 
   
Lysis buffer (100 µl) : Igepal  (0.8%) 0.8 µl 
   40U RNasin 5.0 µl 
   DTT 5.0 µl 
   ddH2O added to  100.0 µl 
   
SOC media (400 ml) : Peptone 4.0 g 
   Yeast extract 4.0 g 
   NaCl 1M                                               2.0 ml 
   KCl 1M                                              500.0 ml 
   ddH2O  added to   400.0 ml 
   Mg+2  2M  2.0 ml 
   Glucose  2M                                                                                     2.0 ml
   
LB-agar (800 ml) : Sodium chloride 8.0 g 
 
   Peptone 8.0 g 
 
  Yeast extract 4.0 g 
 
  Agar-Agar 12.0 g 
 
  Sodium hydroxide (40 mg/ml) 480.0 µl 
 
  ddH2O added to 800.0 ml 
 
  
dNTP solution : dATP (100 Mm)  10.0 ml 
   dCTP (100 mM) 10.0 ml 
   dGTP (100 mM) 10.0 ml 
   dTTP (100 mM) 10.0 ml 
   ddH2O  added to  400.0 ml 
   
Agarose loading buffer : Bromophenol blue           0.0625 g 
 
  Xylencyanol 0.0625 g 
 
  Glycerol 7.5 ml 
 
  ddH2O  added to  25.0 ml 
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IPTG solution : IPTG 1.2 g 
 
  ddH2O  added to   10.0 ml 
 
  
X-gal : X-gal 50.0 mg 
 
 ddH2O  added to  1000.0 ml 
 
  
DEPC-treated water (1000 ml) : DEPC  1.0 ml 
  ddH2O added to                                                                                                      1000.0 ml
   
EDTA 100 Mm  (pH 2.0) : EDTA  37.224 g 
  Water up to  1000.0 ml 
   
3M Sodium Acetate (pH 5.2) : Sodium Acetate 123.1 g 
 
 ddH2O  added to  500.0 ml 
 
  
Stop solution : 3M Sodium Acetate (NaOAc)  2.0 µl 
   pH = 5.2  
   100 mM EDTA  2.0 µl 
   Glycogen (20 mg/ml) 1.0 µl 
 
  
10X PBS : NaCl 8.77 g 
 
  Na2HPO4 1.50 g 
 
  NaH2PO4 2.04 g 
 
  Water up to 1000.0 ml 
 
  
1X PBS : 10X PBS 100.0 ml 
 
  DEPC added to 900.0 ml 
 
  
4% paraformaldehyde (pH 7.3) : Paraformaldehyde 4.0 g 
   1X PBS 100.0 ml 
   
Proteinase K solution : Proteinase K 20 mg 
 
  DEPC-treated H2O 1 ml 
 
  
Yeast tRNA (10 mg/ml) : Yeast tRNA 25.0 mg 
 
  DEPC-treated H2O 
 
2.50 ml 
20X SSC : NaCl 87.65 g 
 
  Sodium citrate 44.1 g 
 
  Water upto 500.0 ml 
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5X SSC : 20X SSC 250.0 ml 
   DEPC water 750.0 ml 
   
2X SSC : 20X SSC 100.0 ml 
   DEPC water 900.0 ml 
   
0.2X SSC : 20X SSC 10.0 ml 
 
  DEPC water 990.0 ml 
 
  
1X PBST : 1X PBS 999.0 ml 
 
  Tween-20 1.0 ml 
 
  
0.5 M Sucrose/PBS  : Sucrose 85.57 g 
(30% sucrose)   1X PBS upto 500.0 ml 
   
Acetylation solution : Triethanolamine 2.33 ml 
 
  Acetic anhydride 500.0 µl 
 
  DEPC water added to 200.0 ml 
 
  
B1 solution : 1 M Tris (pH 7.5) 100.0 ml 
 
  5 M NaCL 30.0 ml 
 
  ddH2O added  to 1000.0 ml 
 
  
Blocking Solution : FCS 2.0 ml 
 
  B1 solution 18.0 ml 
 
  
Hybridization solution : Formamide 65% 32.25 ml 
 
  20X SSC 12.5 ml 
 
  Tween-20, 0.1% 50.0 µl 
 
  1M citric acid 460.0 µl 
 
  Heparin 50 µg/ml 2.5 mg 
 
  tRNA 500µg/ml 2.5 ml 
 
  DEPC water upto 50.0 ml 
 
  
Hybridization washing buffer : Formamide 65% 65.0 ml 
 
  20X SSC 25.0 ml 
 
  Tween -20, 0.1% 100.0 ml 
 
  1M citric acid 1.2 µl 
 
 
  DEPC water upto 100.0 ml 
1X PBS-Tween (PBST) : 1X PBS  999.0 ml 
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   Tween-20  0.50 ml 
  
 
50X TAE buffer, pH 8.0 : Tris 242.0 mg 
 
  Acetic acid 57.1 ml 
 
  EDTA (0.5 M) 100.0 ml 
 
  ddH2O added to 1000.0 ml 
   
2% Agarose gel : Agarose 2.0 g 
  
  1X TAE buffer 100.0 ml 
  
3.1.3 Equipment used in the study 
 
Equipments  Manufacturer 
ABI PRISM® 7000 SDS Applied Biosystems, Foster City, CA 
Agilent 2100 bioanalyzer  Agilent Technologies, CA, USA 
Carbon dioxide incubator (MCO-17AI)  Sanyo, Japan 
Centrifuge (small, medium, larg) Hermle, Wehingen, Germany 
CEQ TM 8000 genetic analysis system Beckman Coulter, Krefeld, Germany 
Confocal laser scanning microscope-510 Carl Zeiss, Germany 
Cryo-tube Nunc, Roskilde, Germany 
Electrophoresis chamber (for agarose gels) Bio-Rad, Munich, Germany 
Four well dishes Thermo Fisher Scientific, Nunc, 
Denmark 
Hybridization chamber GFL, Dülmen, Germany 
IKA vortex mixer Agilent technologies, Germany 
Incubator (BB16) Heraeus, Hanau, Germany 
Inverted microscope   Leica DM-IRB, Germany 
Laminar flow chamber Heraeus, Germany 
MAXQ6000 shacking incubator Thermo scientific, Germany 
Millipore apparatus  Millipore corporation, USA 
Mini centrifuge Labnet, UK 
Micromanipulator Leitz, Germany 
Microplates for real-time PCR STARLAB GmbH, Ahrensburg 
Microwave Micro maxx®, Germany 
Molecular imager chemidoc XRS System Bio-Rad, Munich, Germany 
MyCycler thermal cycler Bio-Rad, Munich, Germany 
NanoDrop 8000 spectrophotometer Thermo scientific,Germany 
PH meter  Kohermann, Germany 
PTC-100 thermal cyclers MJ Research, USA 
Rapid sectioning cryostat Leica microsystem Nussloch GmbH, 
Heidelberger, Germany 
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Refrigerated universal centrifuge  
Z233MK 
Hermle Labortechnik, Wehingen, 
Germany 
Savant speed vac GMI, Inc. Minnesota, USA 
Slide SuperFrost® Plus Braunschweig, Germany 
Stereo microscope SMZ 645 Nikon, Japan 
Thermalshake Gerhardt John Morris scientific, Melbourne 
Tuttnauer autoclave  Connections unlimited, Wettenberg 
Ultra low freezer (-80°C) Labotect GmbH, Gottingen 
UV Transilluminator (Uvi-tec) Uni Equip, Martinsried, Germany 
 
3.1.4 Programs (softwares) and statistical packages used 
 
Software and packages Source 
BLAST program       http://www.ncbi.nlm.nih.gov/Blast/ 
ENSEMBL genome browser  http://www.ensembl.org/ 
Entrez Gene http://www.ncbi.nlm.nih.gov/ 
EndNote X1  Thomoson 
GraphPad prism v.5 GraphPad software, Inc. 
Ingenuity Pathways Analysis 
software (Ingenuity IPA 8.5) 
Ingenuity® Systems, www.ingenuity.com 
MiRBase v.12  http://www.mibase.org/ 
miRDB http://www.mirdb.org/ 
MicroRNA.org-Target and 
Expression 
http://www.microrna.org/ 
PicTar  http://www.pictar.org/ 
Primer Express® software v.2.0      Applied Biosystems, Foster City, CA, USA 
SAbiosciences’s PCR array  
data analysis 
TargetScan  5.1  
http://www.sabiosciences.com/pcrarraydataanal
ysis.php 
http://www.targetscan.org/ 
Weight to molar quantity   http://www.molbiol.ru/eng/scripts/01_07.html 
(for nucleic acids) converter  
ZEN 2008 Light Edition Carl Zeiss, Germany 
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3.2 Methods 
 
3.2.1 Experimental design 
 
 
 Cumulus oocyte complex (COC), in vitro maturation (IVM), brilliant cresyl blue (BCB), matured oocyte 
(Mo), zygote (Z), denuded oocytes (DO) and oocyteoctimized (OOX) 
  
Figure 3.1: Overview of the present study 
 
3.2.2 Cumulus oocyte complexes collection and in vitro maturation 
 
Bovine ovaries were collected from local abattoirs and transported to the laboratory 
within 2-3 hrs in a thermo flask containing 0.9% physiological saline solution (NaCl) at 
39ºC. Before aspiration of COCs, the ovaries were washed twice in 70% ethanol. 
Cumulus oocyte complexes were aspirated from antral follicles having 2-8 mm diameter 
using 5 ml syringe attached to 18 gauge needle. The aspirated follicular fluid was 
collected in 50 ml sterilized tube and allowed to precipitate for 15 min. Only 
morphologically uniform and good quality COCs (oocytes with multiple layers of 
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cumulus cells and has a translucent and homogeneous ooplasm) were picked using 
glass-pipette under stereo microscope (Nikon, Japan) and washed three times in 
maturation medium (Modified Parker Medium (MPM)) supplemented with 15% ostrous 
cow serum (OCS), 0.5 mM l-glutamine, 0.2 mM sodium pyruvate, 50 mg/ml 
gentamycin sulphate and 10 µl/ml follicular stimulating hormone (FSH) (Folltropin, 
Vetrepharm, Canada) before set into culture to obtain matured oocytes or directly 
freezed as immature oocytes. The COCs were cultured in a group of 50 in 400 µl of 
maturation medium under mineral oil in four-well dishes (Thermo Fisher Scientific, 
Nunc, Denmark). Maturation was performed for 24 hr at 39°C under a humidified 
atmosphere of 5% CO2 in air. Both immature and matured COCs were collected and 
subjected to mechanical separation of the oocytes and the surrounding cumulus cells 
using gentle vortexing. Denuded oocytes in a group of 200 and the corresponding 
cumulus cells were snap-frozen in cryo-tubes containing lysis buffer [0.8% Igepal 
(Sigma-Aldrich Chemie GmbH, Munich, Germany), 40U RNasin (Promega, WI, USA) 
and 5 mM DTT (Invitrogen Life Technologies, Karlsruhe, Germany)] and stored at -
80°C until further use. A total of three replicate pools each containing 1600 oocytes and 
their corresponding cumulus cells from both immature and matured COCs were utilized 
for analysis of miRNA using a PCR based miRNA array.  
 
3.2.3 In vitro embryo production 
 
In vitro matured oocytes were collected after 24 hr. A total of six independent in vitro 
maturation runs were conducted to collect three independent pools of 450 matured 
oocytes. For generating different stages of preimplantation embryo, proven bull 
spermatozoa were used at the concentration of 1x106 cells/ml of fertilization medium 
(Fert-TALP). The frozen sperm straws were thawed in a water bath at 39°C for 8 sec 
and the best motile sperm separated by means of the ˝swim up˝ technique (Parrish et al. 
1988). In this technique, the thawed sperm cells were incubated in a tube containing 5 
ml capacitating medium supplemented with heparin at 39°C under a humidified 
atmosphere of 5% CO2 in air for 50 min. During this time the good quality motile sperm 
will go to the upper layer of the media. This layer which contains the motile sperm was 
transferred to new sterilized tube and centrifuged at 10000 rpm for 10 min. The sperm 
pellet was washed two times then resuspended in 3.5 ml capacitating medium for IVF. 
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In vitro matured COCs were washed twice in the fertilization medium and transferred 
into a four-well dish (50 matured COC/well) containing 400 µl of fertilization medium 
(Fert-TALP) supplemented with 2 µg/ml heparin and 0.2 mM sodium pyruvate (Sigma-
Aldrich Chemie GmbH, Munich, Germany) and 25 µl/ml penicillamine hypotaurine 
adrenaline medium was added to each well to initiate sperm motility than covered with 
mineral oil. After 20 hr of co-incubation with spermatozoa at standard incubation 
conditions with 39ºC and humidified atmosphere containing 5% CO2 in air, the 
presumptive zygotes were gently vortexes to separate them from the surrounding 
cumulus cells and dead spermatozoa. Cumulus-free zygotes were washed three times 
and cultured in CR-1aa culture medium (Rosenkrans and First 1994) supplemented with 
10% OCS, 10 µl/ml BME (essential amino acids) and 10 µl/ml MEM (non-essential 
amino acids) (Tesfaye et al. 2010) in the same incubator and under the same conditions 
as used for maturation and fertilization. The oocytes and embryos were collected from 
the culture at specific time points after maturation or fertilization. Matured oocytes were 
collected at 24 hr after maturation, while zygote, 2-cell, 4-cell, 8-cell, morula, and 
blastocyst stage embryos were collected from the culture at 20, 30, 42, 70, 120 and 168 
hr after fertilization, respectively. From six independent IVF runs, three independent 
pools each consisting of 150 zygotes, 100 two-cell, 80 four-cell, 60 eight-cell, 50 
morula and 30 blastocyst stage embryos were collected and snap-frozen in cryo-tubes 
containing lysis buffer until RNA isolation. All frozen oocytes and embryos were stored 
at -80°C. These embryos and matured oocytes were utilized for the expression analysis 
of selected miRNAs and their predicted target mRNAs. 
 
3.2.4 Brilliant cresyl blue (BCB) staining of cumulus oocyte complexes 
 
To investigate the expression of selected miRNAs in the oocytes of different 
competence, the immature COCs were subjected to stain with 26 µM BCB (Sigma-
Aldrich Chemie GmbH, Munich, Germany) diluted in mDPBS for 90 min at 38.5°C in 
humidified air atmosphere (Alm et al. 2005; Bhojwani et al. 2007). After washing, the 
stained COCs were examined under stereo microscope and categorized into two groups 
according to oocyte cytoplasm colouration, which is dependent on the glucose 6 
phosphate dehydrogenase (G6PDH) activity of the oocytes. Fully grown oocytes 
(competent oocyte) are known to have lower G6PDH activity, this decreased indicated 
 Materials and methods                                                                                                 54 
that the oocyte achieved developmental competence, thereby the oocyte cytoplasm 
remain stained blue (BCB+), while growing oocytes (non competent oocyte) have a 
higher G6PDH activity which changes the oocyte cytoplasm to colourless (BCB-). 
From each group triplicate pools of COCs (n=500 COCs per pool) were used for 
analysis after separation of the oocytes from their surrounding cumulus cells 
mechanically. Denuded oocytes and the corresponding cumulus cells of each group 
were washed two times in PBS and were snap-frozen separately in cryo-tubes 
containing lysis buffer and stored in -80°C until further analysis.  
 
3.2.5 Preparation and culture of oocytectomised cumulus cells and denuded oocytes  
 
To reveal the effect of presence or absence of cumulus cells on expression of miRNA in 
oocytes and vice versa, oocytes or cumulus cells were in vitro matured in the presence 
or absence of the other. For this, mechanical removal of oocyte cytoplasm from COCs 
was done using a micromanipulator (Leitz, Germany) fitted to an inverted microscope 
(Leica DM-IRB, Germany). Each time a group of 50 COCs were placed into 
manipulation medium under mineral oil for removal of all contents of the oocyte 
cytoplasm including the nucleus. This was done by holding the COCs with a holding 
pipette and sucking out the cytoplasm contents using an enucleating pipette attached to 
the micromanipulator. In order to get denuded oocytes for maturation, immature COCs 
were subjected to gentle vortexing in PBS for mechanical removal of the cumulus cells. 
After being checked for complete removal of the cumulus cells, denuded oocytes and 
oocyteoctimized cumulus cells were washed twice in drops of fresh maturation medium 
and placed in culture for in vitro maturation. Each time morphologically good quality 
COCs were categorized into three groups. Group-1 includes COCs in vitro matured as 
intact, group-2 includes those oocytes matured without the surrounding cumulus cells 
(denuded oocytes) and group-3 includes cumulus cells matured without the oocyte 
cytoplasm (oocytectomised). The experiment was conducted four times with the same 
handling and culturing conditions. Each time 250 COCs from each of the three 
mentioned groups were snap-frozen in cryo-tubes containing lysis buffer. Collected 
samples were stored in -80°C until expression analysis of selected miRNAs. 
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3.2.6 RNA isolation and first strand cDNA synthesis 
 
3.2.6.1 Total RNA isolation 
 
The total RNA enriched with miRNAs was isolated from the experimental samples 
using miRNeasy® Mini kit (QIAGEN, Hilden, Germany) according to manufacturer's 
instructions. Briefly, three pools of samples from each group, namely: immature 
oocytes and their corresponding cumulus cells, matured oocytes and their corresponding 
cumulus cells, matured oocyte and preimplantation embryo stags, BCB+ and BCB- 
oocyte, cumulus cells derived from BCB+ and BCB-, oocyte matured in presence of 
cumulus cell and vice versa, denuded oocyte and oocyteoctimized cumulus cells. The 
cells were disrupted by adding 700 µl QIAzol Lysis Reagent and homogenized by 
vortexing for 1 min then incubated at room temperature for 5 min. One hundred fourty 
µl chloroform was added to the homogenate, the tube shacked vigorously for 15 sec and 
centrifuged for 15 min at 12000 xg at 4°C in refrigerated universal centrifuge Z233MK 
(Hermle Labortechnik, Wehingen, Germany) after incubation at room temperature for 3 
min. The upper aqueous phase was transferred carefully to a new 2 ml collection tube 
and 525 µl of 100% ethanol was added. After mixing, 700 µl of the sample was pipetted 
onto RNeasy Mini spin column and centrifuged for 15 sec at room temperature. The 
flow-through was discarded and the previous step was repeated with the remaining 
samples. Following this, the spin column was washed by 700 µl RWT buffer and 
centrifuged for 15 sec at 10000 rpm. After discarding the flow-through, 500 µl RPE 
buffer was added to the spin column followed by 15 sec centrifugation 10000 rpm. This 
step was repeated for the second time and centrifuged at the same speed for 2 min. The 
spin column was then transferred to a new 2 ml collection tube and centrifuged at 14000 
rpm for 1 min to eliminate any possible carryover of RPE buffer and residual flow-
through remained on the spin column. To elute total RNA, the RNeasy spin column was 
transferred into new 1.5 ml collection tube to which 30 µl of RNase-free water was 
added to the centre of the RNeasy spin column membrane and centrifuged at speed of 
10000 rpm for 1 min.  Isolated total RNA was stored in -80°C until the further step. 
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3.2.6.2 Small and large RNA isolation  
 
The small RNAs were separated from the large RNA using RT2 qPCR-Grade miRNA 
isolation kit (SABiosciences, Frederick, MD) following manufacturer’s instructions. 
Briefly, lysis and binding buffer G6 was added to bring each total RNA sample to a 
final volume of 400 µl and then 215 µl 100% ethanol was added directly to each sample 
and mixed by vortexing gently. The mixture were added to first spin column and 
centrifuged at 11000 xg for 30 sec. The first spin column contains large RNA (stored at 
4°C until used) and the eluate contains small RNA. Then, 750 µl 100% ethanol was 
added to the eluate. After mixing, 700 µl from ethanol mixture transferred to second 
spin column and centrifuged at 11000 xg for 30 sec. The flow-through was discarded 
and the previous step was repeated with the remaining of the ethanol mixture. 
Following this, 200 µl of washing Buffer working solution was added to both first and 
secand spin column and centrifuged at 11000 xg for 30 sec. After discarding flow-
through, 250 µl of 70% ethanol was added to each first and second spin column and 
centrifuged at 11000 xg for 3 min. Afterwards, the first and second spin column was 
transferred to a new elution tubes and 40 µl RNase-free H2O was added directly to the 
spin column membrane. The spin column membrane was stand for 1 min at room 
temperature, then centrifuged for 1 min at 11000 xg to elute the large and small RNA. 
For all the experiments, the resulting small RNAs and fractionated large RNAs were 
checked for their concentration and integrity (based on 260/280 nm measurement) 
using nanodrop 8000 spectrophotometer (Thermo scientific, Germany) and subsequent 
analysis by using agilent 2100 bioanalyzer (Agilent Technologies, CA, USA).  
 
3.2.6.3 First strand cDNA synthesis 
 
Small RNAs from each treatment groups were used for first strand cDNA synthesis 
using RT2 miRNA first strand kit (SABiosciences, Frederick, MD) following 
manufacturer’s instructions. Briefly, 50 ng of small RNA samples were incubated with 
a mix containing 2 µl of 5X miRNA RT buffer, 1 µl miRNA RT primer, 1 µl DTT (100 
mM) and 1 µl miRNA RT enzyme mix in a 10 µl reaction volume. Reaction incubation 
was performed at 37°C for 2 hr followed by heating at 95°C for 5 min to inactivate the 
reverse transcriptase. Depending on the type of experiment and the amount of small 
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RNA used for RT-PCR, the resulting cDNA samples were diluted before use as 
template for miRNA qPCR assay. The large RNA fractions from the same samples of 
preimplantation embryo stags were recovered and utilized for RT-PCR after removal of 
contaminating DNA using TURBO DNA-free kit (Ambion, Foster City, CA) according 
to manufacturer’s instructions. All DNA-free RNA samples were reverse transcribed 
using Superscript II reverse transcriptase kit (Invitrogen, Karlsruhe, Germany). Briefly, 
maximum volume of 10 µl RNA (with 100 ng of input RNA) from each treatment 
group were co-incubated with 1µl of random hexamer (Invitrogen, CA, USA) and 1 µl 
of oligo (dT)23 (Promega, WI, USA) at 70°C for 3 min followed by incubation on ice 
for 2 min. Reverse transcription was performed in a 20 µl reaction volume containing 4 
µl 5X first strand buffer, 2 µl DTT, 1 µl dNTP, 0.3 µl RNasin and 0.7 µl RT enzyme. 
The reaction was incubated for 90 min at 42 ºC, followed by heat inactivation for 15 
min at 75ºC. The synthesized cDNA was stored at -20ºC for further use.  
 
3.2.7 RT profiler PCR array and data analysis 
 
The RT profiler PCR array were performed using sequence specific miRNA qPCR 
primer sets and RT2 Real-TimeTM PCR master mix (SABiosciences, Frederick, MD) in 
ABI Prism® 7000 SDS (Applied Biosystems, Foster City, CA). Expression profiling of 
miRNAs between oocytes and cumulus cells before and after in vitro maturation was 
performed using RT2 miRNA PCR array related to human cell development and 
differentiation (SABiosciences, Frederick, MD) containing 88 well known human 
homologue miRNAs, four housekeeping small RNAs (SNORD44, SNORD47, 
SNORD48 and U6) and RT negative controls in a 96-well format. Prior to real time 
PCR profiling, 90 µl DNase/RNase-free water was added to each of the 10 µl first 
strand cDNA product from each biological replicates of immature and matured oocytes 
and their corresponding cumulus cells. The PCR master mix was prepared using the 
100 µl diluted cDNA template, 1275 µl 2X RT2 SYBR Green PCR master mix 
(SABiosciences, Frederick, MD) and 1175 µl DNase/RNase-free water. Twenty five µl 
of this mix was distributed to each well of the 96-well plate containing sequence 
specific miRNA primer sets and the respective controls. Following brief centrifugation, 
the plate was loaded onto ABI prism 7000 real time PCR apparatus and run with a 
thermal programme of initial heating at 95°C for 10 min followed by 40 cycles of 95°C 
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for 15 sec and 60°C for 1 min. The specificity of amplification was controlled using a 
melting curve generated at the end of the PCR protocol.  
 
The data was analyzed by comparative threshold cycle (Ct) method and normalization 
was done using geometric mean of four endogenous controls (SNORD44, SNORD47, 
SNORD48 and U6) through SAbiosciences’s PCR array data analysis online web portal 
provided with t-test (http://www.sabiosciences.com/pcrarraydataanalysis.php). The 
threshold level of ≥ 2 fold changes as a cut off value and significant level of p ≤ 0.05 
was taken to screen differentially expressed miRNAs. From this, we selected miRNAs 
for further characterization based on the differential expression intensity between 
oocytes and their cumulus cells at both before and after maturation. 
 
3.2.8 Quantitative real time PCR analysis of selected microRNAs 
 
The expression profiling of selected miRNAs in matured oocyte and preimplantation 
embryo stages has been examined using RT2 miRNA qPCR assay primer set for miR-
205, miR-150, miR-96, miR-122, miR-146a, miR-146b-5p, miR-210, miR-452 and U6 
as endogenous controls with RT2 Real timeTM PCR master mix (SABiosciences, 
Frederick, MD). The PCR master mix was prepared using the 1µl cDNA template, 1µl 
RT2 miRNA qPCR assay primer set, 12.5 µl RT2 Real timeTM PCR master mix and 10.5 
µl ddH2O. The reaction was done by using ABI prism 7000 real time PCR apparatus 
with a thermal programme of initial heating at 95°C for 10 min followed by 40 cycles 
of 95°C for 15 sec and 60°C for 1 min. The stability of the U6 expression was checked 
(Figure 3.2) before it was utilized for data normalization. The relative quantification of 
miRNAs expression was calculated using a comparative threshold cycle (Ct) method as 
desciprd before in previous study (Tesfaye et al. 2009). 
 Where, relative abundance (Fold change) = 2 -∆∆Ct 
∆Ct = average Ct target miRNA - average Ct of normalizer (U6) 
∆∆Ct = ∆Ct target miRNA - ∆Ct of the calibrator 
Calibrator was the one with the highest ∆Ct value among the groups 
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Figure 3.2: The average threshold cycle (Ct) of the endogenous control U6 RNA 
throughout matured oocyte and the preimplantation embryo stages. 
 
3.2.9 MicroRNA target prediction and in silico functional analysis 
 
The target mRNAs of the differentially expressed selected miRNAs were predicted 
using four different search algorithms: TargetScan 5.1 (http://www.targetscan.org/), 
PicTar (http://www.pictar.org/), miRDB (http://www.mirdb.org/) and MicroRNA.org-
Target and Expression (http://www.microrna.org/). The targets with high score and 
predicted at least in two or more target search tools were accepted as a target gene for 
the miRNA under consideration. The biological functions of these predicted targets and 
the molecular pathways in which they could be involved were analysed through the use 
of IPA v.8.5 (Ingenuity® System, www.Ingenuity.com). 
 
3.2.10 Quantification of selected microRNAs target genes  
 
 In this study, quantitative RT-PCR was performed for one target gene per miRNA 
using an ABI Prism® 7000 SDS (Applied Biosystems, Foster City, CA). Predicted target 
transcripts quantified in matured oocyte and preimplantation embryo stages include 
phospholipase C beta 1 (PLCB1) for miR-205, calmodulin-like 4 (CALML4) for miR-
150, cyclin G (CCNG1) for miR-122, 1,4,5-triphosphate receptor 1 (ITPR1) for miR-
96, interleukin-1 receptor-associated kinase 1 (IRAK1) for miR-146a, TNF-receptor-
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associated factor 6 (TRAF6) for miR-146b-5p, eukaryotic translation initiation factor 4 
gamma 3 (EIF4G3) for miR-452 and pannexin 3 (PANX3) for miR-210. Quantification 
of all targets was done in comparison to Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) as endogenous control and standard curve were generated using serial 
dilution of plasmid DNA (101-109 molecules).  
 
3.2.10.1 Primer design, target gene amplification and purification  
 
The primer of selected miRNA target genes were designed for PCR amplification 
according to bovine cDNA sequence using Primer Express software v 2.2 (Applied 
Biosystems, Foster City, CA). Names of the primers, their accession numbers, 
sequences and product sizes are shown in table (1). 
Table 1:  List of specific primers used for quantitative PCR 
       ACC. No = Gene bank accession number, BP= number of base pairs amplified 
Gene ACC. No       Primer sequence (5’–3’) BP 
 
PLCB1 
 
NM_174817 
 
F:GAAATGAAGGACCTGGTTAAGAGA 
R:AGCTGCTCTCCTTCTCAAGTAGTC 
 
111    
CALML4 BC102423 F: CCCAGGACCAAATTAATGAGT 
R: TGTGAGTCTGTAGGTGCCG 
   153 
ITPR1 NM_001099952 F: CGCCCTTCTGCACAATAAT 
R: CCGGAATGGATTTGTTCAT 
   152 
CCNG1 NM_001013364 F: CCAACTTAAGGCATGCTACTG 
R: CCACTGATCTTGGAATGTTTC 
   153 
TRAF6 NM_001034661 F: TGGCAAATGTCATCTGTGAA 
R: CGTGCCAAGTGATTCCTCT 
   153 
IRAK1 NM_001040555 F: CCCCCTCTTCTTCATTCTG 
R: CCTCCTTGAGCCTCTTCAC 
   155 
PANX3 NC_007330 F: ATCACATGCAGGCTGACCT 
R: GGAGCATCTCGTAGATGGAG 
   151 
     
EIF4G3 NM_001078002 F: TCAGGCCAATCAGCACATCA 
R: AAGGCGTTCCGTAAGCACTG 
   209 
     
GAPDH 
 
NM_001034034.1 F: AATGGAGCCATCACCATC 
R: GTGGTTCACGCCCATCACA 
   240 
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Amplification of target genes were preformed in 20 µl PCR reaction volume containing 
2 µl of 10X PCR buffer (Promega, WI, USA), 0.5 µl of each primer (10 pmole), 0.5 µl 
of dNTP (50 µM), 0.2 µl of Taq DNA polymerase (Sigma-Aldrich Inc, MO, USA) and 
14.3 ddH2O which finally added to 2 µl of cDNA templates or 2 µl genomic DNA (50 
ng/µl) as positive control and 2 µl of ddH2O as negative control. The reactions were 
carried out in a mycycler thermal cycler (Bio-Rad, Munich, Germany) and thermal 
cycling program denaturizing at 95°C for 5 min, followed by 40 cycles at 95°C for 30 
sec, annealing at the corresponding temperatures of each primer for 30 sec and extended 
at 72°C for 1 min, final extension step at 72°C for 10 min. After that, 5 µl of the PCR 
products were loaded with 2 µl of loading buffer onto ethidium bromide staining 
agarose gel 2% run in 1X TAE buffer to check for amplification of the desired product. 
Electrophoresis of the amplified PCR products was done for 20 min at 120 voltages and 
DNA bands were observed under molecular imager chemidoc XRS System (Bio-Rad, 
Munich, Germany). To confirm the specify of amplified PCR product, sequencing PCR 
reaction was performed using 5 µl purified PCR product, 2 µl reverse primer or forward 
specific primer, 4 µl DTCS (Beckman Coulter, Krefeld, Germany), 9 µl ddH2O and the 
reaction carried out for 30 cycles at 96°C for 20 sec, 50°C for 20 sec and 60°C for 4 
min, followed by holding at 4°C. Then, the sequencing PCR product was transferred to 
a 1.5 ml sterile tube and mixed with 5 µl stop solution (2.0 µl of 3M Sodium Acetate 
(NaOAc) pH = 5.2, 2.0 µl of 100 mM EDTA (pH =2.0) and 1.0 µl of glycogen (20 
mg/ml). A volume of 60 µl cold ethanol (98%) was added and mixed by vortex and then 
centrifuged at 14000 rmp for 15 min at 4°C in refrigerated universal centrifuge 
Z233MK (Hermle Labortechnik, Wehingen, Germany). The supernatant was removed 
and the pellet washed 2 times with 200 µl cold ethanol (70%) and centrifuged for 5 min 
at 4°C. The pellet was dried by the savant speed vac (GMI, Inc. Minnesota, USA) at 
35°C and resuspended in 40 µl sample loading solution (SLS). The sample was loaded 
in sequencing plate, covered with mineral oil and immediately sequenced using the 
CEQ TM 8000 Genetic Analysis System (Beckman Coulter, Krefeld, Germany). The 
final sequence of each DNA fragment was blast into GenBank database 
(http://www.ncbi.nlm.nih.gov/blast/). The specific PCR product was purified using 
QIAquick PCR purification kit (QIAGEN, Hilden, Germany) according to the 
manufacturer’s instructions. Briefly, buffer PB (Five volumes) was added to one 
volume of the amplified PCR product and mixed. The 700 µl of the mix was pipetted to 
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QIAquick spin column and centrifuged for 30 sec at 12000 rpm. The resulting flow-
through was discarded and the column was placed back into the same tube and 
centrifuged for 30 sec at 12000 rpm after adding 750 µl buffer PE (washing buffer). The 
flow-through was discarded again and the column was centrifuged for additional 1 min 
at 14000 rpm.  Finally, the column was transferred to new 1.5 ml micro centrifuge tube 
and the DNA was eluted by adding 30 µl ddH2O to the centre of the QIAquick 
membrane and centrifuged for 1 min at 12000 rpm. The quality of purified DNA was 
analyzed on 2% agarose gel and stored at -20°C.  
 
3.2.10.2 Ligation, transformation, colony screening and sequencing. 
 
The purified DNA fragments were ligated into the pGEM®-T vector (Promega, WI, 
USA). The ligation reaction was performed in 6 µl total reaction volume containing 2.5 
µl 2X rapid ligation buffer, 0.5 µl of pGEM®-T vector (50 ng/µl), 0.5 µl T4 DNA ligase 
(3 U/µl) and 2 µl of template purified DNA. The reaction was incubated at 4°C 
overnight. In the next day, transformation was done by combining 3 µl of ligation 
reaction with 80 µl of Escherichia coli competent cells (Stratagene, Amsterdam) in a 15 
ml sterilized tube and incubating on ice for 20 min. The mixture was incubated in water 
bath at exactly 42°C for 90 sec and immediately transferred to ice for 2 min. 
Afterwards, 750 µl SOC media was added to the previous mixture and all together was 
incubated at 37°C for 90 min on a MAXQ6000 shaking incubator (Thermo scientific, 
Germany) at 130 rpm. After 70 min, 20 µl of IPTG and 20 µl of X-gal were uniformly 
distributed over the surface of the LB agar/ampicillin plate with a glass spreader. At the 
end of incubation period, the transformation culture was spread completely on two of 
previously prepared LB-agar plates and incubated at 37°C overnight till the colonies 
become visible. Successful cloning of DNA insert in the pGEM®-T vector was checked 
based on the activity of β-galactosidase. The β-galactosidase is an enzyme produced by 
lacZ gene in pGEM®-T vector which interacts with IPTG to produce a blue colony. On 
the other hand, when an insert was successfully cloned, the lacZ gene is disrupted and 
β-galactosidase is not produced any more which resulted in white colonies. Four 
independent white colonies in addition to two blue colonies were picked up and 
suspended in 30 µl 1X PCR buffer for M13 reaction for further confirmation of 
transformation and sequencing. The same colonies were also cultured in 600 µl 
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ampicillin/SOC media in a MAXQ6000 shaking incubator 130 rpm at 37°C for 90 min 
until the result of M13 product was known. Bacteria that were suspended in 30 µl 1X 
PCR were lysis by heating at 95°C for 15 minutes. Then, colonies were screened for the 
insert by performing a PCR with primers designed in M13 promoter region of the 
vector. For this, 20 µl of reaction volume containing 10 µl of lysate, 0.5 µl dNTPs (10 
mM), 0.5 µl of each of primer (forward: 5´-TTGAAAACGACGGCCAGT-3 and 
reverse: 5´ CAGGAAACAGCTATGACC-3), 1µl 10X PCR buffer, 7.4 µl ddH2O and  
0.1 µl of Taq DNA polymerase were amplified in myCycler thermal cycler (Bio-Rad, 
Munich, Germany) and the thermal cycling program denaturizing at 95°C for 3 min, 
followed by 35 cycles at 95°C for 30 sec, annealing at 60°C for 30 sec and extended at 
72°C for 1 min, final extension step at 72°C for 10 min. At the end of the reaction, 5 µl 
of the M13 product mixed with 2 µl loading buffer was loaded to 2% agarose gel 
stained with ethidium bromide. The colonies that contain PCR fragments (white 
colonies) were identified depending on the distance travelled by DNA fragment in 2% 
agarose gel electrophoresis. The blue colonies were at lower position compared to the 
white colonies. Following this, the colonies confirmed for the presence of PCR 
fragment were transferred to 15 ml sterile tube and additional 5 ml of SOC media with 
ampicillin were added and incubation continued overnight in a MAXQ6000 shaking 
incubator 130 rpm at 37°C for further plasmid isolation. The identity of inserts was 
confirmed by sequencing, the M13 PCR products from white colonies containing inserts 
were used as a template for subsequent sequencing. A volume of 5 µl of M13 products 
was purified by adding 1 µl of ExoSAP-IT (USB, Ohio, USA) then incubated at 37°C 
for 45 min followed by enzyme inactivation step at 80°C for 15 min. The purified DNA 
product (6 µl) was subsequently used as template for the sequencing PCR which 
contains 8 µl of ddH2O, 2 µl (1.6 pmole) M13 forward or reverse primer, 4 µl of DTCS. 
The PCR sequencing reaction was performed for 30 cycles at 96°C for 20 sec, 50°C for 
20 sec and 60°C for 4 min, followed by holding at 4°C. The rest of the procedures were 
done as mention before in the previous section. 
 
3.2.10.3 Plasmid isolation and serial dilution preparation 
 
Plasmid DNA was isolated by using GenEluteTM Plasmid Miniprep Kit (Sigma-Aldrich 
Chemie GmbH, Munich, Germany) according to manufacturer’s instructions. Briefly, 5 
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ml overnight cultured competent cells were pelleted by centrifuging at 14000 rpm for 1 
min and the medium was discarded. These pellets were resuspended and vortexes in 
200 µl of resuspension solution. Then, 200 µl of lysis solution was adding and the 
mixture was subsequently mixed by inversion of tubes until it became clear and 
viscous. After incubating at room temperature for 4 min, cell precipitation was done by 
adding 350 µl of neutralization buffer, mixed gently and centrifuged at 14000 rpm for 
10 min. Following this, the GenElute Miniprep binding column was inserted into a 
provided microcentrifuge tube and 500 µl of the column preparation solution was added 
followed by centrifugation at 14000 rpm for 30 sec and discarding the flow-through. 
After that, the cleared lysate was transferred to the column and centrifuge at 14000 rpm 
for 30 sec. The flow-through was discarded and the column was washed by adding 750 
µl of wash solution followed by centrifugation at 14000 rpm for 1 min. Again, the 
flow-through was discarded and the spin column centrifuge at 14000 rpm speed for 2 
min without any additional wash solution. To elute DNA, the spin column was 
transferred into a new collection tube to which 30 µl of ddH2O was added to the centre 
of the spin column membrane and centrifuged at speed of 14000 rpm for 1 min.  
 
For determination of plasmid size and quality, 5 µl of the plasmid DNA was analyzed in 
ethidium bromide stained 2% agarose gel electrophoresis running in 1X TAE buffer. In 
addition, the concentration of the plasmid was determined using nanodrop 8000 
spectrophotometer, the rest was stored at -20°C to be used as template for setting up the 
standard curve in real-time PCR. The serial dilution consisting of 101 to 109 copy 
number of molecules was prepared from plasmid DNA using the online software, 
weight to molar quantity converter (http://molbiol.edu.ru/eng/scripts/h01_07.html) 
which converts known DNA concentration to copy number of molecules. Briefly, to 
determine the number of molecules, the plasmid concentration (ng/µl) and the nucleic 
acid size (The size of the pGEM®-T vector + PCR fragment of each gene) were 
submitted to the software. The dilution that contains 109 molecules was then determined 
in 50 µl volume based on the number of molecules obtained in 1 µl plasmid DNA. 
Following this, 108 dilution was determined using 5 µl of 109 dilution and 45 µl ddH2O. 
The remaining 107-101 dilutions were determined in the similar way. The PCR was 
performed to test whether the serial dilution could be a suitable standard curve achieved 
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for real-time PCR. Afterwards, the plasmid DNA serial dilutions were used as template 
to generate the standard curve during real time PCR analysis. 
 
3.2.10.4 Real time PCR quantification   
 
The real time PCR quantification was performed for target genes using iTaqTM SYBR® 
Green Supermix with ROX (Bio-Rad, Hercules, CA). The quantification based on the 
changes in fluorescence proportional to the increase of product. SYBR Green, which 
emits a fluorescent signal upon binding to double stranded DNA, was used as a 
detector. Fluorescence values were recorded during every cycle representing the amount 
of product amplified to a point known as threshold cycle (Ct). The higher initial 
transcript amount, the sooner accumulated product was detected in the PCR. Prior to 
quantification, the optimum primer concentration was obtained by trying different 
combinations from 200 nM to 600 nM. Results from these primer combinations were 
compared and the one with lowest threshold cycle and minimizing non-specific 
amplification was selected for subsequent reaction. After selection of primer 
concentration, a final assay consisted of 2 µl cDNA as template, forward and reverse 
primers and 10 µl iTaqTM SYBR® Green Supermix with ROX in a total volume of 20 
µl. Thermal parameters used to amplify the template started with an initial denaturation 
at 95°C for 10 min followed by 40 cycles of 95°C for 15 sec denaturation and 60°C for 
1 min annealing and extension. A dissociation curve was generated at the end of the last 
cycle by collecting the fluorescence data at 60°C and taking measurements every 7 sec 
until the temperature reached 95°C. The quantification analysis was done by amplifying 
serial dilutions of target plasmid DNA. Finally, quantitative analysis was done using the 
relative standard curve method (user bulletin #2 ABI PRISM 7700 SDS, 
http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf) and results were reported 
as fold change as compared to the calibrator after normalization of the transcript amount 
to GAPDH gene as endogenous control. 
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3.2.11 In situ hybridization of microRNAs in ovarian cryo-sections, whole mount 
cumulus oocyte complexes and preimplantation embryo stages  
 
For in situ hybridization of miRNAs, as described previously in (Hossain et al. 2009; 
Obernosterer et al. 2007). Bovine ovaries at 21 days of estrous cycle were fixed in 4% 
paraformaldehyde (PFA) overnight at 4°C followed by overnight incubation in PBS 
with 30% sucrose at 4°C. In the next day, remove the specimen from the PBS/sucrose 
solution and tissue-Tek OCT (Sakura Finetek, Zoeterwoude, NL) was added to cover 
the tissue. Cryo-sections of frozen ovarian tissue (10 µm thickness) were prepared at -
20ºC using rapid sectioning cryostat (Leica microsystem Nussloch GmbH, 
Heidelberger, Germany). The sections were mounted on slides and directly fixed in 4% 
PFA for 10 min. The fixed sections were washed three times for 5 min in 1x PBS then 
incubated in different concentration of Ethyl alcohol  50%, 70%, 90% and 100% 
(Freshly prepared in DEPC-treated H2O) for 5 min for each concentration, followed by 
another different concentration 90%, 70% and 50% Ethyl alcohol for 5 min for each 
concentration, respectively. The sections were washed in 1X PBS for 5 min. 
Afterwards, the fixed sections were immersed in acetylation solution for 10 min, then 
washed three times in 1X PBS for 5 min per each times. Proteinase K treatment was 
done with proteinase K solution for 5 min, then washed three times for 5 min in 1X 
PBS. Two hours of pre-hybridization were performed at 61°C in hybridization solution. 
Ovarian sections were incubated overnight at 61°C with 3'-Digoxigenin (DIG) labeled, 
LNA-modified oligonucleotide ISH probes (1pM) for miR-205, miR-210, U6 RNA and 
scrambled RNA sequence (Exiqon, Vedbaek, Denmark) in hybridization solution under 
humidified condition. Hybridized sections were washed two times, one time with pre-
warmed 5X SSC for 10 min and the next time with 0.2X SSC for 1 hr at 61°C. Ovarian 
sections were treated with 0.1 M HCL for 10 min, blocked in B1 solution for 10 min at 
room temperature. Afterward, the ovarian sections were incubated in humidified 
condition at room temperature with 500 µl blocking solution for each slide for 1 hr. The 
anti-DIG-AP antibody was diluted at 1:1500 in blocking solution. Then incubations of 
ovarian sections overnight at 4°C with diluted anti-DIG-AP antibody. The sections were 
washed three times in B1 solution for 5 min, and then incubated with 700 µl Tris 
solution (1 M, pH 8.2) for 10 min. The colour reaction was performed by incubation the 
slides for 3 hr with fast red solution (Dako Deutschland GmbH, Hamburg, Germany) in 
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dark place. After three hours, the colour reaction stopped by slides washing thee time in 
1X PBST for 10 min. Finally, the slides were mounted with Vectashield containing 
DAPI (Vector laboratories, Burlingame, CA) and analyzed by confocal laser scanning 
microscope -510 (Carl Zeiss, Germany). 
 
For whole mount in situ hybridization, cumulus oocyte complexes were aspirated from 
more than 8 mm of ovarian follicles. The COCs (n=5) and embryos (n =7 embryos per 
stage from zygote to blastocyste) were handled and managed with handmade glass 
pipettes (opening 250 µm) under stereo microscope. The pre-fixation, acetylation, 
digestion with Proteinase K, pre-hybridization, hybridization, post-hybridization 
washing was performed in 4-well embryo culture dishes according to the high-
resolution whole mount in situ hybridization protocol from Exiqon with some 
modification. The COCs and embryos were collected and washed two times in PBS 
then in 4% (PFA) overnight at 4°C. In the next day, the COC and embryos transferred 
into 100% Methanol (MeOH) and washed for 5 min. Afterward, rehydration was 
performed by series incubations in 75% MeOH /25% 1X PBS, 50% MeOH /50% 1X 
PBS, 25% MeOH / 75% 1X PBS for 5 min in each time and then washed two times in 
1X PBS for 3 min. After this repeated wash, the COCs and embryos were incubated for 
10 min at room temperature in freshly prepared acetylation solution then washed in 1x 
PBS for 5 min.  Proteinase K treatment (10 µg/ml) was preformed for 5 min at room 
temperature followed by re-fixation in 4% PFA-1X PBS for 5 min and washed in 1X 
PBS for 3 min. The specimen was pre-hybridized in 800 µl of hybridization solution for 
2 hr at 61°C then incubated overnight with 3'-Digoxigenin (DIG) labeled LNA-
modified oligonucleotide probes (1pM) for miR-205, miR-210, U6 RNA and scrambled 
RNA sequence (Exiqon, Vedbaek, Denmark) in hybridization solution in humidified 
chamber at 61°C. After overnight incubation, embryos were washed briefly in 
hybridization washing buffer then series wash in 75% hybridization washing buffer 
/25% 2X SSC, 50% hybridization washing buffer/50% 2X SSC, and 25% hybridization 
washing buffer /75% 2X SSC all at hybridization temperature for 10 min. Then the 
specimens were washed in 2X SSC for 10 min at 61°C then two time in 0.2X SSC for 
30 min at 61°C. The rest of the procedures were similar to cryo-section hybridization 
protocol. Images for the different layers or position of COCs and embryos were taken 
by confocal laser scanning microscope-510 (Carl Zeiss, Germany) using Z-Stack with 1 
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µm interval. Three dimensional images from all the layers or Z positions of single 
embryo were constructed using the software ZEN 2008 Light Edition (Carl Zeiss, 
Germany). 
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4 Results 
4.1 Expression profiling of miRNAs in immature oocytes vs. their surrounding cumulus 
cells  
 
Expression profiling of 88 miRNAs between immature oocytes and their surrounding 
cumulus cells revealed that a total of 47 differentially expressed miRNAs (p ≤ 0.05 and 
fold change ≥ 2) (Figure 4.1A) between the two cell types.  
 
 
 
 
 
 
Figure 4.1: Hierarchical clustering of differentially expressed miRNAs between 
immature oocytes (imo) vs. cumulus cells (imc) (A) and matured oocytes (mo) vs. 
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cumulus cells (mc) (B). Columns represent the similarities or differences in the 
expression pattern within or between biological replicates of oocyte or cumulus cells 
and the horizontal dendrogram represent the clustering of miRNAs according to their 
expression similarities. Red and green colours indicate the higher and lower expression 
level, respectively 
 
Among these, the expression level of eight miRNAs including miR-125a-5p, miR-155, 
miR-210, miR-378 and miR-452 were enriched in cumulus cells. On the other hand, the 
expression level of 39 differentially expressed miRNAs was enriched in immature 
oocytes compared to their surrounding cumulus cells. Among these, miR-146a, miR-
146b-5p, miR-183, miR-18b, miR-96, miR-150 and miR-205 exhibited between 56 to 
2109 fold change increases in the oocytes. The list of all differentially expressed 
miRNAs between immature oocytes and their surrounding cumulus cells is described in 
table (2). 
 
Table 2: List of differentially expressed miRNAs between immature oocytes and their 
surrounding cumulus cells  
 
 
MiRNA 
 
 
Fold change  
(Mean ± SD) 
 
p-value 
 
miR-488 
 
49.39 ± 0.95 
 
0.026091 
miR-133b 54.18 ± 0.65 0.011529 
miR-214 2.43 ± 0.60 0.001691 
miR-205 2109.88 ± 0.35 0.002081 
miR-1 31.41 ± 0.49 0.001502 
miR-150 715.57 ± 0.20 0.001268 
miR-129-5p 19.24 ± 0.08 0.003916 
miR-498 49.39 ± 0.45 0.00321 
miR-518b 58.33 ± 0.40 0.003193 
miR-520g 74.18 ± 0.29 0.003134 
miR-208a 14.89 ± 1.03 0.005478 
miR-345 12.58 ± 1.03 0.004175 
miR-375 20.72 ± 0.66 0.004603 
miR-146b-5p 92.17 ± 0.56 0.000002 
miR-302c 37.09 ± 0.98 < 0.00001 
miR-134 32.44 ± 0.74 0.000001 
miR-124 20.39 ±  0.53 < 0.00001 
miR-301a 5.43 ± 1.46 0.000413 
miR-206 28.11 ± 0.60 0.000027 
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miR-132 20.06 ± 0.54 0.000125 
miR-15b 2.54 ± 1.04 0.000976 
miR-100 13.20 ± 0.74 0.000327 
miR-7 20.48 ± 0.77 0.000055 
miR-18b 197.58 ± 0.82 0.000043 
miR-183 127.38 ±  0.60 0.000052 
miR-182 87.00 ± 0.54 0.000007 
miR-18a 8.36 ± 0.87 0.000014 
miR-17 2.40 ± 0.79 0.002948 
miR-23b 3.51 ±  0.57 0.000781 
miR-194 4.25 ± 0.83 0.001866 
miR-192 2.50 ± 0.75 0.012918 
miR-16 2.27 ± 0.77 0.030143 
miR-26a 2.09 ± 0.64 0.024601 
miR-223 4.79 ± 1.07 0.02624 
miR-10b 19.78 ± 0.96 0.002339 
miR-218 18.72 ± 0.89 0.001003 
miR-146a 56.48 ± 0.91 0.001352 
miR-424 5.76 ± 1.00 0.009166 
miR-96 323.95 ± 0.90 0.004585 
miR-210 -16.96 ± 1.09 0.0193 
miR-452 -3.14 ± 0.54 0.027883 
let-7g -2.62 ± 0.78 0.041633 
miR-378 -20.49 ±  3.82 0.015314 
let-7b -3.12 ± 0.59 0.009613 
miR-155 -17.55 ± 2.19 0.045894 
miR-125a-5p -47.63 ±  6.36 0.043974 
let-7c -2.14 ± 0.47 0.037073 
Positive fold change means up-regulated in oocytes and negative fold change means down regulated in 
oocytes compared to surrounding cumulus cells. 
 
 
4.2 Expression profiling of miRNAs in matured oocytes vs. their surrounding cumulus 
cells 
 
The expression analysis of miRNAs between matured oocytes vs. their surrounding 
cumulus cells was preformed by using the same miRNA PCR array that consists of 88 
miRNAs. The result revealed that 51 miRNAs were differentially expressed (p ≤ 0.05 
and fold change ≥ 2) between these two groups of cells. From those, six miRNAs (miR-
155, miR-210, miR-378, miR-452, miR-181a and miR-222) were enriched in cumulus 
cells and 45 miRNAs were enriched in matured oocytes (Figure 4.1B). Several miRNAs 
including miR-317-3p, miR146a, miR-18b, miR-146b-5p, miR-424, miR-9, miR-150, 
miR-205 and miR-122 were among the top miRNAs (109 to 2433 fold changes) 
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enriched in matured oocytes compared to their surrounding cumulus cells. The detail list 
of all differentially expressed miRNAs is described in table (3) 
 
Table 3: List of differentially expressed miRNAs between matured oocytes and their         
surrounding cumulus cells 
 
 
MiRNA 
 
 
Fold change 
(Mean ± SD) 
 
p-value 
 
miR-424 237.06 ± 7.95 0.001934 
miR-18a 6.51 ±1.47 0.010765 
miR-205 1773.55 ± 1.51 0.008389 
miR-20b 3.52 ±1.41 0.010345 
miR-301a 4.14 ± 1.50 0.018357 
miR-20a 2.12 ± 1.43 0.047371 
miR-18b 133.04 ± 1.84 0.032683 
miR-96 15.09 ± 0.90 0.000021 
miR-302c 37.86 ± 1.26 0.000106 
miR-302a 46.28 ± 0.84 0.001537 
miR-194 7.24 ± 0.82 0.000568 
miR-133b 30.96 ± 1.65 0.00331 
miR-146a 116.63 ± 1.21 0.000083 
miR-1 39.19 ± 1.89 0.000008 
miR-124 14.75 ± 1.09 0.000003 
miR-33a 3.46 ± 0.98 0.044276 
miR-129-5p 4.96 ± 0.84 0.029574 
miR-10a 68.55 ± 0.51 0.029162 
miR-134 16.94 ± 0.28 0.026959 
miR-183 6.30 ± 0.35 0.046364 
miR-503 85.57 ± 0.55 0.047496 
miR-520g 55.04 ± 0.10 0.045680 
miR-488 53.66 ± 0.19 0.035662 
miR-206 30.25 ± 0.30 0.042302 
miR-10b 62.07 ± 0.26 0.039812 
miR-126 13.54 ± 2.15 0.007329 
miR-195 2.81 ± 0.77 0.010008 
miR-218 6.13 ± 0.48 0.019668 
miR-182 5.00 ± 0.52 0.02036 
miR-192 7.83 ± 0.54 0.013054 
miR-150 1666.29 ± 0.98 0.017642 
miR-7 54.91 ± 0.43 0.020461 
miR-371-3p 109.83 ± 0.91 0.019111 
miR-92a 5.51 ± 0.77 0.014021 
miR-100 37.94 ± 0.48 0.015319 
miR-214 3.50 ± 1.01 0.008226 
miR-345 19.50 ± 0.65 0.004917 
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miR-146b-5p 139.34 ± 0.46 0.008366 
miR-9 269.80 ± 0.52 0.007456 
miR-122 2433.96 ± 0.64 0.010694 
miR-23b 13.51 ± 0.62 0.009962 
miR-16 4.92 ± 0.69 0.004289 
miR-26a 4.35 ± 0.69 0.007508 
miR-128 5.63 ± 0.80 0.010281 
miR-15b 6.86 ± 0.80 0.010547 
miR-155 -2.37 ± 0.41 0.046329 
miR-210 -2.67 ± 1.22 0.036641 
miR-378 -3.10 ± 1.45 0.012184 
miR-452 -2.68 ± 1.47 0.044323 
miR-181a -2.92 ± 2.08 0.034214 
miR-222 -4.93 ± 1.49 0.012613 
Positive fold change means up-regulated in oocytes and negative fold change means down regulated in 
oocytes compared to the surrounding cumulus cells.  
 
 
4.3 Commonly differentially expressed miRNAs in immature or matured oocyte vs. 
their surrounding cumulus cells  
 
To identify the miRNAs that are constantly expressed in oocytes or cumulus during 
oocytes maturation, we merged the two data sets described above. From this analysis, 
we have identified 33 miRNAs commonly differentially expressed between oocytes and 
surrounding cells before and after maturation. From those miR-155, miR-210, miR-378, 
miR-452 were enriched in cumulus cells compared to the oocytes before and after 
maturation (Table 4). On the other hand, 29 miRNAs including miR-205, miR-150, 
miR-96, miR-122, miR-146a and miR-146b-5p were enriched in immature and matured 
oocytes compared to their surrounding cumulus cells (Table 4). 
 
Table 4: List of commonly differentially expressed miRNAs between oocytes and their 
surrounding cumulus cells after and before maturation 
 
Immature oocyte vs. its 
surrounding cumulus cells 
Matured oocyte vs. its surrounding 
cumulus cells 
 
MiRNA 
 Fold change  
(mean ± SD) 
p-value Fold change 
(mean ± SD) 
p-value 
 
MiR-182 
 
87.00 ± 0.54 
 
0.000007 
 
5.00 ± 0.52 
 
0.02036 
MiR-1 31.41 ± 0.49 0.001502 39.19± 1.89 0.000008 
MiR-146b-5p 92.17 ± 0.56 0.000002 139.34 ± 0.46 0.008366 
MiR-301a 5.43 ± 1.46 0.000413 4.14± 1.50 0.018357 
MiR-488 49.39 ± 0.95 0.026091 53.66 ± 0.19 0.035662 
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MiR-18a 8.36 ± 0.87 0.000014 6.51 ± 1.47 0.010765 
MiR-100 13.20 ± 1.03 0.000327 37.94 ± 0.48 0.015319 
MiR-134 32.44 ± 0.74 0.000001 16.94 ± 0.28 0.026959 
MiR-206 28.11 ± 0.60 0.000027 30.25 ± 0.30 0.042302 
MiR-23b 3.51 ± 0.57 0.000781 13.51 ± 0.62 0.009962 
MiR-214 2.43 ± 0.60 0.001691 3.49 ± 1.01 0.008226 
MiR-18b 197.58 ± 0.82 0.000043 133.04 ± 1.84 0.032683 
MiR-345 12.58 ± 1.03 0.004175 19.50 ± 0.65 0.004917 
MiR-129-5p 19.24 ± 0.08 0.003916 4.95 ± 0.84 0.029574 
MiR-96 323.95 ± 0.90 0.004585 15.09 ± 0.90 0.000021 
MiR-183 127.38 ± 0.60 0.000052 6.30 ± 0.35 0.046364 
MiR-194 4.25 ± 0.83 0.001866 7.24 ± 0.82 0.000568 
MiR-218 18.71 ± 0.89 0.001003 6.13  ± 0.48 0.019668 
MiR-205 2109.88 ± 0.35 0.002081 1773.55 ± 1.51 0.008389 
MiR-10b 19.78 ± 0.96 0.002339 62.07 ± 0.26 0.039812 
MiR-133b 54.17 ± 0.65 0.011529 30.96 ± 1.65 0.00331 
MiR-520g 74.18 ± 0.29 0.003134 55.04± 0.10 0.04568 
MiR-124 20.39 ± 0.53 < 0.00001 14.75 ± 1.09 0.000003 
MiR-150 715.57 ± 0.20 0.001268 1666.29 ± 0.98 0.017642 
MiR-15b 2.54 ± 1.04 0.000976 6.86 ± 0.80 0.010547 
MiR-302c 37.09 ± 0.98 < 0.00001 37.86 ± 1.26 0.000106 
MiR-7 20.48 ± 0.77 0.000055 54.91 ± 0.43 0.02046 
MiR-146a 56.48 ± 0.91 0.001352 116.63 ± 1.21 0.000083 
MiR-122 66.09 ± 4.89 0.367784 2433.95 ± 0.64 0.010669 
MiR-155 -17.55 ± 2.19 0.045894 -2.37 ± 0.41 0.046329 
MiR-210 -16.96 ± 1.09 0.0193 -2.67 ± 1.22 0.036641 
MiR-378 -20.49 ± 3.82 0.015314 -3,09 ± 1.45 0.012184 
MiR-452 -3.14 ± 0.54 0.027883 -2.68 ± 1.47 0.044323 
Positive fold change means up-regulated in oocytes and negative fold change means down regulated in 
oocytes compared to the surrounding cumulus cells 
 
 
4.4 Expression pattern of miRNAs during bovine oocyte maturation 
 
The differential expression of miRNA identified during oocyte maturation in both 
oocyte and cumulus cells by the comparison between immature and matured oocytes 
which showed that 18 miRNAs to be differentially expressed and all were highly 
abundant in matured oocytes (Figure 4.2A and Table 5). Similarly, the comparative 
analysis of miRNAs between cumulus cells surrounded the oocyte before and after 
maturation showed that 16 miRNAs to be differentially expressed, of which 13 and 3 
miRNAs were highly abundant in cumulus cells derived from matured and immature 
COCs, respectively (Figure 4.2B and Table 5).  
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Figure 4.2: Hierarchical clustering of miRNAs differentially expressed between 
matured oocytes (mo) vs. immature oocyte (imo) (A) and cumulus cells derived from 
matured COCs (mc) vs. immature COCs (imc) (B). Columns represent the expression 
from a single PCR array with miRNA represented by raws, which are clustered 
according to their pattern of expression in three biological replicates from both stages of 
oocytes and cumulus cells. Shades of colours indicate the level of expression of 
miRNAs in matured and immature oocytes (A) or matured and immature cumulus cells 
(B) with a level increasing from green to red 
 
Table 5: List of differentially expressed miRNAs between matured vs. immature 
oocytes and matured vs. immature cumulus cells 
 
Matured oocytes vs. immature oocyte Matured cumulus cells vs.  immature 
cumulus cells 
MiRNA  Fold change  
(mean ± SD)  
p-value  MiRNA  Fold change  
(mean ± 
SD)  
p-value  
 
let-7e  
 
2.75 ± 0.67  
 
0.007809  
 
miR-155 
 
75.79 ± 1.09 
 
0.000643 
miR-125a-5p  25.64 ± 6.38  0.048675  miR-182 43.93 ± 1.14 0.003009 
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miR-125b  164.30 ± 5.97  0.042853  miR-222 33.99 ± 0.82 0.006578 
miR-122  125.97 ± 4.97  0.029304  miR-132 89.31 ± 0.61 0.000053 
miR-155  560.36 ± 2.12  0.039682  miR-21 13.09 ± 1.60 0.033336 
miR-126  12.47 ± 3.88  0.021730  miR-129-5p 6.03 ± 0.87 0.001556 
miR-92a  48.62 ± 7.39  0.046121  miR-96 40.81 ± 0.73 0.005935 
miR-182  2.53 ± 0.63  0.043930  miR-183 68.63 ± 0.94 0.004014 
miR-302a  7.80 ± 2.25  0.010798  miR-218 8.25 ± 1.37 0.036779 
miR-146b-5p  2.48 ± 0.55  0.040028  miR-520g 3.87 ± 1.16 0.035594 
miR-222  4.89 ± 1.30  0.000319  Let-7d 2.04 ± 0.72 0.039373 
miR-132  4.81 ± 0.50  0.031369  miR-208a 3.08 ± 0.99 0.01712 
miR-23b  2.88 ± 0.63  0.029389  miR-375 18.77 ± 0.32 0.000063 
miR-21  11.58 ± 0.91  0.018912  miR-210 -4.79 ± 0.75 0.034768 
let-7a 2.75 ± 0.67 0.007809  miR-33a -2.51 ± 0.59 0.036418 
miR-218 2.70 ± 0.77  0.042421  miR-128 -2.57 ± 0.59 0.048758 
miR-128  2.21 ± 0.77  0.042421     
miR-15b  2.19 ± 0.71  0.039268     
Positive fold change means up-regulation and negative fold change means down regulation 
  
 
4.5 Target prediction of selected miRNAs and their functional annotation 
 
Following identification of commonly differentially expressed miRNA in immature or 
matured oocyte vs. surrounding cumulus cells, six miRNAs enriched in oocyte (miR-
205, miR-150, miR-96, miR-122, miR-146a and miR-146b-5p) and two miRNAs 
enriched in cumulus cells were selected based on their expression pattern. The target 
genes of selected miRNAs were identified using four online tools, TargetScan, PicTar, 
miRDB and MicroRNA.org-Target and Expression, based on their score and their 
prediction at least in two or more target search tools. The result revealed that, 
accordingly, 854 and 234 genes were found to be targeted by miRNAs enriched in 
oocytes and cumulus cells, respectively. To obtain an overview on the functional role of 
differentially expressed selected miRNAs, the predicted targets genes were then 
uploaded into the Ingenuity pathway analysis system (IPA) to identify the molecular 
networks (biological functions) and pathways based on the information in the IPA data 
base. The analysis identified 25 and 13 molecular networks involved by the target genes 
of miRNAs enriched in oocyte and cumulus cells, respectively (Table 6 and 7). Among 
these, cellular assembly and organization, cell cycle, carbohydrate metabolism, 
molecular transport, cellular development, cell signaling, cell death, cellular growth and 
proliferation, reproductive system development and function, embryonic development, 
amino acid metabolism, small molecule biochemistry, gene expression, cell to cell 
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signaling and interaction, and lipid metabolism were the most representative molecular 
networks identified by this analysis. 
 
Table 6: Molecular networks involved by target genes of selected miRNAs enriched in 
oocyte 
 
ID Molecule in network Score Focus 
molecules 
Top function 
 
1 
 
AFF1, AIFM2, ANLN, ARIH2, BAI3, 
C13ORF34, CACYBP, CCAR1, 
CCNG1, CENPF, CEP55, ENSA, 
FBXL3, FBXL5, FBXO4, HS3ST1, 
ING4, JMJD1C, KDM2B, LIN9, MSL2, 
P4HA1, PERP, PROSC,  SCN3B, 
SIAH1, SIAH2, SKP1, TBL1X, THAP8 
 
 
47 
 
33 
 
Cell Cycle, Cellular 
Movement, Cell 
Morphology 
 
2 ACSL1, ADIPOR2, ATXN1, 
C10ORF118, C2ORF3, CMTM6, 
CXORF21, CYP4A11, DOCK1, E2F3, 
ERO1L, FADS1, FOXO1, ICMT,  MYB 
(includes EG:4602), NLK, NOVA1,  
PRMT3, PSMA4, RAB23, RAPGEF4, 
RDH11, RIMS1,  RXRG, SGMS1, 
ZHX1, ZHX2 
 
36 27 Lipid Metabolism, 
Molecular Transport, Small 
Molecule Biochemistry 
 
3 ABR,  AOC3, BZW1, CALCR, 
CCDC80, CLDN11, CREB3L2, CYBB, 
ESM1, EXT1,  FOXF1, FOXF2, KLF7, 
LTBP2, MAGI1, MMD, NFAT5, PC, 
PGM2L1, PTP4A1, PTPRJ, RAB32, 
SLA, SLC1A2, SLC7A1, SQLE, TNF, 
TNFAIP8, TNRC6A, ZFP36L1 
 
35 30 Developmental Disorder, 
Skeletal and Muscular 
Disorders, Gastrointestinal 
Disease 
 
4 ADAM19, C1q, CBFA2T3, CCK, 
CDKN1B, CFH, COPS8, DCN, DLG2, 
ERBB4, EREG, ESRRG, GYPA, HBP1,  
INADL,  LRP1, LRP2, LRP10,  
NLGN2, PDE7A, PDGF BB, 
PLEKHA1, PSMF1, QKI, , RBM11, 
RGS2, RHOXF2, SLC1A1 
 
35 26 Cell Cycle, Cellular 
Growth and Proliferation, 
Immunological Disease 
 
5 BRPF3, CAMK2G, CASP7, CREBL2, 
EGR2, FOXK2, FYN, GLP1R, HAS2, 
HERC3, HNRNPU, LRRC7, 
MAMLD1, NBEA (includes EG:26960), 
OVOL1, PSMD3, PTGER3, RPS6KA3, 
SFRP4, SMAD4, SMARCD1, SRP72, 
TCR, TOR1A, TOR1AIP2,  UCK2, 
ZNF331 
 
35 26 Cellular Development, 
Reproductive System 
Development and Function, 
Cell-mediated Immune 
Response 
 
6 ADAMTS9, ALDH1B1, AMPH, 
CACNB4, GABRA4, GABRG2, GLRB, 
GLRX3, GPHN, HOXA2, ITCH, 
MTSS1, NECAP1 NUMB, OCRL, 
30 24 Connective Tissue 
Development and Function, 
Embryonic Development, 
Skeletal and Muscular 
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PPP3R1, PRDX4, SOX6, SOX11, 
SOX5 (includes EG:6660), SYNJ2, 
SYNJ2BP, TNFSF4, ZFAND5 
 
System Development and 
Function 
 
7 COX11, CPEB1, DPYD, EIF4B, EIF4E,  
EIF4G2, ENTPD1,  FBXW2, HNRNPD,  
HTR2B, KIAA1199, KL, MED1, 
MPZL1, NTN4, PDCD4, PLXNA2, 
PRKAR1A, SEMA3A, SHC4, SLC9A1, 
SMC3, UBR5 
 
29 23 Gene Expression, Protein 
Synthesis, RNA Post-
Transcriptional 
Modification 
 
8  ADCY6, Arp2/3, ARPC5, DTNA, 
ENC1, EPB41, EZR,  FN1, GNE, 
GPLD1, GRPR, HSP90B1, MLPH, 
MORF4L1, MSN, MYO5A, MYO5B, 
MYRIP, OCLN, PFN2PRKCA,  
RAB8B, SAR1A 
 
27 22 Cellular Assembly and 
Organization, Hair and 
Skin Development and 
Function, Genetic Disorder 
 
9 C5ORF22, CACNA1G, CASP2, CDA, 
CLIC4, CUX1, DHFR, DUOX2,  E2F5, 
FOXD3,  HOXA5, Importin alpha, 
Importin beta, IPO5, IPO8, KAT2B, 
KPNA1, KPNB1, MLL,  PAPPA,  
RARB,  SMC2, STAR, SUZ12 
 
26 22 Cancer, Endocrine System 
Development and Function, 
Organ Development 
 
10 ABI2, C3ORF10, CAST, CDH11, CTH, 
DIO2,  IFRD1, ITGAX, MARCH6, 
PPBP, RANBP9, RASGRP1, SHPRH, 
SNAP23, TLL1, UBE2G1, UBE2J1, 
UBE2N, VAMP2, VAPA 
 
23 20 Cell Signaling, Cellular 
Assembly and 
Organization, Cellular 
Function and Maintenance 
 
11 AICDA, ATF5, CALCRL, CD226, 
CD40LG, HSP90AA1, IL7, ITGB3, 
KIF11, LDLR, LIPG, LRRK2, LYN, 
METAP1, NR2F2, NR3C2, NRCAM, 
PTCH1, STIL, STK24, ZC3HAV1 
 
23 21 Cell-To-Cell Signaling and 
Interaction, Skeletal and 
Muscular System 
Development and Function, 
Cellular Movement 
 
12 ADRBK2, AKT3, CASR, DLAT, 
GOLGA7, MTCH2, MUC4, NRAS, 
NTRK2,, PDK1, PDK4, PI3K, 
PIK3AP1, PIP4K2A, PKM2, PLCB1, 
PLCB4, RFXAP, STYK1, TP53BP2,  
 
22 19 Lipid Metabolism, Nucleic 
Acid Metabolism, Small 
Molecule Biochemistry 
 
13 AKAP9, AMPK, ASAH1, CADM1, 
CAMK2N1,  CLIC5, CPD, ERRFI1,  
GYS1, ITPR1, KCNJ16, PDE3B, 
PFKFB2, PHKB, PPP1R15B, 
PPP1R3A, SLC8A1,  STK3, TACC1 
 
20 18 Carbohydrate Metabolism, 
Nervous System 
Development and Function, 
Behavior 
 
14 ALK, CBL, CD80, DIXDC1, DLGAP2, 
DUSP4, FRK, FRS2, GPC3, LCOR, 
MECOM, PNN, RALGPS1, SATB2, 
SORBS1, YES1, ZDHHC17, ZEB1 
 
20 18 Cellular Growth and 
Proliferation, Tumor 
Morphology, Tissue 
Development 
 
15 BCL2A1, CFL2, DYRK1A, HSPA2, 
IRAK1, IRAK2, MAP2K3, MAP3K2, 
MAP3K3, MAP3K12, MS4A1, 
MYO1B, NEK2, PMAIP1, SCIN, 
STK39, UBA52 
18 17 Cell Signaling, Cell-To-
Cell Signaling and 
Interaction, Hematological 
System Development and 
Function 
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16 BTBD3, CAMSAP1L1, DULLARD, 
GALNT2, GALNT3, GALNT12, 
GGNBP2, KIAA2022, LRCH2, 
MAMDC2, MBD6, MEGF9,  RC3H1, 
VEZF1, ZC3H12B, ZFAND3 
 
17 16 Post-Translational 
Modification, Genetic 
Disorder, Skeletal and 
Muscular Disorders 
 
17 BAI2, C15ORF29, C3ORF34, 
C8ORF41, CACNA2D2, DNAL1, 
DPH5, HOOK3, KLHL20, NBPF3, 
NSL1, PAPOLA, PJA2, 
SLC25A1,TUBE1, ZNF589 
 
16 16 Cellular Development, 
Cellular Growth and 
Proliferation, Reproductive 
System Development and 
Function 
 
18 AK3, C3ORF58, COMMD10, DDAH2, 
ELOVL3, ETNK1, GAA, KIAA1949, 
MGRN1,MYPN, NEU1, TMSB4Y, 
TMX1,TRAPPC2,YKT6 
 
15 15 Cellular Assembly and 
Organization, Cellular 
Compromise, Hair and 
Skin Development and 
Function 
 
19 ANKIB1, ANKRD27, C19ORF12,  
DEPDC1, FAM35A (includes 
EG:54537), FMO2, GNPDA2, 
LIMCH1, LRRC58, PLP2, RBM47, 
SLC16A9, SLC22A5, SLC30A9, UST 
 
15 15 
 
Gene Expression, Drug 
Metabolism, Genetic 
Disorder 
 
20 AGMAT, BCORL1, CLASP2, CMTM4, 
ELOVL7, GPR124, INSIG2, KANK4, 
MSL2,  PKP4, PRTFDC1, RBPMS2, 
SLC10A3, TDRD6, VAT1 
 
15 15 Cell-To-Cell Signaling and 
Interaction, Cellular 
Assembly and 
Organization, Lipid 
Metabolism 
 
21 ABAT, ANKRD57, AVIL, C9ORF86, 
CHN1 (includes EG:1123), CHST1, 
FEZ2, GAN, IGSF5, RAB35, 
RAB11FIP4, SNX7, STRBP, TBRG1 
 
14 14 Cell Morphology, Cellular 
Development, Cancer 
 
22  ADAMDEC1, C9ORF72, DNAJB7, 
FAM49B, IFIT5, KBTBD8, METTL9 
(includes EG:51108), MTAP (includes 
EG:4507), PHF3, RIMBP2, RORB, 
SHOX2, SLITRK2, UPP2 
 
14 14 Drug Metabolism, Lipid 
Metabolism, Small 
Molecule Biochemistry 
 
23 ACSL4, ARF6, CS, ERLIN1, ETF1, 
GXYLT1, NPEPPS, PLSCR4, 
PPARGC1A, SFRS6, SRPRB, TRAF6, 
TRDMT1, WWC2 
 
 
14 14 RNA Post-Transcriptional 
Modification, Carbohydrate 
Metabolism, Nucleic Acid 
Metabolism 
 
24 ADK, C1ORF25, IMPACT, IPO9, 
LFNG, LMNB2, MOBKL1A, MYO9A, 
PRKRA, RASSF8, 
SIRPB1,SLC25A19,TNRC6B, ZFP30 
 
13 14 Protein Synthesis, Energy 
Production, Molecular 
Transport 
 
25 C6ORF97, CASC4, N6AMT1,SEC23IP, 
SLC19A3, SLC35A3, SLC38A4, 
TDRKH, TMEM216, TRMT12, 
ZNF253, ZNF577, ZNF614 
12 13 Gene Expression, 
Endocrine System 
Disorders, Genetic 
Disorder 
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Table 7: Molecular networks involved by target genes of selected miRNAs enriched in 
cumulus cells 
 
ID Molecule in network Score Focus 
molecules 
Top function 
 
1 
 
 
BECN1,  CAPN9, CASD1, CNP,  
CORO2B, DR1,  FUBP1, GABPA, GDE1, 
IGF2, LAMC1,  LIFR, LIMS1, MLL2, 
PNN, PPP1CB, PPP1R2, PPP1R10, 
PPP1R3D, PTPN21, RAB31, RASGRP1, 
RELN,TLX1, ZEB1 
 
 
46 
 
25 
 
 
 
 
 
 
Cancer, Reproductive 
System Disease, Skeletal 
and Muscular System 
Development and 
Function 
2 ACVR1B,  ANGPT2,   INPP5D, IRS2, 
LCP2, LIG4, MYBL1,  NKIRAS1,  
PGM2L1,  PKN2, PSAP, PTGER2, PTPRJ,  
RPS6KA3, RUNX3, SIPA1L1, SMAD2,  
SNAI2, SYNGAP1,  VEGFA 
 
29 20 Tissue Morphology, Cell 
Signaling, Cardiovascular 
System Development and 
Function 
 
3 AKAP5, CACNA1C,  DYRK1A, ELK4, 
ELOVL5,   PRKAR2B, PRKD3, RAB3B, 
RAD18, RGS13, SERTAD2, SF3B1, 
SHPRH, SLC6A1, SPRED2, VBP1 
 
24 16 Gene Expression, 
Immunological Disease, 
Connective Tissue 
Development and 
Function 
 
4 C18ORF45,  COL23A1,  EXOSC3,  
FAM76B,  GGNBP2, HIATL1, KCMF1, 
NR1D2, PAN3,  RUNX1T1, SLC8A3, 
TMEM165, YIPF4, YTHDC1,  ZNF692 
 
23 15 Cell Death, Cellular 
Development, 
Reproductive System 
Disease 
 
5 ALG2, CASC1, CHN1 (includes EG:1123),  
DSG1, DSG3, EFNA3, FAM73B, 
GOLPH3,  IRF8,  NPHP1,  POU2AF1, 
PPA2, RPA1,  SERPINB9,  VAMP7 
 
23 15 Genetic Disorder, 
Ophthalmic Disease, 
Cellular Development 
6 AGL, AIFM3,  ARHGEF10,  CNTN3, , 
ENOX2, IPO5, NECAB1,  PAPD5, PHF6, 
RAB27B,  RNF111, SEMA5B,  SLC17A8,  
SLC7A11,  SOX7 
 
23 15 Amino Acid Metabolism, 
Small Molecule 
Biochemistry, Molecular 
Transport 
 
7 AKAP2, ARMC10, ATIC,  DACT1, 
DNAH5,  ELOVL6, ERC2,  KLF12,  
NPEPPS,  PLCB4,  RRP15, SLC4A11, 
SNRK,  USH2A 
 
21 14 Cell Death, Lymphoid 
Tissue Structure and 
Development, 
Cardiovascular System 
Development and 
Function 
 
8   ALDH5A1, ANAPC4, ECM2, ELAVL2, 
FCHSD2,  GGPS1,  HNMT,  NOC3L,  
PGM2L1,  TTC13, XYLT1, ZDHHC21, 
ZNF532 
 
19 13 Cellular Development, 
Cellular Growth and 
Proliferation, Connective 
Tissue Development and 
Function 
 
9 BICD2, C1ORF212,  ISCU, LUC7L2,  
NAP1L5,  NDUFA4,  NFIC,  RYK, SDF2, 
SERP1, TNPO3,  ZFR, ZNF292 
 
 
 
19 
 
 
13 
Cell-To-Cell Signaling 
and Interaction, Cellular 
Assembly and 
Organization, Cellular 
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Function and 
Maintenance 
 
10  APBA3,  CIAPIN1, CYGB, DLX1,  E2F3, 
FGFRL1, IMMP2L,  MED20, MYOM1, 
PANX3,  RCAN2,  WDR35 (includes 
EG:57539) 
 
17 12 Gene Expression, Cell 
Death, Cancer 
11 DIMT1L, GPRIN3,  LXN, METTL13,  
MKLN1, RPL22, SLC6A15, SSX2,  
ZNF462, ZNF526, ZNF644 
 
15 11 Cell-To-Cell Signaling 
and Interaction, Cancer, 
Cellular Development 
 
12 ADD3,  CCKBR,  HMGCS1,  KCNH5, 
LAPTM5, MFN1,  REPS2,  SH3BGRL,  
TMEM55A,  TOPORS,  ZNF140 
 
15 11 Cellular Assembly and 
Organization, Cell 
Morphology, Lipid 
Metabolism 
13 ANKRD17, BAZ2B, C12ORF5,  GEMIN8, 
H2AFY, NUFIP1, PER3,  SCARA3,  
SNX18, TMED7 
13 10 Cell Cycle, Cancer, 
Cellular Compromise 
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Moreover, genes targeted by miRNAs enriched in oocytes were found to be involved in 
eleven significant pathways including the GnRH, cell cycle, G-protein coupled receptor 
signaling pathway, apoptosis signaling pathway (Figure 4.3A). Similarly, the genes 
targeted by miRNA enriched in cumulus cells were found to be involved in seven 
different key molecular pathways including CDK5 signaling pathway, insulin receptor 
signaling and protein kinase A signaling pathway (Figure 4.3B).  
 
 
Figure 4.3: The most significant canonical pathway involved by genes targeted of 
miRNAs enriched in oocytes (A) and miRNAs enriched in cumulus cells (B). The bars 
represent the p-value for each pathway. The orange irregular line is a graph of the ratio 
of genes from the data set to the total number of genes involved in the pathway for the 
different pathways 
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Due to large number of target genes, we systematically selected one gene for each 
selected miRNA and the sequence complementarities between seed region of selected 
miRNAs and the 3'-UTR of target genes is indicated in figure 4.4. The further 
characterization of target genes was done only for these genes in the following sections. 
 
 
 
Figure 4.4: Sequence complementarities between selected miRNAs and their 
target mRNA 3'-UTR 
 
4.6 Co-expression study of selected miRNAs and target genes in early developmental 
stages 
 
To evaluate whether the expression of the selected miRNAs will be retained or 
degraded during the early embryo formation, the expression patterns of these miRNAs 
were then analyzed in matured oocyte and different stages of preimplantation embryo 
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(zygotes, 2-cell, 4-cell, 8-cell, morula and blastocyst). The results have shown that the 
expression of all oocyte enriched miRNAs were highly abundant in early stages of 
development up to 4-cell embryo, followed by dramatic reduction in expression from 8-
cells until the blastocyst stage. Similarly, two miRNAs (miR-452 and miR-210) 
enriched in cumulus were selected based on their expression pattern and their 
expression profile was analyzed in different stages of preimplantation embryo 
development. Unlike those enriched in oocytes, these miRNAs showed no defined 
pattern of expression throughout the developmental stages and could be detected at 
relatively lower level in all stages of development (Figure 4.5). 
 
After selecting the targets genes using four different target search tools based on their 
score and their prediction at least in two or more target search tools, the expression 
profiling of one target gene for each selected miRNA, based on sequence 
complementarities, were analyzed in matured oocyte and different stages of 
preimplantation embryo. The results have shown that three genes, namely PLCB1, 
ITPR1 and IRAK1 showed a reversed expression profile compared to the profile 
observed by their targeting miRNAs (miR-205, miR-96 and miR-146a), respectively 
(Figure 4.5). However, CALML4 and TRAF6 transcripts showed a similar expression 
profile to their targeting miRNAs, namely miR-150 and miR-146b-5p (Figure 4.5). On 
the other hand, the relative abundance of CCNG1 which is the target of miR-122 was 
detectable until later stages of development irrespective of the expression of the 
targeting miRNA. As it is the case for targeting miRNAs (miR-210 and miR-452), the 
target genes PANX3 and EIF4G3, were showed no clear trend in expression profile 
throughout the preimplantation period (Figure 4.5). 
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Figure 4.5: Relative abundance of miRNAs enriched in oocyte (miR-205, 150, 96, 122, 
146a and 146b-5p), miRNAs enriched in cumulus cells (miR-210 and miR-452) and 
their target genes in bovine matured oocyte (mo) and preimplantation embryo stages 
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4.7 Expression of selected miRNAs in cumulus oocyte complexes of varying 
competence  
 
The brilliant cresyl blue (BCB) staining was used to differentiate fully grown (BCB+) 
and growing (BCB-) oocytes based on the level of G6PDH activity. All studied 
miRNAs are found to be abundant at higher level (p ≤ 0.05) in fully grown (BCB+) 
oocytes compared to their growing (BCB-) counterparts (Figure 4.6A). Specially, miR-
150, miR-122 and miR-146b-5p have shown a remarkable difference in their relative 
abundance between BCB+ and BCB- oocytes. However, except miR-96, miR-122, 
miR-146a and miR-452 none of the selected miRNAs showed significant difference in 
their expression between cumulus cells derived from BCB+ and BCB- COCs (Figure 
4.6B). 
 
 
 
Figure 4.6: The relative abundance of selected miRNAs in oocytes (A) and cumulus 
cells (B) derived from bovine COCs screened by brilliant cresyl blue staining as 
growing (BCB-) and fully grown (BCB+) oocytes. The fold change in transcript 
abundance was calculated taking the oocytes and cumulus cells from the BCB- group as 
calibrator and their expression level set as one following normalization by endogenous 
Results                          87 
control U6 RNA. Significant differences (p ≤ 0.05) between oocytes (BCB+ and BCB-) 
and cumulus cells (from BCB+ and BCB- COCs) in the relative abundance of specific 
miRNAs are indicated by star (*) 
 
4.8 Effect of oocyte and cumulus cell factors for the expression of miRNAs 
 
In order to elucidate whether the oocyte (as source of oocyte-secreted factors) is 
required for the expression of miRNAs in the surrounding cumulus cells and the vice 
versa, comparative analysis of oocytes matured with or without cumulus cells and 
cumulus cells matured with or without the oocyte cytoplasm were performed using the 
eight miRNAs. As shown in figure 4.7, the relative abundance of the majority of 
miRNAs was found to be higher (p ≤ 0.05) in oocytes matured without the surrounding 
cumulus cells except for miR-96. On the other hand, a 16-fold increase in the relative 
abundance of miR-210 was observed in cumulus cells matured without the oocyte 
cytoplasm compared to those matured in the presence of oocyte cytoplasm. However, 
no significant differences were found in the relative abundance of miR-452 in these 
experimental groups. 
 
Figure 4.7: Relative expression level of miRNAs in oocytes matured with (OO+CC) or 
without (OO-CC) the surrounding cumulus cells and in cumulus cells matured with 
(CC+OO) or without (CC-OO) the oocyte cytoplasm. Samples with the highest 
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normalized value were used as a calibrator. Statistical significance (p ≤ 0.05) between 
oocytes or cumulus cells is indicated by star (*) 
 
4.9 Spatio-temporal distribution of miR-205 and miR-210 in ovarian sections, cumulus 
oocyte complexes and early preimplantation embryonic stages 
 
In situ hybridization was performed to examine the cell type distribution of miR-205 
and miR-210 enriched in oocyte and cumulus cells, respectively in section of bovine 
follicles (primary, secondary, early antral and tertiary follicles). A strong fluorescence 
signal of miR-205 was detected in the oocyte cytoplasm compared to the surrounding 
cumulus cells and other ovarian cells during the later stages of follicular development 
namely: early antral and tertiary follicles (Figure 4.8.1B, 1A). However, the expression 
level of miR-205 was not detectable in the oocyte cytoplasm at primary and secondary 
follicles (Figure 4.8.1C, 1D). On the other hand, miR-210 was found to be highly 
abundant in cumulus and granulosa cells compared to the oocyte cytoplasm in all stages 
of follicular development. Differences in miR-210 signal intensity between oocyte and 
surrounding cells was clear at the later stages of follicular development (early antral and 
tertiary follicles). Moreover, miR-210 was found to be localized in a single layer of 
cumulus cells of primary follicles (Figure 4.8.2D) and in multiple layers of cumulus 
cells in secondary, early antral and tertiary follicles (Figure 4.8.2C, B, A). While the 
oocyte cytoplasm in the primary follicle showed no miR-210 expression (Figure 
4.8.2D), slight signals were detected in oocyte cytoplasm of the secondary, early antral 
and tertiary follicle stages (Figure 4.8.2C, B, A). The nuclear U6 RNA which was used 
as positive control in this study was detected in all follicular sections being localized in 
the nucleus (Figure 4.8.3A, B).  
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Figure 4.8: In situ detection of miR-205 and 210 in bovine follicular cryo-sections. 
Ovarian follicular cryo-sections were in situ hybridized with 3'-digoxigenin labeled 
locked nucleic acid (LNA) microRNA probes of miR-205 (1), miR-210 (2), U6 RNA 
(3) and scrambled miRNA (4). Cells with higher expression are marked by arrows. A, 
B, C and D represent tertiary, early antral, secondary and primary follicle, respectively 
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Cumulus oocyte complexes and in vitro produced bovine post fertilization 
developmental stages (zygote, 2-cell, 4-cell, 8-cell and blastocyst) were used to 
investigate the cellular distribution of these miRNAs in early stages of embryo 
development. Both 2- and 3-dimensional presentations showed that miR-205 was 
detected in oocytes and all stages of development with a reduced signal between 8-cell 
and blastocyst stages compared to the signal detected at oocyte, zygote, 2-cell and 4-cell 
stages (Figure 4.9). However, miR-210 is detected in cumulus cells of the COC and at 
all stages of development but without noticeable difference in signal intensity between 
the developmental stages. 
 
 
Figure 4.9: In situ detection of miR-205 and 210 in whole mount cumulus oocyte 
complexes and preimplantation embryo stages. Whole mount COCs and bovine 
preimplantation embryo stages were in situ hybridized with 3'-digoxigenin labeled 
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locked nucleic acid (LNA) microRNA probes of miR-205, miR-210 and scrambled 
miRNA. Hybridization signal and nucleus of the COCs and embryos were visualized by 
Fast Red (Cy-3) and DAPI, respectively. Images from at least 20 different layers or 
positions (Z positions) of single embryo were used to construct 3 dimensional (3D) 
image, where and 2 dimensional (2D) images represented here from only one position. 
Scale bar denotes 50 µm 
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5 Discussion  
 
5.1 Identification of miRNAs expressed in oocyte and their surrounding cumulus cells 
before and after in vitro maturation 
 
Mammalian oocytes, cumulus cells and other follicular cells are known to have distinct 
transcript profile and efforts are being made to correlate this profile or the expression of 
specific marker genes with oocyte developmental competence (Hamel et al. 2008; 
Ouandaogo et al. 2011; Robert et al. 2001). Recent study showed large scale of gene 
expression in oocyte and their companion CCs at germinal vesicle and metaphase II 
stages (Regassa et al. 2011). Furthermore, a distinct set of proteins were found by 
comparative analysis of bovine germinal vesicle oocytes and their surrounding cumulus 
cells (Memili et al. 2007; Peddinti et al. 2010). However, the identities and the role of 
post-transcriptional regulator miRNAs in bovine cumulus oocyte complex are poorly 
understood. MicroRNAs are reported to regulate the activity of about 30% of the 
protien coding genes in human (Lewis et al. 2005). As most microRNA sequences are 
conserved across related animal species (Griffiths-Jones et al. 2006; Niwa and Slack 
2007) and due to the similarity in oocyte biology and many aspects of ovarian follicular 
dynamics between human and bovine species (Biggers et al. 1967; Buccione et al. 
1990).  In the present study we have used a human cell development and differentiation 
miRNA PCR array to compare the miRNA expression profile of oocytes and cumulus 
cells at GV and MII stages and distinct set of miRNAs were identified being enriched 
either in oocytes or cumulus cells, and from this set eight miRNAs were selected for 
future characterization. The result showed that oocytes at both GV and MII stages were 
enriched with large number of miRNAs under investigation compared to their 
surrounding cumulus cells. On the contrary recent studies showed higher level of 
protien expression in cumulus cell compared to GV oocyte (Memili et al. 2007; Peddinti 
et al. 2010). Study of the dynamic nature miRNAs expression in oocytes or cumulus 
cells before and after maturation revealed that miRNAs accumulation increases with 
maturation in vitro. This is in agreement with the dynamic pattern of miRNA expression 
in mouse oocytes during oogenesis, where many miRNAs have been detected in the 
matured dicer+ oocyte (Tang et al. 2007). 
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MicroRNAs are known to be expressed in developmental time and tissue specific 
manner (Plasterk 2006). The data in the present study and also by Tesfaye et al. (2009) 
showed that bovine oocyte maturation involves a wave of expression of miRNAs in 
oocytes and cumulus cells with distinct cell specific. The overall dynamics of miRNA 
expression during bovine oocyte maturation found in this study is different from the 
global mRNA transcript pattern between GV and MII in bovine and human oocytes 
reported by other studies (Assou et al. 2006; Fair et al. 2007; Mamo et al. 2011). This 
may suggest the potential role of those miRNA in regulation of transcripts and protein 
storage turnover through acceleration of deadenylation and decay of maternal mRNA 
(Giraldez et al. 2006).  
 
5.2 Expression profile of selected miRNAs and their targets in preimplantation embryo 
and localization of two selected miRNAs  
 
The embryonic genome has almost no impact on the earliest steps of the developmental 
program and the early mammalian embryo development is dependent on the maternal 
stores of mRNA and protein before the activation of embryonic genome. The transition 
from maternal-to-zygotic regulation is the first major change, which occurs after 
fertilization and comprises a dramatic reprogramming of gene expression that is 
essential for the development of most organisms. As mRNA, microRNAs play essential 
roles in gene regulation during early development (Castro et al. 2010; Choi et al. 2007; 
Giraldez et al. 2006; Martello et al. 2007). The miRNAs suppress translation in a 
sequence-specific manner and facilitate shifts in gene expression during developmental 
transitions, involvement of regulatory maternal miRNAs in maternal-zygotic transition 
was evidenced in mouse (Murchison et al. 2007; Tang et al. 2007), zebrafish (Giraldez 
et al. 2006), xenopus laevis and drosophila (Iovino et al. 2009; Lund et al. 2009). In the 
present study, the expression profiling of selected miRNAs in early stages of bovine 
preimplantation embryo showed various pattern of expression. Especially miRNAs 
enriched in oocytes showed a typical maternal expression profile in which expression 
was higher at earlier stages of development and drastically reduced between 8-cells and 
blastocyst stages (Figure 4.5). This is an additional evidence for dependence of early 
bovine embryo development on maternally inherited miRNAs, which are known to 
regulate the degradation of maternal mRNA or protein as observed in mouse and bovine 
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embryos (Lykke-Andersen et al. 2008; Tripurani et al. 2011), until the major activation 
bovine embryonic genome at 8-16 cell stage (Barnes and First 1991; Memili and First 
1999; Telford et al. 1990). In addition, the same expression trend has been revealed in 
recent study where miR-424 and miR-10b are higher in GV and MII oocyte stage and 
early embryo until maternal-zygotic transition, but tend to decreased at morula and 
blastocyte stage (Tripurani et al. 2010a). Similarly, miR-196a in bovine which increased 
near eight cell stage and declines at morula and blastocyte stages of embryogenesis 
(Tripurani et al. 2011). 
 
The predicted targets of selected miRNAs are reported to be involved in various 
biological process and molecular pathway which are vital for oocyte maturation. The 
GnRH signaling and G-protien coupled receptor signaling are dominant pathways for 
oocyte enriched miRNA targets (Figure 4.3A). The GnRH signaling controls 
biosynthesis and release of luteinizing hormone (LH) and follicle-stimulating hormone 
(FSH) that in turn regulate development and activity of the ovaries (Jeong and Kaiser 
2006). Gonadotropin-releasing hormone acts via G-protein coupled receptors (Gq/G11) 
lead to activation of phospholipase C (PLC, apparently PLC β1) which hydrolyzed 
phosphatidylinositol 1,4,5 bisphosphat (PIP2) to inostiol 1,4,5 triphosphate (IP3) and 
diacylglycerol (DAG). IP3 bind to receptors in the endoplasmic reticulum to release 
Ca2+ transiently from these intracellular stores and this elicits a rapid spike of LH 
release. Also, DAG activates protien kinase Cs (PKCs) that phosphorylate protien 
involved in the more sustained release of LH and gonadotrophin biogenesis (Kraus et al. 
2001; McArdle et al. 2002; Millar 2006). 
   
Comparative analysis of differentially expressed miRNAs and their predicted target 
genes during preimplantation embryo development revealed a reciprocal expression 
pattern for miR-205 and PLCB1 transcript, miR-96 and ITPR1 transcript, miR-146a and 
IRAK1 transcripts (Figure 4.5). This may show the possible mRNA degrading mode-of-
action of the miRNAs in the post transcriptional regulation of the corresponding target 
genes. The PLCB1 gene is important element of the phosphoinostide pathway this 
pathway act principally by generating the release calcium. The nuclear phosphoinositide 
cycle in mouse oocytes seems to be essentially regulated by the PLCB1 isoform, 
microinjected into the GV, the anti-PLCB1 induced an inhibition of both nuclear and 
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cytoplasmic Ca2+ oscillations and meiosis resumption (Avazeri et al. 2000; Avazeri and 
Lefevre 1998). The functional role of ITPR1 (Target of miR-96) in operating Ca2+ 
release in oocytes at fertilization has been demonstrated in the golden hamster, mouse 
and frogs (Miyazaki et al. 1992; Runft et al. 1999; Xu et al. 1994). In human oocytes, 
the type I InsP3R are prominently expressed in oocytes, zygotes and embryos and are 
dynamically redistributed through maturation, fertilization and early embryogenesis 
(Goud et al. 1999). In addition, the expression of CCNG1 gene which may play role as a 
positive modulator of cell cycle in ovarian follicular development and oocyte 
maturation (Liu et al. 2006) remained constant throughout the developmental stages 
irrespective of the expression profile of its targeting miR-122. Similarly, miRNAs 
enriched in cumulus cells (miR-452 and miR-210) and their corresponding predicted 
target mRNA transcripts showed similar expression pattern in which all are detected in 
a relatively lower level in all stages of development without any defined profile.  
 
The data of the present study in the relationship between the expression profile of  
selected  miRNAs and their targets showed various scenario, this different relationship 
in expression profile of miRNA and target mRNA reflects the existing challenge in 
target identification because of varying outcome of binding of miRNAs to their target 
genes which might not result in alternation of target gene expression level (Brennecke et 
al. 2005; Grimson et al. 2007). Rather, the interaction may be induced translational 
repression which appears to be cap and poly A-tail dependent during initiation step 
(Humphreys et al. 2005; Pillai et al. 2005). Localization of miR-205 and miR-210 in 
early stages of bovine preimplantation embryos has validated the expression profile 
obtained by quantitative real time PCR and suggests the potential involvement of these 
miRNAs in early embryogenesis.                            
 
5.3 Expression analysis of selected miRNAs in growing and fully grown oocytes 
 
The quality of oocytes or developmental competence plays an important role in a proper 
embryo development, it is acquired during folliculogenesis as the oocyte grows and 
during the period of oocyte maturation (Mermillod et al. 1999). Several morphological, 
cellular and molecular criteria have been proposed to evaluate oocyte quality or 
competence (Wang and Sun 2007). Morphological evaluation is usually applied to the 
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whole COC, whereas compact, continuous multilayer cumulus investment and bright, 
homogeneous ooplasm are considered as a sign of immature oocyte quality (Blondin 
and Sirard 1995). Molecular markers of oocyte quality could also be identified in 
cumulus cells or in follicular fluid. For instance, the rate of apoptosis in bovine cumulus 
cells before (Feng et al. 2007; Zeuner et al. 2003) or during in vito maturation (Ikeda et 
al. 2003) and several potential cumulus cell genes (HAS2, TNFAIP6,PTGS2 , GREM1, 
INHBA, BTC, CD44 and EGFR) identified as marker for human and bovine oocyte 
competence (Assidi et al. 2008; McKenzie et al. 2004; Caixeta et al., 2009). Brilliant 
cresyl blue (BCB) staining has been proposed as an easy and vital way to evaluate 
glucose 6-phosphate dehydrogenase (G6PDH) activity in oocytes (Alm et al. 2005),  
where, there is negative correlation between G6PDH activity level and oocyte quality. 
Moreover, BCB staining before IVM did not affect IVP and this making BCB staining 
method an appropriate way to evaluate oocyte quality. The gene expression profiles of 
fully growing (competent) oocytes (BCB+) were markedly different from those of 
growing (non competent) ones (BCB−) and this associated the characteristic process in 
each one where in BCB+ oocytes, the majority of expressed genes are associated with 
regulation of the cell cycle, transcription and translation, while BCB− oocytes encoded 
genes controlling ATP synthesis mitochondrial electron transport and calcium ion 
binding (Torner et al. 2008). A range of miRNA regulated proteins were identified 
during oocyte maturation or growth in Drosophila (Nakahara et al., 2005) and mouse 
(Tang et al. 2007). Similarly, we have confirmed the differential expression of miRNAs 
during oocyte growth by investigating the expression of selected miRNAs in growing 
(BCB-) and fully grown (BCB+) oocytes. Almost all selected miRNAs were found to 
increase in their abundance in fully grown oocytes compared to their growing 
counterparts. During oocyte growth, the synthesis of RNA is increased and reaches a 
peak at the beginning of follicular antrum formation (Moor et al. 1998; Wassarman and 
Kinloch 1992). So this may be explain the trend of miRNA in growing and fully 
growing oocyte where at growing stage the oocyte synthesis and accumulate mRNA 
and protein for future using during development. This trend was further validated by the 
increasing intensity of miR-205 signal in oocyte cytoplasm during their growth from 
primary follicle to tertiary follicle (Figure 4.8). However, except miR-96, miR-122, 
miR-146a and miR-452 the expression of selected miRNAs in cumulus cells derived 
from BCB+ and BCB- COCs showed no significant difference.  
 Discussion 97 
5.4 Relative expression level of selected miRNAs in presence or absence of oocyte or 
cumulus cell after maturation 
 
While paracrine growth factors secreted by oocytes are involved in expansion of 
cumulus cells number and function, regulation of follicular cell function and pre- and 
post-ovulatory events (Gilchrist et al. 2001), the cumulus cell support oocyte metabolic 
processes such as glycolysis and amino acid uptake and regulate meiotic progression 
(Buccione et al. 1990; Tanghe et al. 2002). So far limited number of oocyte secreted 
factors (OSFs), are known to regulate cumulus and granulosa cell function. These 
include GDF9 and BMP15 which have a profound effect on the expression of genes in 
cumulus cells and enhance oocyte developmental competence (Hussein et al. 2006). 
Moreover, the presence or absence of oocyte and cumulus cells factors during bovine 
oocyte maturation led to transcriptome profile changes in both cell types (Regassa et al. 
2011). Similarly, in the present study the presence of cumulus cells during oocyte 
maturation and vice versa was found to be important in the regulation of miRNAs 
expression in either of the two cell types, except for cumulus enriched miRNAs, all 
oocyte enriched miRNAs were found to be up-regulated in the absence of the 
surrounding cumulus cells during maturation. According to the fact that removal of 
cumulus cells at the beginning of in vitro oocyte maturation or shortly before 
fertilization resulted in detrimental effect on oocyte maturation, fertilization and 
subsequent development (Fatehi et al. 2002; Hussein et al. 2006; Zhang et al. 1995) and 
based on our results, we suggest that these miRNAs may involve in the regulation of 
genes associated with impaired nuclear maturation of oocytes due to absence of 
cumulus cell factors. On the other hand, Hussein et al. (2005) showed that removal of 
oocyte from cumulus oocyte complex led to increased  the cumulus cell apoptosis 
compared with COC and the level of apoptosis in cumulus cells without oocyte was 
reversed when co-culture with oocyte. Interestingly in the present study, the absence of 
oocyte factors due to removal of oocyte from COC led to increase the expression of 
miR-210 in cumulus cells compared to those matured with oocyte cytoplasm. This is in 
agreement with the inhibitor effect of some miRNAs to the apoptosis, and miR-210 is 
one of these miRNA which decrease production of pro-apoptotic caspases (Wang and 
Lee 2009: Sirotkin et al. 2010). The summarized hypothesis in figure 5.1 on 
dependency of the two cell types to each other for miRNA expression needs further 
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investigation in order to identify the specific oocyte or cumulus cells factors and the 
mode of transcriptional regulation of the miRNAs. 
 
 
 Figure 5.1: Hypothetical illustration depicting the dependency of bovine oocyte and 
cumulus cells in the relative abundance of miRNAs transcribed from their genome on 
the presence or absence of cumulus cell factor (CSF) and oocyte secreting factor (OSF), 
respectively. Green arrows indicate reduced level of miRNA expression. The inward 
and outward blue arrows indicate the effect of CSF and OSF on oocyte and cumulus cell 
development, respectively 
 
5.5 Localization of miR-205 and miR-210 in ovarian sections 
 
Mammalian folliculogenesis is a complex process through which primordial follicles 
develop into preovulatory follicles. During this time, oocyte increase in size 
accompanied by the proliferation and differentiation of their surrounding granulosa and 
theca cells. For this, spatio-temporal expressions of hundreds of genes have been shown 
to be essential (Matzuk et al. 2002; Roy and Matzuk 2006). The role of miRNAs have 
been evidenced in the ovaries through impaired function of corpus luteum and infertility 
in Dicer knockout mice (Otsuka et al. 2008). As observed by the genes, the results in the 
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present study have evidenced the spatio-temporal expression of miRNAs during bovine 
follicular development. Differences in the signal intensity in localization of miR-205 
and miR-210 were found between oocytes and surrounding cumulus cells as early as the 
primary follicles stage and persist until the matured follicle. So, the miRNA may have 
importance in regulating genes involved in follicular development. In agreement with 
other study showed that blocking of miRNA as (miR-21) through ovarian bursal 
injection with a blocking LNA-21, led to decrease in the ovulation rate (Carletti et al. 
2010). Similarly, the effect targeted deletion of Dicer (the miRNA processing key 
proteins) on ovulation rate (Hong et al. 2008; Nagaraja et al. 2008).  As miR-210, which 
its signal intensity was higher in cumulus and granulosa cells in all stages of follicular 
development. Recent study revealed that the levels of miR-210 decreased in 64% of 
ovarian carcinomas and the authors suggested that this miRNA have tumor suppressive 
function (Dahiya and Morin 2010). However, the exact role of these non coding RNAs 
during bovine follicular development needs to be the focus of future research.  
 
In conclusion, to the best of our knowledge, here we reported for the first time the 
classes of miRNA enriched in bovine oocytes or the surrounding cumulus cells during 
oocyte maturation which is a step forward in identifying miRNAs required for oocyte-
cumulus communication. Moreover, we have also evidenced the dynamic degradation 
of miRNAs during oocyte maturation and interdependency of oocyte and cumulus cell 
on the activity of the miRNAs. Furthermore, the potential role of maternal miRNAs in 
early bovine embryo development could be depicted from their expression dynamics 
during preimplantation stage period. However, further functional studies on those 
differentially expressed miRNAs is required to understand the key role of miRNAs 
during oocyte maturation and their subsequent role during early embryonic 
development. 
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6. Summary 
 
MicroRNAs are post transcriptional regulator that influence expression of hundreds of 
genes in numerous biological processes including development. The present study was 
preformed to identify the presence and expression of miRNAs in oocyte and their 
surrounding cumulus cells during maturation where the bidirectional communication 
between both cell types is important during oocyte maturation for the acquisition of 
developmental competence and subsequent embryonic and fetal development. For this, 
a total of three replicate pools each containing 1600 oocytes and the corresponding 
cumulus cells from both immature and matured COCs were used for total RNA 
isolation using miRNeasy® Mini kit. The isolated total RNA was fractionated into small 
and large RNA using RT2 qPCR-Grade miRNA isolation kit. From each oocyte and 
cumulus cell groups, 50 ng of small RNA was used for reverse transcription using RT2 
miRNA first strand kit. The resulting cDNA from small RNA was used as template to 
profile 88 human miRNAs related to cell development and differentiation using RT 
profiler PCR array. The data was analyzed using comparative threshold cycle (Ct) 
method after normalization with endogenous control RNAs (SNORD44, SNORD47, 
SNORD48 and U6). The result of PCR array revealed that a total of 47 and 51 miRNAs 
to be highly abundant in immature and matured oocyte, respectively compared to their 
corresponding cumulus cells, while 8 and 6 miRNAs were enriched in cumulus cells 
compared to immature and matured oocytes, respectively. Based on expression 
intensity, six oocyte enriched miRNAs (miR-205, miR-150, miR-96, miR-122, miR-
146a and miR-146b-5p) and two cumulus cell enriched miRNAs (miR-452 and miR-
210) were selected for further characterization. These selected miRNAs were quantified 
during preimplantation embryo developmental stages (Zygote, 2-cell, 4-cell, 8-cell, 
morula and blastocyste) using quantitative real time PCR. The result revealed that all 
oocyte specific miRNAs were found to be highly abundant in early stages of embryo 
development and decreased after 8-cell until the blastocyst stage following a typical 
maternal transcript profile. Similar  expression pattern has been observed during in situ 
localization of one of selected miRNA (miR-205) using 3'-Digoxigenin (DIG) labeled, 
LNA-modified oligonucleotide ISH probes in preimplantation embryo stages, in which 
signals were higher until 4-cell stage and reduced between 8-cell and blastocyst. 
However, the expression of miR-210 and miR-452 showed no defined profile in 
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preimplantation embryo stages. To identify the predicted targets of eight selected 
miRNAs, we used in silico analysis based on four target prediction softwares and we 
found that 854 and 234 genes are predicted to be targets of selected miRNAs enriched 
in oocyte and cumulus cells, respectively. Furthermore, from these targets one gene for 
each miRNA was selected to further analysis in preimplantation embryo stages. Some 
targets as (PLCB1, ITPR1 and IRAK1) targets of (miR-205, miR-96 and miR-146a), 
respectively have been showed an opposite expression profile compared to the profile 
observed by their targeting miRNAs, while other target  genes such as CALML4 and 
TRAF6 transcripts showed a similar expression profile as their targeting miRNAs.  
 
The expression profile of the selected eight miRNAs was investigated in oocyte and 
cumulus cells from cumulus oocyte complexes of varying competence separated  based 
on brilliant cresyl blue (BCB) staining. Results showed that all studied miRNAs are 
found to be highly abundant (p ≤ 0.05) in fully grown (competent) oocytes (BCB+) 
compared to their growing (BCB-) (non competent) counterparts. Moreover, to reveal 
the effect of oocyte or cumulus cells factors on the expression of miRNA in both cell 
types during maturation, we used three different groups (cumulus oocyte complex 
matured as intact (COC), oocyte matured without cumulus cells (DO), and cumulus 
cells matured without oocyte (OOX)). The result of quantification showed that miR-
205, miR-150, miR-122, miR-146a, miR-146b-5p and miR-452 were found to be 
abundant at higher level (p ≤ 0.05) in oocyte matured without cumulus cells (DO) 
compared to those matured in the presence of cumulus cells (COC). On the other hand, 
the expression of miR-205, miR-150 and miR-122 in cumulus cell was higher in 
presence of oocyte cytoplasm during maturation, while 16 fold increases in relative 
abundance of miR-210 was observed in oocyteoctimized cumulus cells (OOX). Finally, 
in situ localization of miR-205 and miR-210 in ovarian follicle revealed a spatio-
temporal expression during follicular development and support the notion that miRNAs 
may have role during folliculogenesis. Collectively, these results demonstrated that 
bovine oocyte and cumulus cells have distinct set of miRNA, which may have role in 
the physiology of the two cell types and their communication to each other. However, 
the exact role of these miRNAs in oocyte maturation in particular and early embryonic 
development in general needs further investigation. 
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7. Zusammenfassung 
 
MicroRNAs sind post transkriptionelle Regulatoren, die die Expression von hunderten 
Genen beeinflussen, und an einer Vielzahl von biologischen Prozessen einschließlich 
der Entwicklung beteiligt sind. Die vorliegende Studie wurde durchgeführt, um die 
Präsenz sowie die Expression von miRNAs in Eizellen und ihren umliegenden 
Kumuluszellen während der Maturation zu untersuchen. Die bi-direktionelle 
Kommunikation zwischen den beiden Zelltypen ist endscheidend während der 
Eizellenreife für den Erwerb der Eentwicklungskompetenz und anschließenden 
embryonalen und fetalen Entwicklung. Dazu wurden insgesamt drei replizierte Pools 
von jeweils 1600 Eizellen und den ent-sprechenden Kumuluszellen separat von unreifen 
und reifen Kumuluseizellen-komplexen (COCs) verwendet, um miRNA mittels des 
miRNeasy® mini Kit  zu isolieren. Die isolierte totale RNA wurde mit Hilfe des RT² 
qPCR-Grade miRNA Isolationskits in kleine und große RNA unterteilt. Von jeder 
Gruppe von Eizellen und Kumuluszellen wurden 50ng small-RNA verwendet, um eine 
reverse Transkription mit dem RT² miRNA first strand Kit durchzuführen. Die daraus 
resultierenden cDNA von small-RNA wurde verwendet, um mit dem SYBER-green 
basierender real time PCR System Expressionsprofile von 88 humanen miRNAs zu 
erfassen. Diese humanen miRNAs sind relevant für die Zellentwicklung und -
differenzierung. Die Auswertung der Daten erfolgte, nach Normalisierung mit 
endogenen Kontroll-RNAs (SNORD44, SNORD47, SNORD48 und U6), auf Grundlage 
der komparativen Ct Methode. Das Ergebnis des PCR Arrays zeigte daß insgesamt 47 
bzw. 51 miRNAs unterschiedlich zwischen immaturen bzw. reifen Eizellen und ihren 
umgebenden Kumuluszellen exprimiert waren, während acht bzw. sechs miRNAs in 
Kumuluszellen von unreifen bzw. unreifen Eizellen angereichert waren. Basierend auf 
den Expressionsintensitäten von sechs in Eizellen (miR-205, -150, -122, -96, -146a und 
146b-5p) und zwei in Kumuluszellen angereicherten miRNAs (miR-452 und miR-210), 
wurden diese für eine weitere Charakterisierung in Präimplantationsstadien von 
Embryonen ausgewählt.  
 
Die ausgewählten miRNAs wurden während den Präimplantionsentwicklunsstadien der 
Embryonen (Zygote, 2-Zell-, 4-Zell-, 8-Zell-Stadien, Morula und Blastozyste) mit 
quantitativer real time PCR quantifiziert. Die Ergebnisse zeigten, dass alle eizellen-
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spezifischen-miRNAs in den frühen Stadien der Embryonalentwicklung deutlich erhöht 
exprimiert waren und nach dem 8-Zell-Stadium im expressionsuniveau sanken. Bis hin 
zum Blastozystenstadium folgten die embryonen den typischen maternalen 
Expressionsmustern. Vergleichbare Ergebnisse wurden bei der in situ Lokalisierung von 
miR-205 mit Hilfe von 3’Digoxigenin (DIG) gelabelten, LNA-modifizierten 
Oligonukleotide ISH Probes in Embryonen des Präimplantationsstadiums erzielt, bei 
denen das Signal bis zum 4-Zellstadium höher war und sich zwischen dem 8-Zell- und 
Blastozystenstadium reduzierte. Leider zeigten die ausgewählten miRNAs miR-210 und 
miR-452 kein definiertes Profil im Präimplantationsstadium von Embryonen.  
 
Um mögliche Zielgene dieser acht ausgewählten miRNAs zu identifizieren, wurden in 
silico Analysen mittels vier verschiedener Online-Platformen zur „Target-Prediction“ 
durchgeführt. So konnten 854 bzw. 234 Gene für die ausgewählten miRNAs 
vorhergesagt werden, die in Eizellen und Kumuluszellen exprimiert waren. Basierend 
auf diesen Analysen wurden Expressionsprofile von möglichen Zielgenen der miRNAs 
ermittelt. Diese zeigten, dass einige Zielgene (PLCB1, ITPR1 und IRAK1) ein reverses 
Expressionsprofil im Vergleich zu den beobachteten Profilen ihrer miRNAs (miR-205, 
miR-96 und miR-146a) aufwiesen, während andere Zielgene wie die Transkripte von 
CALML4 und TRAF6 ein vergleichbares Expressionsprofil wie ihre Ziel-miRNAs 
hatten.  
 
Die Genexpressionsanalyse von acht ausgewählten miRNAs wurde in noch wachsenden 
wie auch in ausgewachsenen Eizellen, die mittels Brillantkresylblau (BCB)-Färbung 
separiert wurden, sowie ihren umgebenden Kumuluszellen durchgeführt. Diese 
Untersuchung zeigte, dass alle ausgewählten miRNAs signifikant verschieden 
exprimiert waren (p ≤ 0.05), beim Vergleich von ausgewachsenen (kompetenten) 
Eizellen (BCB+) mit entsprechenden noch wachsenden (nicht kompetenten) Eizellen 
(BCB-). Um ferner den Effekt der Eizelle oder der Kumuluszelle an sich auf die 
Expression von miRNA in beiden Zelltypen während der Maturation aufzuzeigen, 
wurden drei verschiedene Gruppen (intakter Kumuluseizellenkomplex nach Reifung 
(COC), reife Eizellen ohne umliegenden Kumuluszellen (DO) und gereifte 
Kumuluszellen ohne Eizelle (OOX)) für weitere Untersuchungen verwendet. Die 
Ergebnisse der Quantifizierung zeigten, dass die miRNAs miR-205, miR-150, miR-122, 
Zusammenfassung 104 
miR-146a, miR-146b-5p und miR-452 in gereiften Eizellen ohne Kumuluszellen (DO) 
stark angereichert (p ≤ 0.05) waren verglichen mit gereiften Eizellen mit umliegenden 
Kumuluszellen (COC). Andererseits waren die Expressionen von miR-205, miR-150 
und miR-122 in Kumuluszellen höher in der Gegenwart von Eizellenzytoplasma, 
während eine 16-fache relative Anreicherung von miR-210 in Eizellen mit 
oocytesektomies Kumuluszellen (OOX) beobachtet werden konnte. Schließlich zeigte 
die in situ Lokalisierung von miR-205 und miR-210 eine raum-zeitliche Expression 
während der Follikelentwicklung und unterstützt die Annahme, dass miRNAs eine 
Rolle bei der Follikulogenese spielen. Insgesamt verdeutlichen diese Ergebnisse, dass 
bovine Eizellen und Kumuluszellen über eine ausgeprägte Gruppe an miRNA verfügen, 
die möglicherweise eine Rolle in der Physiologie der beiden Zelltypen sowie ihrer 
Kommunikation miteinander spielt. Jedoch sind weitere Untersuchungen notwendig, 
um die Bedeutung der miRNAs insbesondere in reifen Eizellen und in der frühen 
embryonalen Entwicklung tiefer zu klären. 
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